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 ABSTRACT 
 
 1 
1 ABSTRACT 
Innovative 96-well microplates equipped with optical oxygen sensors were applied for high 
throughput applications for mammalian cell culture. The oxygen uptake rates of the cells 
could be calculated from online monitoring of dissolved oxygen. The microplates were 
applied for process development using statistical experimental design with regard to medium 
optimization offering significant cost benefits and reducing the time generally required to 
carry out the process. With viability assay developed using the microplates, the toxicity of 
compounds could be tested in primary cells as well as adherent and suspension cells. The 
advantage of this assay over the presently available assays includes its kinetic nature and that 
the cells could be processed for further studies. 
The physiology of Chinese hamster ovary (CHO) cells was investigated by isotopic labeling 
studies. Cells were grown in parallel in multiple labeled carbon substrates. Based on the 
carbon isotope distribution in the metabolites, a model for the metabolism of pyruvate is 
proposed. There was evidence for the cytosolic compartmentation of pyruvate. The model 
proposes that this might be due to metabolic channeling occurring in glycolysis. Moreover, 
from the data, metabolism of glycine and serine was investigated. It is seen that the reverse 
glycine cleavage system and the glyoxylate cycle is active in CHO cells. Relative fluxes in the 
major metabolic pathways of CHO cells were estimated. 
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2 ZUSAMMENFASSUNG 
In der vorliegenden Arbeit wurden 96-well Mikrotiterplatten, ausgestattet mit optischen 
Sauerstoffsensoren, für die „high throughput“-Anwendung mit Säuger-Zellkulturen 
eingesetzt. Die Sauerstoff-Aufnahmeraten der Zellen konnten dabei durch online Messung des 
Gelöstsauerstoffs bestimmt werden. Die verwendeten Mikrotiterplatten wurden zur 
Mediumoptimierung mittels „statistical experimental design“ mit entsprechender Senkung 
von Kosten und Zeit eingesetzt. Außerdem konnte mit den Mikrotiterplatten die Toxizität von 
Substanzen für Primärzellen sowie für adhärent und in Suspension wachsenden Zellen durch 
Einsatz eines „viability assays“ bestimmt werden. Der hier angewendete Ansatz bietet 
gegenüber den bisher verfügbaren Tests den entscheidenden Vorteil, einer dynamischen 
Messung und dass die Zellen für weitere Studien verwendet werden können. 
Des Weiteren wurde die Physiologie von Chinese hamster ovary (CHO) Zellen durch 
13
C-
Markierungsstudien untersucht. Zellen wurden zu diesem Zweck auf Kohlenstoff-markierten 
Substraten kultiviert. Basierend auf der Kohlenstoffverteilung im Stoffwechsel wurde ein 
Modell für den Pyruvat-Metabolismus vorgeschlagen. Dabei ergaben sich Hinweise auf eine 
zytosolische Kompartimentierung von Pyruvat bedingt durch „Metabolic Channeling“ in der 
Glycolyse. Im Glycin/Serin-Stoffwechsel waren das „reverse Gylcin Cleavage System“ und 
der Glyoxylat-Weg in CHO-Zellen aktiv. 
 
 
 
 
 INTRODUCTION 
 
 3 
3 INTRODUCTION 
3.1 Objective 
 
The history of cell culture dates back to early twentieth century. However, it was only during 
the 1940’s and 1950’s that there was a rapid development in the techniques for cell culture. 
Mammalian cells are cells which are generally part of an organ of an organism, differentiated 
to perform specific functions. These cells can be extracted and be grown in vitro. Many of 
them survive but do not multiply in vitro. However, cells can acquire the ability to proliferate 
indefinitely either by random mutation or by genetic transformation. Many immortalized cell 
lines derived from various organs and organisms are now commercially available. The cell 
lines can either be adherent, i.e. requiring a support for growth or can grow in suspension.  
The Chinese hamster ovary (CHO) cell line was developed at the end of the 1950 (Puck et al., 
1958) and it is available both as an adherent and as a suspension cell line. These cells are 
routinely used in biological and medical research. However, the main usage of these cell lines 
has been in the production of proteins for therapeutic and diagnostic purposes. The main 
advantage of using these and other mammalian cell lines for production is their ability to 
produce proteins with the correct conformation and post-translational modifications. CHO 
cells are also routinely used for cytotoxicity testing (Hsie and Schenley, 1983). In this regard 
it is important to develop methods which can lead to process improvements such as 
development of high throughput methods for large scale handling of the cells. Moreover, it is 
also important to have a better understanding of the cellular metabolism. The development of 
high throughput methods with a better understanding of the cellular metabolism would result 
in superior industrial cell culture processes as well as knowledge of the effect various 
environmental conditions have on the cellular physiology. The objective of this thesis is to 
develop methods for quantitative physiological studies as well as for high throughput 
application for the CHO cells. The high throughput applications are achieved using innovative 
96-well microplates equipped with optical sensors for oxygen monitoring. Methods are 
developed for quantitative physiological studies for application in the technique of metabolic 
flux analysis.  
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3.2 Thesis organization 
 
The thesis is organized in two major parts. The first part of the thesis deals with the high 
throughput application of innovative 96-well microplates equipped with optical sensors for 
oxygen monitoring. These plates are shown to be applicable for high throughput respiration 
measurements, medium optimization for cellular growth and in vitro cytotoxicity testing. The 
second part of the thesis deals with the quantitative physiological studies of the cellular 
metabolism. A brief review of cellular biochemistry and the technique of metabolic flux 
analysis are given. It is followed by the development of methods required for the generation 
of data required for flux analysis. Physiological interpretations concerning the cellular 
physiology obtained from the experiments performed with labeled substrates are then 
presented.  
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4 MICROTITER PLATES IMMOBILIZED WITH 
OXYGEN SENSOR  
4.1 Introduction 
 
Advances in molecular biology, human genetics and functional genomics continue to produce 
increasing numbers of molecular targets available for therapeutic intervention. This, coupled 
with major increases in compound collections produced by combinatorial technologies, has 
fuelled an important need for improvements in high-throughput capabilities (Hertzberg and 
Pope, 2000). Moreover, with the advances in the production of biologicals, high throughput 
methods are needed for acceleration of process development. Mammalian cells have become 
an integral part in the process of drug screening and also for the production of biologically 
important proteins. Hence high throughput methods catering to mammalian cell culture are 
needed.  
Generally microplates are used for the routine culturing of cells. Microplates are available for 
the growth of both adherent and suspension cell cultures in static condition. They are 
presently available in 6, 8, 12, 24, 96, 384, 1536 and 3456 well formats. Each well of the plate 
can be used for cell culture. The choice of the format depends upon the end application of the 
cell culture. Many well plates are used simultaneously for screening drugs and for other 
biochemical assays.  However, monitoring of cell growth in these well plates is problematic. 
Most of the methods of determining cell viability are end-point assays and hence the cells 
cannot be processed further. In this part the use of novel 96-well microplates immobilized 
with optical oxygen sensors as a method for the online monitoring of cell growth is described. 
Moreover the application of these plates for process development as well as cytotoxicity 
screening is described. 
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4.2 Materials and methods 
 
4.2.1 Cell lines and stock maintenance 
Chinese Hamster Ovary (CHO) cell line T-CHO ATIII, obtained from Gesellschaft fuer 
Biotechnologische Forschung mbH (Braunschweig, Germany), was one of the cell lines used 
for this work. The cells produce recombinant Antithrombin III, which has clinical applications 
for its coagulation inhibitory activity. The cells are grown in suspension and are adapted to 
serum free medium. CHO-S-SFM II (GIBCO, Invitrogen Corporation, USA), a serum free 
medium for CHO suspension cells was used for the routine growth and maintenance of cells. 
A 1 mL cryopreserved aliquot of the cells was rapidly thawed to 37 ºC and washed twice with 
pre-warmed medium to remove any traces of cryoprotectant before inoculating the cells at a 
density of 1-2 × 10
5 
cells mL
-1
 in 15-25 mL of medium. The cells were grown in 250 mL 
spinner flasks (Techne, Staffordshire, United Kingdom) placed in an incubator (INCO2, 
Memmert GmbH + Co.KG, Schwabach, Germany) set at 37 °C and 88 % relative humidity 
with an overlay of 12 % CO2. The spinner flasks were placed on a stirrer (Model 104-S, 
Techne, Staffordshire, United Kingdom) which has maximum speed of 80 rpm.  To 
demonstrate the application of the plates for medium optimization, the cells were adapted to 
grow in a protein and peptide free, chemically defined media (SMIF 6, Life Technologies, 
Karlsruhe, Germany). 
Cryopreserved stock aliquots were prepared from cells grown in CHO-S-SFM II. The 
cryoprotectant solution was serum free medium CHO-S-SFM II with 10 % Dimethyl 
sulfoxide (DMSO). Typically 4-10 × 10
6
 viable cells mL
-1
 in the cryoprotectant solution were 
taken and aliquots of 1 mL volumes in 2 mL plastic cryovials were prepared. Due to the non-
availability of a programmable freezer the following steps of slow freezing were followed. 
Initially the cryovials were held at 4 ºC for 2-3 h and than transferred to a well insulated 
Styrofoam box. This Styrofoam box was than held at -20 ºC for 5-6 h and than transferred 
immediately to -70 ºC for overnight cooling. The cryovials were then removed from the box 
and quickly stored in liquid nitrogen storage canisters till further usage.  
The other suspension cell line used in this work was HL-60 (human acute myeloid leukemia). 
The cell line was obtained from German collection of microorganisms and cell cultures 
(DSMZ) (Braunschweig, Germany) and Roswell Park Memorial Institute (RPMI) 1640 
medium with 10 % fetal bovine serum (FBS) was used for growth. These cells are also 
adapted for suspension growth and were grown in 250 mL spinner flasks placed in a 12 % 
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CO2 humidified gas controlled incubator at 37 °C. The process of thawing and freezing was 
similar to the one described above with the only change being in the medium used and the 
cryoprotectant solution in this case being RPMI 1640 medium with 10 % FBS with either 10 
% glycerol or 10 % DMSO. Stocks were made both with 10 % Glycerol and 10 % DMSO due 
to the potential toxicity and differentiation caused by DMSO.   
Both the cells cultures were maintained in growth phase by changing the media using the 
serial dilution method. Cells were grown in spinner flasks till a density of about 2×10
6
 cells 
mL
-1
 for CHO cells and around 1×10
6
 cells mL
-1
 for HL-60 cells, centrifuged, transferred at a 
cell density of 2-3 ×10
5
 cells mL
-1
 in fresh media into spinner flasks and allowed to grow. The 
HL-60 cells were harvested at a lower cell density since they can potentially differentiate at 
high cell densities. 
The culture of the adherent cell line human colon carcinoma cell line Caco-2 and primary rat 
hepatocytes for toxicity studies were carried out in cooperation with the firm Pharmacelsus 
GmbH, Saarland University, Saarbrücken, Germany.  
The human colon carcinoma cell line Caco-2 (DSMZ, Braunschweig, Germany) was cultured 
in Dulbeccos Modified Eagle Medium (DMEM) pH 7.6. The following supplements were 
added: Minimum Essential Medium with Non-Essential Amino Acids (1X), 100 U ml
-1
 
Penicillin, 100 µM ml
-1
 Streptomycin and 10 % fetal calf serum (FCS). For growth studies 44 
mM HEPES were added. All reagents were purchased from C.C. Products GmbH (Cell 
Culture Products, Neustadt, Germany). The cells were seeded to 25 cm
2
 culture flasks 
(Greiner Bio-One GmbH, Frickenhausen, Germany) and cultivated at 37°C in a humidified 
incubator with 5 % CO2. The medium was changed every 2 days and the cells were passaged 
at 90 % confluence.  
Hepatocytes were isolated from male Wistar rats (250-350 g, Harlan-Winkelmann, Germany) 
by an in situ enzymatic perfusion (Seglen, 1976). After the two-step collagenase perfusion, 
the liver was transferred in ice cold Hank’s medium and the hepatocytes were liberated from 
the connective-vascular tissue by shaking the liver. The cells suspension was then filtered 
through sterile gauze (250 µm mesh openings). This cell suspension was then diluted 1:1 with 
WME-I (Williams medium E with 10 % FCS and 50 µg/ml Gentamycin) to inactivate 
collagenase. In order to achieve high purity the cell suspension was centrifuged at 50 g and 4 
°C for 20 min over a 30 % Percoll gradient (Nussler et al., 2001). The supernatant with non-
parenchymal and dead cells was removed, and the final cell pellet was resuspended in 10 ml 
growth medium (Williams medium E with 1 µM Insulin, 15 mM HEPES, 100 U/ml 
Penicillin, 100 µg/ml Streptomycin, 50 µg/ml Gentamycine, 1.4 µM Hydrocortisone and 10 
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% FCS). With this protocol approximately 5 x 10
8
 cells per rat liver were obtained and the 
viability was greater than 80 % as determined by trypan blue exclusion staining. All cell 
culture reagents were purchased from C.C. Products GmbH (Cell Culture Products, Neustadt, 
Germany). 
 
4.2.2 Oxygen-sensor microtiter plate 
The oxygen-sensor microtiter plates (MTP) were provided by PRESENS, Precision Sensing 
GmbH (Regensburg, Germany). The ‘U’ bottomed well plates (OP96U) were used for the 
growth of suspension cells while the flat bottomed (OP96F) plates were used for the primary 
and adherent cell lines. OXOPLATE OP96U (Figure 4.2.1) is a sterile polystyrene micro plate 
in the common 96 round well format, supplied with lid. An oxygen sensor is immobilized on 
the bottom of each well. This sensor can be read out from the bottom side with a 
commercially available reader. The OXOPLATE OP96F is similar with the round well format 
replaced by flat welled.  
 
 
Figure 4.2.1: Oxoplate (OP96U) 96 well round bottom MTP with integrated oxygen sensor. 
 
The sensor contains two different dyes. One is the oxygen indicator. Its phosphorescence 
intensity Iind is dependent on the concentration of oxygen in the sample filled into the well. 
The other dye is the reference. Its fluorescence intensity Iref is independent of the oxygen 
concentration.  
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Using the luminescence intensities, the ratio IR can be calculated. This referenced signal IR 
corresponds to the concentration of oxygen. 
    
ref
ind
R
I
I
I =     (4.2.1) 
Calibration is done by the determination of zero point by the chemical removal of dissolved 
oxygen using sodium dithionite or sodium sulfite and by subsequent saturation with oxygen 
from air. 
The relationship between fluorescence intensity and dissolved oxygen concentration is 
nonlinear and described by the Stern-Volmer equation for collision quenching: 
    
][1
1
20, OKI
I
SVR
R
+
=     (4.2.2) 
Where IR,0 is the fluorescence intensity ratio in the absence of oxygen, IR is the fluorescence 
intensity ratio at the oxygen concentration [O2] and KSV is the Stern-Volmer constant. More 
information and detailed procedures are described elsewhere (John et al., 2003). . 
Measurements were carried out in two fluorescence readers, both equipped with integrated 
shakers and temperature control (Fluostar, BMG Labtechnologies, Offenburg, Germany and 
Fluoroskan Ascent, Labsystems, Finland) using duel kinetic mode. The former was used 
generally for static culture and the latter for suspension culture due to the availability of 
higher shaking rates. The fluorescence intensities were measured with the filter combinations 
544 nm/650 nm and 544 nm/590 nm. The first combination measured fluorescence depending 
on oxygen concentration, whereas the latter showed the oxygen independent constant 
fluorescence of the reference signal.  
 
4.2.3 Culture enumeration and viability assay 
Cells were counted using a Neubauer hemocytometer. Cell concentration and viability were 
determined using the trypan blue exclusion method (Morris et al., 1997). 50 µL of the cell 
suspension was diluted 1:1 in a 0.4 % trypan blue in Phosphate Buffered Saline (pH 7.5). 
Viable cells exclude the dye while the non-viable cells are stained blue.  
Cell vitality and metabolic activity were also compared using the MTT assay (Morris et al., 
1997) using standard protocol. Briefly a stock solution of 5 mg mL
-1
 of 3-(4,5-
Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide  (MTT stain) (Sigma-Aldrich Chemie 
Gmbh, Steinheim, Germany) was prepared in Phosphate Buffered Saline (pH 7.5) and filtered 
through a 0.22 µm filter to sterilize and remove any insoluble matter. Wells of a 96-well 
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microtiter plate were filled with 100 µL of cell suspension; to this was added 10 µL of MTT 
solution and incubated at 37 ºC for 2 h in a humidified incubator. Yellow MTT (a tetrazole) is 
reduced to insoluble purple formazan by the mitochondria of living cells. The insoluble 
formazan is solubilised using acidified propanol (0.04 M HCl in propan-2-ol) and the 
absorbance of the resulting solution is read at a test wave length of 570 nM and a reference 
wavelength of 630 nM (for cell debris).  
 
4.2.4 Microtiter plate (MTP) growth of cells  
The cells were grown in the absence of CO2 incubation thus affecting the bicarbonate 
buffering of the medium. To provide additional buffering capacity, the CHO-S-SFM II 
medium was modified by the addition of HEPES (Sigma-Aldrich Chemie Gmbh, Steinheim, 
Germany) buffer. The final concentration of the HEPES buffer in the medium was 35 mM.  
Inoculum cultivations were made using modified medium in spinner flasks with incubation. 
Cells in the growth phase were harvested and centrifuged for 10 min at 1000 rpm and 4 °C 
(Function Line, Heraeus Instruments, Osterode, Germany). The resulting pellet was 
suspended in fresh medium. Volume was adjusted to give an initial viable cell density from 3 
× 105 cells/ml to 6 × 105 cells/ml. From this, aliquots of 200 µL were transferred to the wells 
of the microplate, covered with lid and cultivated in the fluorescence reader (Fluoroskan 
Ascent, Labsystems, Finland) at 37 °C and 660 rpm (orbital) with a shaking diameter of 2 
mm. 
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4.3 Respiration rate measurements 
 
4.3.1 Motivation and theory 
O2 uptake rates of animal cells are well known indicators for metabolic activity and can be 
used to predict the state of growth (Ramirez and Mutharasan, 1990; Eyer et al., 1995; 
Ducommun et al., 2000; Schoenherr et al., 2000). This has been applied for laboratory and 
large scale cell cultures in fermentors using electrodes but rarely for small scale cultures. The 
critical issue of O2 availability and mixing in small scale cultivations is generally overlooked 
(Weiss et al., 2002) and this can affect the final research outcome as O2 influences growth and 
product formation (Ozturk and Palsson, 1990b). For small scale cell culture, microplates are 
generally used both for adherent as well as suspended cells in static condition. But monitoring 
of culture has remained a problem and is achieved mainly by off-line measurements.   
Newly developed microplates with O2 sensors have been described very recently and used for 
monitoring respiration of microorganism (Stitt et al., 2002; John et al., 2003). John et al. (2003) 
reported mass transfer characteristics in 96 well plates, based on fluorescence O2 sensing. 
O'Riordan et al. (2000) determined dissolved O2 in microplates by measuring fluorescence 
phase shift. They were able to detect the activity of the fission yeast Schizosaccharomyces 
pombe above 10
4
 cells ml
-1
. These applications have been directed towards cultivation of 
bacterial or yeast cells which have high respiratory activities compared to mammalian cells. 
Hynes et al. (2003) measured dissolved O2 in microplates using a dissolved O2 sensor and 
applied it to mammalian cell monitoring. 
In this chapter, the application of microplates with immobilized dissolved O2 sensor for the 
determination of O2 uptake rates and specific uptake rates of suspended mammalian cells is 
described. The measured data is evaluated using simple models and compared with cultures in 
spinner flask. The possibility of simplifying and accelerating the measurement for potential high-
throughput measurements is investigated. 
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4.3.2 Uptake rates and Kla measurements 
Oxygen uptake rate can be determined from a stationary liquid phase O2 balance, 
 
          (4.3.1) 
 
where aqO ][ 2  and  
*
2 ][ aqO  are the dissolved oxygen concentrations in the liquid phase and in 
equilibrium with the gas phase, respectively, and akL  is the volumetric liquid phase mass 
transfer coefficient. The first term in the right hand side of the equation represents the transfer 
rate of oxygen from the atmosphere into the medium and OUR is the oxygen uptake rate of 
cellular, enzymatic or chemical reactions. For cellular processes, 
 
     
2
= OOUR q X    (4.3.2) 
where 
2O
q  is the specific oxygen uptake rate and X is the viable cell number. 
 
 [O2]aq was measured using the oxygen sensor coated microplate in conjunction with the 
fluorescence reader. The kLa was determined experimentally, for the cultivation conditions, 
using sodium dithionite (Fluka Chemie AG, Buchs, Switzerland) by the method earlier (John 
et al., 2003) using the software BERKELEY MADONNA.  
The estimated kLa was 0.9 h
-1
 thus giving a maximum oxygen transfer rate of 0.21 mM h
-1 
(Figure 4.3.1). This value is not as high as reported in previous literature (Hermann et al., 
2003) but may be attributed to the presence of a lid during the measuring process.  
 
 
 
 
 
 
 
 
 
 
 
( ) OUROOak
dt
Od
aqaqL
aq
−−= ][][
][
2
*
2
2
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Figure 4.3.1: Dynamic estimation of kLa using dithionite. The rise of oxygen is first order and 
kLa is estimated from liquid phase oxygen balance using a simulation program of 
BERKELEY MADONNA. The value is found to be 0.9 h
-1
, giving a maximum oxygen 
transfer rate of 0.21 mM h
-1
. The abbreviations in the inbox are explained in the program 
supplied in Appendix.   
 
4.3.3 Growth of CHO cells 
To check the applicability of the oxoplates, an initial simple experiment with cell culture was 
carried out. T CHO ATIII cells were seeded at different densities in quadruplicates (1.6 × 10
6
, 
8 × 10
5
, 4 × 10
5
 and 2 × 10
5 
Cells mL
-1
) in Oxoplate OP96U and grown in Fluorescence 
reader (Fluostar, BMG Labtechnologies, Offenburg, Germany) at 37°C under ambient 
atmospheric conditions. The cycle time was 30 minutes with orbital shaking at 70 rpm 
(shaking diameter of 3 mm) for 5 minutes before the readings. Cultivation was carried out for 
90 hrs with readings being taken every 30 min. Figure 4.3.2 shows the oxygen profile of the 
cells and as it is evident from the figure, the oxygen profile corresponds to the growth profile 
and is density dependent. Thus, the cells with higher cell density start initially with lower 
dissolved oxygen and as the time progresses the oxygen levels increase. This is most probably 
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due to the loss of viability of the cells, as this phenomenon is observed with a cell density 
dependent delay in the various cultures.  
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Figure 4.3.2: Oxygen profiles of CHO cells with different cell densities. Cells were cultured 
at different cell densities in triplicates in the oxoplate. The error bars depicting the standard 
deviation are indicated on each of the curve.  
 
CHO cells were cultivated parallel in microtiter plate and spinner flask. The plate was read 
every 30 min for the entire cultivation period of 48 h with the shaking parameters given in 
material and methods section. The breakup of the cycle time for shaking and measurement is 
given elsewhere (John et al., 2003). The outer wells of the plate were not used for cultivation 
and were filled with water to reduce evaporation (John et al., 2003). Only 8 innermost wells 
were read, 4 for calibration and 4 replicates for cell growth. Sampling from the plate was done 
regularly to compare the growth in MTP with spinner flask. The method of “sacrificial wells” 
was employed for the sampling of cells, with two wells extracted for every time point. 
Sampling was done starting from “sacrificing” the wells on the periphery, proceeding towards 
the center. Sterility was ensured during cultivation and sampling. 
Figure 4.3.3 gives the growth characteristics in both systems. The growth of cells was 
compared by doing viability assay on regularly timed samples. The pH of the samples was 
measured to check the buffering effect in the absence of CO2 incubation. From the data plot it 
is clear that the growth of cells in both systems is comparable for a 48 h period. There is an 
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increase in pH at the initial phase of growth in MTP. This can be due to the effect of CO2 
evolution from bicarbonate in the medium.   
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Figure 4.3.3: Growth Comparison of CHO cells in oxygen sensor coated MTP (without CO2 
incubation) with spinner flask (in CO2 incubator). MTP cultivations were carried out in the 
Fluoroskan Ascent reader at 37°C and at 660 rpm (orbital) with a shaking diameter of 2 mm.  
 
The dissolved oxygen profile of the above cell growth in MTP is given in Figure 4.3.4 (A). As 
seen, the shaking at the rate employed ensured that there was no oxygen limitation during the 
entire cultivation period. 
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4.3.4 On-line measurement of oxygen uptake rates 
The oxygen uptake rates of cells offer a valuable insight into culture viability and its 
metabolic activity. For the determination of oxygen uptake rate from the dissolved oxygen 
profile of cell growth, the oxygen transfer rate into the system should be known. 
This transfer rate is dependent on the mass transfer coefficient (kLa) of the system which was 
determined as described earlier. The oxygen uptake rate of the cells was calculated from the 
oxygen mass balance (Eq. 4.3.1) by using the derivative of the dissolved oxygen profile and 
the estimated kLa. The so called “respirogram” [Figure 4.3.4 (A)] of the cells is thus obtained, 
giving a measure of the respiratory activity of the cells.   
Figure 4.3.4 (B) depicts the specific oxygen uptake rate (
2O
q ) of the cells, calculated from 
OUR and the cell counts in parallel wells, at different time points. The specific oxygen uptake 
is found to decreases with time with a value of 3.2 × 10-13 Mol (O2) Cell
-1
 h
-1
 at 15 h 
cultivation going down to 1.8 × 10-13 Mol (O2) Cell
-1
 h
-1 
at 48 h. This value is in accordance to 
the values reported in earlier studies (Ducommun et al., 2000).  The decrease of 
2O
q is most 
likely due to the effect known as "crowding phenomenon", which refers to the decrease in 
specific oxygen uptake rate with increasing cell densities (Trubel and Barnikol, 1998). 
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Figure 4.3.4: (A) The online dissolved oxygen (D.O) profile with the respirogram of the 
CHO cell growth in oxygen sensor coated MTP. The respirogram was constructed by 
estimation of oxygen uptake rates (OUR) using the D.O profile. (B) The specific oxygen 
uptake rates at different time points calculated from OUR and the viable cell counts of parallel 
wells given in Figure 4.3.3  
 
4.3.5 Culture viability based on OUR  
It was also of interest to measure oxygen uptake rates of sampled cells. A simple method, 
described earlier for yeast using a different system, was followed (O'Riordan et al., 2000). 
Cells in exponential growth phase from a spinner flask were harvested and centrifuged for 10 
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min at 1000 rpm and 4°C. These were re-suspended in fresh medium at various cell densities. 
150 µl of the suspended cells were added on to the plates and layered with mineral oil 
(Sigma-Aldrich Chemie Gmbh, Steinheim, Germany) to reduce oxygen transfer. The layer of 
oil does not totally prevent the transfer of oxygen. Oil may act as a reservoir for oxygen, but 
as seen from Figure 4.3.5 the transfer of oxygen to the liquid is significantly reduced by 
applying an oil layer. The oxygen drop was noted every 2 minutes in the reader for 1 h. 
Initially, dissolved oxygen decreased linearly showing zero order kinetics. Since gas-liquid 
mass transfer was found to be negligible in comparison to the consumption rate under these 
conditions, the OUR of the cells was estimated using the liquid phase oxygen balance (Eq. 
4.3.1) and setting kLa to be zero.  
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Figure 4.3.5: The comparison of oxygen transfer without layer of mineral oil and with the 
presence of a layer of mineral oil on top. 150 µl of 1 % Sodium sulphite solution was layered 
with was 50 µl mineral oil (150 µl Sul + 50 µl oil) and the oxygen transfer compared with 1 
% Sodium sulphite solution (150 µl Sul). The sulphite removes the oxygen from water. The 
transfer of oxygen is slower with the presence of mineral oil. 
 
 
Figure 4.3.6 shows the plot of OUR vs. cell density which was found to be linear and 
compared well with the MTT assay. The specific oxygen uptake rate was determined from the 
slope of the plot. The value of 3.18 × 10-13 mol (O2) Cell
-1
 h
-1 
obtained is in agreement with 
the results obtained during the continuous monitoring of cell growth which had a value of 3.2 
× 10-13 mol (O2) Cell
-1
 h
-1
 at 15 h of cultivation [Figure 4.3.4 (B)]. 
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(B) 
Figure 4.3.6: (A) Oxygen uptake rate (OUR) of sampled cells, from a spinner flask, at 
various dilutions was determined by layering it with mineral oil. The viable cell density was 
determined using trypan blue. The OUR is estimated from liquid phase oxygen balance with 
no oxygen transfer. The slope of the fitted curve gives the average specific oxygen uptake rate 
and is equal to 3.18 × 10-13 Mol (O2) Cell
-1
 h
-1
.   
(B) The sampled cells were also assayed using MTT (Abs540).  
 
A method for a quick assay to measure viability was explored. The dissolved oxygen 
concentrations at a given time point were plotted against the respective cell densities (Figure 
4.3.7). The plots were found to be linear, for a short time over a long range and vice versa.  
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Figure 4.3.7: The dissolved oxygen concentration at a few time points for different cell 
densities prepared from a spinner flask culture when layered with mineral oil.  
 
The method was also tried without the use of oil layer. The hypothesis that cells in same 
phase of growth i.e. cells having the same specific oxygen uptake rates should show a linear 
relationship with regard to the dissolved oxygen (D.O) concentration at a particular time was 
tested using the oxoplate OP96U. Actively growing cells from a spinner flask culture were 
taken and serially diluted using media. 200 µl of each of these were then seeded in the 
Oxoplate, incubated in the Fluoroskan Ascent reader at 37 °C for 30 min and then shaken at a 
speed of 250 rpm before the measurement (Figure 4.3.8). The relationship was found to be 
linear to a maximum cell density of 1 × 10
6
 cells mL
-1
. This method can thus be used as a 
quick reference for viable cell density measurements compared to other time consuming 
assays (MTT, ATP etc).  
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Figure 4.3.8: Relationship between Dissolved Oxygen and Cell Density. It was found to be 
linear till a cell density of maximum 1 × 10
6
 cells mL
-1
.  This can be used as a quick assay 
method.  
 
The methods developed here will not only provide an avenue for process control but also pave 
way for important interpretations with relation to oxygen uptake, culture viability etc. We show 
their applicability in process optimization by using them for medium optimization and also in 
drug testing as a tool for cytotoxicity testing in the subsequent chapters.  
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4.4 Medium optimization 
 
4.4.1 Motivation and theory 
 Development of processes involving mammalian cell cultures producing 
therapeutically important proteins is generally very time consuming. Medium optimization 
plays a key role in this process (Hesse and Wagner, 2000). Classically this is done by the 
addition or deletion of components, one at a time, to see their influence on the process. 
However, this approach has a lot of problems associated with it including false optimums, 
much experimentation, no information of interactions etc. Therefore, statistical design is used 
to minimize experimental efforts and provide relevant information (Ertola et al., 1995; 
Massart et al., 1997). Essential items to start such optimization are the selection of potentially 
influencing parameters, the measurement of the output and the method of experimental design 
applied. The selection of input variables depends strongly on the specific problem. The inputs 
could involve specific individual components of a media or complex media supplements or 
operating variables such as pH or temperature. The output is generally the growth rate or 
production rate (Castro et al., 1992; Lee et al., 1999). However, for the primary phases this is 
generally the cell proliferation. Recently Chun et al. (2003) applied statistical experimental 
design to identify growth factors in an overall effort to accelerate recombinant CHO medium 
development with cell proliferation as the output variable. In this context the measurement of 
oxygen uptake rate (OUR) as the output parameter is of high interest because it is a known 
indicator for metabolic activity and directly reflects culture viability (Ramirez and 
Mutharasan, 1990; Eyer et al., 1995; Ducommun et al., 2000; Schoenherr et al., 2000). 
Despite the use of experimental design strategies the number of experiments required for 
optimization studies is still large considering the large number of potential influencing 
parameters in mammalian cell culture (Palmqvist et al., 1999; Adinarayana and Ellaiah, 
2002). Therefore, high-throughput methods for cultivation and on-line monitoring such as 96 
well microtiter plates with on-line oxygen sensing are needed. The application of these plates 
for culture viability measurements using oxygen uptake rate has been shown in the previous 
chapter. The viability-OUR relationship changes if the specific OUR is changing. One can, 
however, expect that in almost any case less favorable media composition would decrease 
both culture viability as well as cell specific OUR. This additive effect would even simplify 
finding an optimum media composition.  Here we show the applicability of these microplates 
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for medium optimization using statistical experimental design with oxygen uptake rate as a 
parameter.  
 
4.4.2 Statistical experimental design 
In an experiment, one or more process variables (or factors) are deliberately varied in order to 
observe the effect these changes have on one or more response variables. The (statistical) 
design of experiments (DOE) is an efficient procedure for planning experiments so that the 
data obtained can be analyzed to yield valid and objective conclusions. DOE begins with 
determining the objectives of an experiment and selecting the process factors for the study. 
An Experimental Design is the laying out of a detailed experimental plan in advance of doing 
the experiment. Well chosen experimental designs maximize the amount of "information" that 
can be obtained for a given amount of experimental effort.   
It is common to begin with a process model of the `black box' type, with several discrete or 
continuous input factors that can be controlled, i.e. varied at will, and one or more measured 
output responses. Experimental data are then used to derive an empirical (approximation) 
model linking the outputs and inputs.  
A common experimental design is one with all input factors set at two levels each. These 
levels are called `high' and `low' with a range width of `+1' and `-1', respectively. A design 
with all possible high/low combinations of all the input factors is called a full factorial design 
in two levels. If there are k factors, each at 2 levels, a full factorial design has 2
k
 runs. For 
example the two-level, full factorial design for three factors, namely the 2
3
 design has eight 
runs (not counting replicates or centre point runs). Graphically, we can represent the 2
3
 design 
by the cube shown in Figure 4.4.1.  
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Figure 4.4.1: A 2
3
 two-level, full factorial design; factors X1, X2, X3. The arrows show the 
direction of increase of the factors. The numbers `1' through `8' at the corners of the design 
box reference the `Standard Order' of runs [Figure derived from NIST statistical handbook 
(http://www.itl.nist.gov/div898/handbook)] 
 
The present experiments are aimed to show the applicability of microplates with immobilized 
oxygen sensors as a system to study media optimization in primary stages. The protein and 
peptide free, chemically defined media SMIF 6 was used for the study. The medium 
components varied were inorganic salt mixture (A), glutamine (B) and glucose (C). The 2
3 
full 
factorial central composite design used in response surface methodologies was applied. This 
consists of the evaluation of the relationship between controlled experimental factors and the 
measured response, in this case being the oxygen uptake rate of the cells at the end of 
cultivation time.  
For statistical calculations, the variables were coded as according to the following equation. 
   XXXx ii ∆−= /)( 0      (4.4.1) 
Where xi is the i
th
 coded value of the variable X, X is the variable A, B or C, Xi is the i
th
 natural 
value of X, X0 is the centre value of X and ∆X is the step change value of X. The range and 
levels of the factors varied are given in the Table 4.4.1. 
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Table 4.4.1: Range and levels of the factors varied in optimization experiments. 
CODED VALUES INORGANIC 
SALTS (A) 
(% Conc.) 
GLUTAMINE (B) 
(% Conc.) 
GLUCOSE (C) 
(% Conc.) 
-2 33.33 33.33 33.33 
-1 66.66 66.66 66.66 
0 100 100 100 
1 133.33 133.33 133.33 
2 166.66 166.66 166.66 
∆X 33.33 33.33 33.33 
% Concentration refers to the concentration as a percentage used in the original medium. 
 
Six star points and six centre point replicates were employed in the design for the fitting. The 
star points and the factorial points were done in triplicate, thus requiring a total of 48 
experiments. All the experiments were carried out in one run using a single microtiter plate 
with immobilized oxygen sensors, thus reducing the blocking effects (inter-experiment 
variations). The central points were taken as those in which the cells were known to be viable, 
and in which the stock cells were prepared, i.e. the concentrations in the chemically defined 
medium used for the cell growth. These concentrations were designated as 100 % and step 
changes were applied. The tabulation of the experimental variations and the observed 
response are given in Table 4.4.2. 
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Table 4.4.2: Medium formulations according to the statistical design with observed and 
predicted response. The predicted response is obtained from the regression model developed. 
Run No. A B C Observed 
Response OUR 
(×10-6 M h-1) 
Predicted 
Response OUR 
(×10-6 M h-1) 
1 -1 -1 -1 0.093 0.11 
2 -1 -1 -1 0.119 0.11 
3 -1 -1 -1 0.109 0.11 
4 1 -1 -1 0.093 0.085 
5 1 -1 -1 0.062 0.085 
6 1 -1 -1 0.096 0.085 
7 -1 1 -1 0.119 0.13 
8 -1 1 -1 0.137 0.13 
9 -1 1 -1 0.132 0.13 
10 1 1 -1 0.149 0.15 
11 1 1 -1 0.145 0.15 
12 1 1 -1 0.142 0.15 
13 -1 -1 1 0.144 0.14 
14 -1 -1 1 0.140 0.14 
15 -1 -1 1 0.134 0.14 
16 1 -1 1 0.138 0.12 
17 1 -1 1 0.095 0.12 
18 1 -1 1 0.135 0.12 
19 -1 1 1 0.143 0.16 
20 -1 1 1 0.153 0.16 
21 -1 1 1 0.16 0.16 
22 1 1 1 0.135 0.12 
23 1 1 1 0.125 0.12 
24 1 1 1 0.1 0.12 
25 -2 0 0 0.023 0.051 
26 -2 0 0 0.09 0.051 
27 -2 0 0 0.048 0.051 
28 2 0 0 0.014 0.021 
29 2 0 0 0.005 0.021 
30 2 0 0 0.043 0.021 
31 0 -2 0 0.16 0.15 
32 0 -2 0 0.159 0.15 
33 0 -2 0 0.16 0.15 
34 0 2 0 0.17 0.16 
35 0 2 0 0.166 0.16 
36 0 2 0 0.17 0.16 
37 0 0 -2 0.15 0.15 
38 0 0 -2 0.155 0.15 
39 0 0 -2 0.153 0.15 
40 0 0 2 0.161 0.16 
41 0 0 2 0.158 0.16 
42 0 0 2 0.156 0.16 
43 0 0 0 0.168 0.16 
44 0 0 0 0.160 0.16 
45 0 0 0 0.162 0.16 
46 0 0 0 0.155 0.16 
47 0 0 0 0.160 0.16 
48 0 0 0 0.143 0.16 
 
Run 1-24 represent the Factorial Design, Run 25-42 are the Star points and Run 43-48 are the 
Central points. 
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4.4.3 Cell growth and oxygen uptake rate (OUR) determination 
The cell inoculum was grown in the chemically defined media in spinner flasks with CO2 
incubation and provided with additional buffering by the addition of 35 mM HEPES. All the 
different media compositions used for the study were prepared with 35 mM HEPES buffering 
to carry out the cultivation without CO2 incubation and a lower concentration of sodium 
bicarbonate. Cells in growth phase were harvested and equal volume (containing equal no. of 
viable cells) was transferred to 1.5 ml tubes, centrifuged and re-suspended in the various 
media compositions to give a final viable cell concentration of 1 × 105- 2 × 105 cells/ml. This 
ensured that the final viable cell concentration inoculated into each media formulation was the 
same. 200µl of these were transferred to the wells of the microplate, covered with lid and 
cultivated in the fluorescence reader at 37°C and 660 rpm (orbital) with a shaking diameter of 
2 mm. The plate was read every 30 min for the cultivation period of 72 hours. The outer wells 
of the plate were not used for cultivation and were filled with water to reduce evaporation. All 
the other wells were used for the experimentation which included the calibration points of the 
plate. At the end of 72 h, it was seen that the evaporation from the wells varied from 25µl at 
the well designated as B11 (outermost used for the growth experiment) to 15µl at the 
innermost well (D6). The evaporation was the highest in the outermost wells (A1, A2, A12 
etc), which were not used for the study. This uneven evaporation across the plate, which was 
always below 15 %, is one of the limitations of the system leading to variable osmolalities in 
different wells. However, it has been shown that an increase of up to 20 % in osmolality has 
no effect on growth rate in case of CHO cells (Kimura and Miller, 1996).  
Oxygen uptake rate was estimated for each of the wells using a stationary liquid phase O2 
balance using equation (4.3.1) supplied in the materials and methods section and given below 
(John et al., 2003), 
 
( ) OUROOak
dt
Od
aqaqL
aq
−−= ][][
][
2
*
2
2
     (4.4.2) 
 
where aqO ][ 2  and 
*
2 ][ aqO  are the dissolved oxygen concentrations in the liquid phase and in 
equilibrium with the gas phase, respectively, and akL  is the volumetric liquid phase mass 
transfer coefficient.  [O2]aq was measured using the oxygen sensor coated microplate in 
conjunction with the fluorescence reader. The saturation oxygen concentration *2 ][ aqO  is 0.21 
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mM, which is the solubility of oxygen in water at 37°C. The kLa was determined 
experimentally as 0.9 h
-1
, as has been shown before, for the cultivation conditions, using 
sodium dithionite (Fluka Chemie AG, Buchs, Switzerland).   
4.4.4 Results and discussion 
On-line oxygen profile and oxygen uptake rate  
In the previous chapter, the oxygen uptake rates of cells, measured using oxygen sensor 
coated microplate, were shown to be directly related to culture viability. The online dissolved 
oxygen profiles obtained are converted to the oxygen uptake rates by using equation (4.4.2). 
Figure 4.4.2 shows both the dissolved oxygen profile as well as the uptake rate of two 
different media formulations. Figure 4.4.2(A) shows the profile and uptake for medium 
formulation with the coded values A=0, B=0 and C=0. Figure 4.4.2(B) shows the same with 
the medium formulation of coded values A=2, B=0 and C=0. From the figure it can be seen 
that there is a marked difference in the profiles of both, with the former showing a higher final 
oxygen uptake than the latter. This effect is most probably due to the presence of certain 
component or components in toxic concentrations. Thus by comparing the two profiles a 
preliminary idea on the effect of different compositions can be obtained. From the figure it is 
clear that a high concentration of inorganic salt mixture causes a decrease in cell vitality. Also 
potential components limitations could be identified with 72 h oxygen profiles.   
The final oxygen uptake obtained for each formulation after 72 h is listed in Table 4.4.2.  
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Figure 4.4.2: The dissolved oxygen and oxygen uptake profile of two media formulations. 
(a). Media formulation with compositions known to support viability (A=0, B=0 & C=0), (b). 
Media formulation with higher amount of inorganic salt mixture (A=2, B=0 & C=0). 
Concentration levels A, B and C are specified in Table 4.4.1. 
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Development of regression equation 
The experimentations were carried out using the 2
3
 full factorial central composite design. 
Design Expert 6.0 (Stat Ease Inc, Minneapolis, US) was used for the regression analysis.  A 
second order polynomial model (which includes the linear, quadratic and the interaction 
terms) is generally adequate to describe the system. But this was found to have a lack of fit 
with an F-value of 3.14 (Massart et al., 1997). So a reduced third order model was applied. 
The model is described by the equation  
 
 
ABCbCAbBAb
BCbACbABbAbCbBbAbbOUR
***
*******
10
2
9
2
8
765
2
43210
+++
+++++++=
 (4.4.3) 
 
where A is the concentration of inorganic salt mixture, B is the concentration of glutamine 
and C is the concentration of glucose. Also b0 is the intercept coefficient and bi=1…6 are the 
coefficients referring to the measures of effect of the various variables involving A, B, and C. 
This model was not aliased (confounded) and therefore could be applied. The analysis of 
variance (ANOVA) of the model demonstrates that the model is significant (Table 4.4.3), as is 
evident from Fisher F test (Fmodel = 42.20) and a low probability of failure 
(“Prob>F”=<0.0001) (Massart et al., 1997). The "Lack of Fit F-value" of 0.52 implied that the 
Lack of Fit was not significant relative to the pure error. The goodness of fit was checked by 
the determination coefficient (R
2
). For this analysis, the value of the determination coefficient 
(R
2
=0.92) showed that there was a good agreement in the model and the responses. The 
adjusted determination coefficient (adj.R
2
=0.856) too indicated significance of the model.  
The application of the methodology yielded the following equation with the estimated 
coefficients, 
 
 
ABCCABABCAC
ABACBAOUR
3232333
32333
10*729.610*335.710*926.910*011.910*851.4
10*206.3030.010*575.110*079.210*517.716.0
−−−−−
−−−−
−++−−
+−++−=
  (4.4.4) 
 
where the terms have the same notation as in equation (4.4.3). The significance of each 
coefficient was estimated by the F-value. In this case A, A2, B*C, A
2
*B and A*B*C are 
significant model terms. The predicted response of each of the runs from the model is 
compared with the observed response in Table 4.4.2.  
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Table 4.4.3: ANOVA for the response surface reduced cubic model. 
Source  Sum of 
Squares 
Degree 
of 
Freedom 
Mean 
Square 
F- 
Value 
Prob>F  
Model 0.079 10 7.887×10-3 
 
42.20 <0.001 Significant 
A 2.71×10-3 1 2.71×10-3 14.51 0.0005 Significant 
B 1.04×10-4 1 1.04×10-4 0.55 0.4611  
C 5.95×10-5 1 5.95×10-5 0.32 0.5759  
A
2
 0.067 1 0.067 357.32 <0.001 Significant 
AB 2.47×10-4 1 2.47×10-4 1.32 0.2580  
AC 5.65×10-4 1 5.65×10-4 3.02 0.0905  
BC 1.95×10-3 1 1.95×10-3 10.43 0.0026 Significant 
A
2
B 1.18×10-3 1 1.18×10-3 6.33 0.0164 Significant 
A
2
C 6.46×10-4 1 6.46×10-4 3.45 0.0710  
 
ABC 1.09×10-3 1 1.09×10-3 5.81 0.0210 Significant 
Residual 6.92×10-3 37 1.87×10-4    
Lack of fit 4.13×10-4 4 1.03×10-4 0.52 0.7189 Not 
Significant 
Pure Error 6.50×10-3 33 1.97×10-4  
Cor Total 0.086 47  
The Model F-Value of 42.20 implies the model is significant. Values of “Prob>F”, probability 
of failure, less than 0.05 indicate model terms significant. 
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Response surface plots of two variables, keeping the others constant, are useful to understand 
the influence of main and interacting effects of the factors. Figure 4.4.3 (A, B & C) shows the 
response surface plots of the three tested variables. The salt mixture exerts the most effect on 
the rates with no dramatic effects seen by the variation in glucose and glutamine 
concentrations in the concentration range used. The long term effects of these composition 
ranges are however, not taken into account for this particular set of experimentations.  
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Figure 4.4.3: Response surface plot showing effects of media components on the oxygen 
uptake and hence the culture viability. All other variables are held constant. Concentration 
levels are specified in Table 4.4.1. 
A) Effect of inorganic salt and glutamine concentrations 
B) Effect of glucose and inorganic salt concentrations 
C) Effect of glucose and glutamine concentrations. 
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A growth experiment was performed with the optimized medium composition obtained from 
the regression analysis, and the composition is shown along with its predicted response in 
Table 4.4.4 and is marked selected.  
 
Table 4.4.4: Optimum media compositions obtained from the model (equation 4.4.4). 
No. A-Inorganic 
salt conc. (%) 
B-Glutamine 
conc. (%) 
C-Glucose conc. 
(%) 
Predicted 
OUR. 
Solution 
Reduced third order model. 
1 117.3 165.9 41.26 0.20 Selected 
2 105.7 142.3 52 0.18  
 
A growth experiment was also performed with a second optimum given by the analysis to 
check the validity of the model. The oxygen uptake profiles of the compositions in 
comparison with the original composition are given in Figure 4.4.5 (A & B). It is seen that the 
proliferation rate of the cells with the new medium is significantly higher than with the 
original medium in the initial culture phase thus showing the applicability of the method used. 
Using OUR for earlier growth phases, e.g. 48 h and 60 h, similar optimum concentrations 
could be obtained with a standard deviation in the concentration of 10 %.  
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Figure 4.4.4: The oxygen uptake profiles of the medium composition obtained from 
optimization compared with the original composition.  
A) Medium formulation with the optimized composition 1 (A=117.3 %, B=166 %, C=41.26 
%) compared with the composition (A=100 %, B=100 %, C=100 %) 
 B) Medium formulation with the optimized composition 1 (A=105.7 %, B=142.3 %, C=52 
%) compared with the composition (A=100 %, B=100 %, C=100 %) 
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4.4.5 Conclusions 
The above experiments show that microplates coated with oxygen sensors could be used in 
the primary step of media optimization. The system is fast, allows high-throughput 
experiments and measures the metabolic activity of cells. The two major limitations of the 
method as presented here are: (i) the limited time for growths experiments (<100 h) due to the 
evaporation from the wells, (ii) the fact that the experiments in the present experimental set-
up have to be done in externally buffered media with HEPES. The uneven evaporation of 
media from the wells of the plates and presence of HEPES could confound the analysis in 
case of sensitive cell lines. However, both could be overcome by putting the microplate reader 
into an appropriately humidified chamber with controlled addition of carbon dioxide. Loss of 
water could also be compensated for by the addition of water after e.g. 80 hours. The method 
may also be extended by the measurement of the product formed as a secondary output in the 
statistical analysis. The method is highly cost effective since the amount of media required is 
very small for each run, a lot of samples can be analyzed at a single go and the oxygen uptake 
rate measurements are entirely automatic minimizing labor cost. This method seems directly 
applicable for almost any culture of suspended and probably also attached animal cells which 
can be grown in microplates and have comparable oxygen uptake rates as the cells used here. 
This method seems also useful for other purposes as e.g. test of raw materials and conditions 
of cell stocks which are considered important in mammalian cell production (Hesse and 
Wagner, 2000) . 
 A new approach using microtiter plate cultivation with on-line measurement of dissolved 
oxygen (DO) was applied for medium optimization of mammalian cell culture. Applying 
dynamic liquid phase balance, oxygen uptake rates were calculated from the DO level and 
used as an indicator for culture viability. The developed method was successfully applied to 
optimization of the concentration of glucose, glutamine and inorganic salts for cultivation of a 
Chinese Hamster Ovary (CHO) cell line. Using a 2
3
 full factorial central composite design, 
the optimum medium composition could be identified in one single run. The developed 
method exhibits high potential to improve procedures of medium optimization for animal cell 
cultivation by allowing the investigation of large sets of potentially important variables in 
short time and with reduced effort. 
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4.5 Cytotoxicity Testing 
 
4.5.1 Motivation and theory 
Everyday new substances and chemicals are developed using combinatorial chemistry that 
can synthesize very large number of molecules at about 10,000 varieties of congeners in a 
stroke, which have the potential to act as drugs or therapeutic agents. These must be screened 
for potential risk to the health or the environment. The screening includes in-vivo and in-vitro 
testing models. However, in recent years the emphasis has been on in-vitro testing using 
human tumors or cell-line models which include primary cells or established cell lines (Davila 
et al., 1998). In this regard cell proliferation and cytotoxicity assays play a crucial role. 
Numerous assays are available for these purposes (Mosmann, 1983; Souchier et al., 1995; 
Jones et al., 2001). These assays are important tools for in-vitro testing in pharmaceutical 
research and their scientific as well as their commercial potential cannot be over-emphasized. 
Cell viability is usually assessed by membrane integrity (e.g. trypan blue exclusion) and cell 
proliferation by labeled nucleotide incorporation [e.g. [
3
H]-thymidine), ATP or metabolic 
markers as MTT, XTT etc (Cunningham, 2001)]. Choosing the right kind of assay for the 
system to be studied is important and depends on the information sought (Riss and Moravec, 
2004). A better understanding is necessary of what each assay measures as the end point, how 
the measurement correlates with cell viability or proliferation and what are its potential 
limitations. Also knowledge about changes occurring during different mechanisms of cell 
death will help deciding which endpoint to choose for a cytotoxicity assay. If the information 
sought is just the difference in treated and untreated cells with a compound then the choice of 
assay becomes less complicated. However, for more information on the mechanism of death, 
the duration of exposure to toxin, the concentration of test compound and thus the choice of 
assay become critical. The above come into play because of the inherent disadvantage of the 
assays to measure endpoints. In this part of the thesis a cell proliferation/cytotoxicity assay is 
reported, which can potentially be useful for eliciting information on mechanisms of cell 
death, as it is both kinetic and non-destructive to the cells. The assay makes use of 96-well 
plates with immobilized internally referenced oxygen sensors which permit determination of 
the respiration rate of the cells for each well of the plate. These rates are known indicators for 
metabolic activity and can be used to predict the state of growth
 
(Ramirez and Mutharasan, 
1990; Eyer et al., 1995; Ducommun et al., 2000; Schoenherr et al., 2000). Earlier reports 
using oxygen microplates have shown the application and effectiveness of the system 
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(Wodnicka et al., 2000; Stitt et al., 2002; Hutter and John, 2004; Wittmann et al., 2004). This 
chapter focuses on the assay methodology of cell proliferation and cytotoxicity testing using 
oxygen sensor plates. Its distinguishing feature lies in its applications for primary cell cultures 
(e.g. rat hepatocytes) as well as for adherent and suspension cell lines using flat bottomed and 
‘U’ bottomed well plates. Both adherent and suspension cells can be monitored directly in the 
plates and harvested for further processing thus requiring no additional procedures or further 
reagents. It can also be easily adapted for medium to high throughput methods. The assay 
outcome corresponds well with results of conventional systems presently in use like e.g. 
MTT. The robustness of the assay was confirmed using the statistical Z`-factor (Zhang et al., 
1999).  
 
4.5.2 Cytotoxic compounds 
Compounds used for cytotoxicity assays (Diclofenac, Clozapine, Sodium dodecyl sulfate 
(SDS), 2-Thiouracil, Tamoxifen and Tranylcypromine) were purchased from Sigma-Aldrich 
(Taufkirchen, Germany) and the required stocks prepared in an appropriate solvent vehicle. 
Sodium azide was purchased from Fluka Chemie (Buchs, Switzerland). 
 
4.5.3 Microtiter plate (MTP) growth of cells and cytotoxicity assay 
The cells were grown in the absence of CO2 incubation thus affecting the bicarbonate 
buffering of the media. To provide additional buffering capacity, the media was modified by 
the addition of HEPES buffer. Also the outermost wells of the plate were not used for 
cultivation and were filled with water to reduce evaporation. All the other wells were used for 
the experimentation which included the 4 wells for the calibration of the plate. Sterility was 
ensured during the entire cultivation period by covering the plate with a sterile lid. The 
growth of cells in these modified conditions was found to be similar to the conditions in CO2 
incubator as shown in the earlier chapter.  
 
Primary rat hepatocytes: 
For respiration studies freshly prepared hepatocytes were seeded in different concentrations 
(300 µl per well) in 96-well flat-bottom oxygen-sensor microtiter plates (OP96U) coated with 
Collagen Type I. The cells were incubated at 37°C in a humidified incubator at 95 % air and 5 
% CO2 and after 1h of attachment the medium was replaced by fresh growth medium. 
Immediately the plate was placed into a 37 °C temperature controlled fluorescence reader and 
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read every 30 min. For the studies involving solvents and cytotoxicity, the solvents and 
compounds were appropriately diluted in culture medium. Cells were seeded at densities of 2 
x 10
4 
- 2 x 10
5
 cells mL
-1
 and allowed to attach. The overlaying medium was than removed 
from the cells and 300 µl of the diluted test solutions was added in triplicates with the plates 
being read every 30 min. For cytotoxicity assays the plate was read for a period of 6 hours and 
an MTT assay was performed simultaneously for the corresponding.   
 
Cell lines: 
To determine the oxygen profile, Caco-2 cells were seeded in Oxoplates at different cell 
densities. Similar conditions as above were used. Before application of the compounds, Caco-
2 cells were incubated for 16-20 h at 37°C in a humidified incubator at 95 % air and 5 % CO2. 
The compounds were diluted in culture medium and added to the cells in triplicate after the 
culture medium was removed.  
For suspension cells the inoculum cultivations were made using medium with 35 mM HEPES 
in spinner flasks with CO2 incubation. Cells in growth phase were harvested and equal 
volume (containing equal no. of viable cells) was transferred to 1.5 ml tubes, centrifuged and 
re-suspended in media, containing different concentrations of the substance to be tested, to 
give a final viable cell concentration of 1 × 105- 2 × 105 cells/ml. This ensured that the final 
viable cell concentration inoculated was the same. 200 µl of these were transferred to the 
wells of the microplate in triplicates, covered with lid and cultivated in the fluorescence 
reader at 37°C and 660 rpm (orbital) with a shaking diameter of 2 mm. The plate was read 
every 30 min for the cultivation period. The tested substances included tamoxifen and 
diclofenac for HL60 cells and sodium azide for CHO cells.  
 
4.5.4 Comparison of oxygen uptake rates with MTT assay 
It has been previously shown that the oxygen uptake rate compares well with the conventional 
assay such as MTT. Figure 4.5.1 shows the linearity between the MTT assay and OUR 
measurement for a range of 5 x 10
5
 cells/ml to 2 x 10
6
 cells/ml from sampled CHO cells. The 
OUR is calculated from the drop observed in dissolved oxygen over a period of  3 hours using 
Eq.4.3.1 allowing 30 minutes for the system to stabilize. From the Figure it is clear that both 
results are highly comparable with a R
2 
value of 0.98
 
and thus the OUR measurement could be 
used in place of the conventional MTT assay.  
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Figure 4.5.1: Comparison of MTT assay with OUR measurements of sampled CHO cells.  
CHO cells in the range of 5 x 10
5
 cells/ml to 2 x 10
6
 cells/ml were seeded in sensor coated 
plates in triplicates and the average uptake rate was calculated from the drop in oxygen noted. 
Parallel experiment was done for the MTT assay (Abs540). 
 
4.5.5 Growth of primary and adherent cells on MTP 
The main advantage of the present system is to allow the growth of adherent cells on the flat 
bottomed plates, which can then be used in cytotoxicity studies. Figure 4.5.2 shows the 
oxygen profiles of different initial seeding densities of primary rat hepatocytes and Caco-2 
cells, an adherent cell line, on the Oxoplates. In the case of the dividing Caco-2 cells, a cell 
density dependent increase in the respiration rates was observed as tracked by the changes in 
the dissolved oxygen concentration shown in Figure 4.5.2 (A). Since primary rat hepatocytes 
are non-dividing cells, other characteristics in the respiration rates were seen for different 
seeding densities than for Caco-2 cells. For the non-dividing hepatocytes, the seeding of a 
minimum critical cell concentration is essential for the formation of a monolayer culture 
which allows the maintaining of the respiratory and metabolic activity of the cells. Figure 
4.5.2 (B) shows that small cell concentrations do not result in a decrease of the dissolved 
oxygen concentration over time. In contrast, seeding concentrations greater than 1.9 x 10
4
 
cells/well display a very steep decrease of the oxygen concentrations since the critical cell 
concentration for monolayer formation is reached. From Figure 4.5.2 (B) it can be seen that 
the respiration rate for adequate cell numbers remain constant at steady state value. The 
decrease in the respiration rate, as evidenced by an increase in the dissolved oxygen 
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concentration with time at higher seed densities, might be due to depletion of components 
from the media as it is seen to be cell density dependent.  
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Figure 4.5.2: Dissolved oxygen profiles of different cell densities of primary hepatocytes (A) 
and CaCo2 cells (B) grown on flat bottomed Oxoplate.  
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Effect of solvents on cell viability  
New candidate compounds are often poorly soluble in water and have to be solved in solvents 
like DMSO or Ethanol. For the assay system to be reliable under all conditions, the solvents 
should not influence or interfere with the system. In order to determine the effects of 
commonly used solvents on cell viability and the assay system, DMSO and ethanol were 
tested using primary rat hepatocytes at a concentration generally used (2 %). Triton X, a 
detergent known to be toxic at the given concentration, was used as a negative control. Figure 
4.5.3 gives the respiration profiles in terms of dissolved oxygen concentration showing that 
the solvents DMSO and ethanol do not have any effect on the system or viability at the given 
concentration as seen in comparison with control culture. As expected, cells treated with 
Triton X show no sign of viability as it can be seen from the dissolved oxygen concentration 
remaining constant at saturation.  
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Figure 4.5.3:  Effect of solvents on primary rat hepatocytes. 2 % Triton X, DMSO and 
ethanol were used to check their effect on the respiration of the cells.  
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4.5.6 Cytotoxicity assays and LC50 determination 
Acute toxic effects (those that occur after a single exposure) of substances are typically 
measured and defined in terms of the lethal dose 50 (LD50) or lethal concentration 50 (LC50). 
The LC50 is defined as the amount of chemical that when exposed to test animal or cell culture 
testing systems, will be lethal to fifty percent of the test population. This means that the lower 
the value of the LD50 and LC50 the more toxic the substance and vice versa. 
The oxoplates were applied for the detection of cytotoxicity. Sodium azide, a well known 
toxic agent, was used for the test. CHO cells in suspension were used and the test was carried 
out in U-bottomed well plates. Figure 4.5.4 shows the oxygen uptake rates of CHO cells, at 
different concentrations of azide, for a 24 h period. The response of the cells to the compound 
is clear from the curves and is found to be dose dependent. At higher concentrations of azide 
(>0.25 mM) the cells do not show any significant oxygen uptake thus indicating loss of 
viability. At low concentrations there is seemingly no effect on the respiration. These curves 
are then used to determine the LC50 of the compound using a four parameter sigmoidal dose-
response fit (Origin 6.0, OriginLab Corporation, Northampton, USA).  
 
HillslopeXLC
BottomTop
BottomY
*)(log 50101
)(
−+
−
+=    (4.5.1) 
 
where X is the logarithm of concentration and Y is the response; Y starts at Bottom and goes 
to Top with a sigmoid shape with bottom and top representing the responses of the control 
and the highest concentration used respectively. 
 The use of dissolved oxygen concentration as the response would simplify the calculations. 
We observe that the derivative term of liquid phase oxygen balance equation (4.3.1) does not 
contribute significantly to the overall observed OUR which is dependent more on the oxygen 
gradient, thus making it proportional to the dissolved oxygen concentration. Figure 4.5.4(B) 
shows the dissolved oxygen response of azide on the cells. 
 
 
 MICROTITER PLATES IMMOBILIZED WITH OXYGEN SENSOR 
 
 45 
0 5 10 15 20 25
0.00
0.02
0.04
0.06
0.08
0.10
0.12
0.14
O
U
R
(x
1
0
-6
m
o
l 
m
l-1
 h
-1
)
Time(h)
 1mM
 0.25mM
 0.0625mM
 0.004mM
 Control
 
(A) 
0 5 10 15 20 25
0.06
0.08
0.10
0.12
0.14
0.16
0.18
0.20
0.22
D
.O
(m
M
)
Time(h)
 1mM
 0.25mM
 0.0625mM
 0.004mM
 Control
 
(B) 
Figure 4.5.4: A 24 h cytotoxic assay for Sodium azide using CHO cells done with Oxoplate. 
The respiration rates calculated with equation (4.3.1) are shown for various concentrations 
used. All experiments were made in triplicates and the standard deviation is shown.  
 
Figure 4.5.5 compares the azide dose curves for the same with oxygen uptake and, to 
eliminate calculations, dissolved oxygen taken as the responses. Figure 4.5.5 (A) gives the 
curve with OUR as response and Figure 4.5.5 (B) with DO for a 24 h period. The LC50 values 
obtained from both the curves are very similar with a value of 0.078 mM for OUR as response 
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and 0.077 mM for DO as response. Hence the OUR response could be replaced by DO. This 
helps to simplify the calculation without affecting the final result.  
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Figure 4.5.5: The sodium azide dose response curves with CHO cells comparing the LC 50 
obtained with OUR and DO as response at the end of 24h measurement. (A) The dose 
response curve with OUR as the response giving an LC50 value of 0.078 mM. (B) The dose 
response curve with DO as the response giving an LC50 value of 0.077 mM.  
 
 
 MICROTITER PLATES IMMOBILIZED WITH OXYGEN SENSOR 
 
 47 
LC50 determination of known reference compounds 
Primary hepatocytes from the rat were used to determine the LC50 values of known reference 
drugs using the DO response determined via Oxoplates and the classical MTT staining as the 
parameter for viability. The resulting LC50 values were compared with values obtained by 
MTT staining and published values. As shown in Table 4.5.1, the values obtained via the 
oxygen respiration rate are in good accordance to the values assessed by MTT staining. In 
addition, the determined LC50 values are in the same range as published LC50 values for 
human hepatocytes (Li et al., 1999). The deviation for tranylcypromin can be due to 
interspecies differences.  
 
Table 4.5.1: LC50 values for known reference compounds in primary rat or human 
hepatocytes obtained via different methods for viability detection. The values were 
determined using triplicates of the concentration and the standard deviation of the resulting 
oxygen measurements was always found to be ±10 %. LC50 Literature is from published LC50 
values for human hepatocytes (Li et al., 1999). 
 
Compound LC50 (rat, 
Oxoplate) 
LC50 (rat, MTT) LC50 Literature 
(human, MTT) 
Diclofenac 648 µM 537 µM 350 µM 
Clozapine 174 µM 211 µM 315 µM 
Tranylcypromine 2729 µM 4671 µM 1000 µM 
Tamoxifen 72 µM 88 µM 50 µM 
2-Thiouracil > 5000 µM > 5000 µM > 1000 µM 
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4.5.7 Z`-Factor of assay 
The robustness of an assay and its reliability is statistically given by the Z`-factor. Z`-factor, 
the “screening window coefficient” compares the assay’s dynamic range to data variation. 
The Z`-factor was determined from the cytotoxic assay of azide on CHO cells where 3 wells 
were plated with the same concentration. The three wells with azide concentration of 1 mM 
were taken as the negative control and the wells without azide as positive control. The Z`-
factor was calculated using the following formula: 
NCPC
NCPCZ
µµ
σσ
−
+
−=
)33(
1'        (4.5.2) 
where σ is the standard deviation, µ is the mean, PC refers to the positive control and NC to 
the negative control. 
A Z`-factor equal to 1 indicates a perfect assay whereas Z`-factors of above 0.5 indicate 
excellent assays for cell based systems. Using the above formula, the assay gave a Z`-factor of 
0.72 with OUR as the response and 0.74 with DO as the response, showing that the assay 
system is robust. 
 
4.5.8 Cell death kinetics 
The kinetics of cell death was followed by the use of known compounds on HL60 cell line. 
Figure 4.5.6 shows an example using tamoxifen. Tamoxifen is an anti-estrogen used as 
adjuvant in therapy following primary treatment for early stage breast cancer. Its mechanism 
has been attributed to the induction of apoptosis, cell death arrest and accumulation of 
metabolites (Yao et al., 2001; Brandt et al., 2004). The experiments were carried out for 72 h 
to determine the effects of the compound. Figure 4.5.6 (A) gives a typical kinetic toxicity 
curve of tamoxifen on HL60 cells at various concentrations. The curves show unique patterns, 
thus emphasizing the importance of the endpoint to be chosen along with the effect of 
concentration. Figure 4.5.6 (B) gives the dose-response at various time points. The LC50 is 
found to decrease from 0.047 mM at 10 h to 0.007 mM at 60 h thus emphasizing the 
importance of delayed toxic effects. Since the assay is nondestructive, the cells could be 
harvested for further analysis. 
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Figure 4.5.6: Kinetic dose response of HL60 cells to tamoxifen. (A) The cell death kinetic 
curve at different concentrations of Tamoxifen with HL60 cell line. (B) The dose response at 
different time points showing the LC50 shift with respect to time, 0.047 mM at 10 h to 0.007 
mM at 60 h calculated using a four parameter sigmoidal dose-response fit.  
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Kinetic Analysis 
The kinetic curves of tamoxifen were compared with those obtained from SDS. While 
tamoxifen is known to cause cell death by primarily apoptosis followed by secondary 
necrosis, SDS is a known necrotic agent which causes death by cell wall disruption. The time 
course of LC50 was followed for both the compounds. The LC50 of tamoxifen decreases from 
0.049 mM at 6 h to 0.009 mM at 48 h.  As seen from Figure 4.5.7 there is a sudden drop in 
LC50 from 6 h to 12 h with little change during 12 h to 36 h followed by a drop from 36 h to 
48 h, thus indicating different mechanisms of cell death being involved. However, the time 
course of LC50 with SDS shows no such characteristics, thus indicating a simple death 
mechanism. 
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Figure 4.5.7: Time dependence of the 50 % lethal concentration (LC50) of HL60 cells: (A) 
tamoxifen and diclofenac and (B) SDS. The LC50 was determined using Eq. 4.5.2. Each 
LC50 value is the average of three parallel respiration measurements. The error bars indicate 
the standard deviation of these three values. 
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4.5.9 Conclusions 
This chapter describes an assay system which can be applied to a wide range of cell based 
systems. The assay is robust, flexible and applicable for medium to high-throughput systems. 
Its main advantages over other systems are its kinetic nature, the automatic on-line 
measurement and that the cells can further be processed for any subsequent analysis. We 
expect this system to be useful to further understand cell death mechanisms and also in drug 
development and research.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 PHYSIOLOGICAL INVESTIGATIONS ON CHO CELLS 
 
 53 
5 PHYSIOLOGICAL INVESTIGATIONS ON CHO 
CELLS 
 
5.1 Introduction 
 
Metabolic flux analysis has become an important tool in metabolic engineering along with in 
depth physiological studies and has been extensively used for microorganisms. Its use for 
mammalian cells has been limited owing to the complexity of the system. However, there are 
examples for the use of this technique. This has been applied by using material balance 
techniques, radioactive labeling or stable isotope labeling to measure the fluxes through major 
pathways or of a particular enzyme. The pre-requisite for the application of this technique is a 
thorough knowledge about the cellular metabolism to be quantified. In this part of the thesis 
strategies and methodologies are developed for the generation of data which can later be 
applied for the quantification of metabolic fluxes in CHO cells. Moreover, a few special 
physiological studies of the cell line have been carried out.  
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5.2 Review of cellular biochemistry 
 
Metabolism is the overall process through which cells acquire and utilize energy to carry out 
various cellular functions. Hence it is the complete set of the chemical reactions which occur 
in the cells. Metabolism consists of catabolism, which represents the breakdown of substrates 
and biosynthetic precursor substances for the production of energy, and anabolism, which 
uses this energy to construct components of cells such as proteins and nucleic acids. The 
chemical reactions of metabolism are organized into metabolic pathways, in which one 
chemical is transformed into another by a sequence of enzymes. The mammalian cell 
metabolism is complex which makes its quantitative analysis difficult. Glucose and glutamine 
are the primary fuels for mammalian cells for the production of energy (Eagle, 1955; Reitzer 
et al., 1979; Newsholme et al., 1985; Neermann and Wagner, 1996). The cells require the 
conversion of nutrients to energy, reducing power and biosynthetic precursors for its growth 
and maintenance. Energy is present in cells in the form of the high energy molecule adenosine 
5-triphosphate (ATP), while the reducing power is provided by the reduced form of 
nicotinamide adenine dinucleotide (NADH) and nicotinamide adenine dinucleotide phosphate 
(NADPH). Generally, for biosynthesis reactions NADPH is used whereas NADH is used for 
the production of ATP. Several distinct but linked metabolic pathways are used by cells to 
breakdown fuel molecules and transfer the energy released for ATP production and for 
biosynthesis. The catabolism of glucose by way of the glycolysis, pentose phosphate pathway 
and the citric acid cycle, which is also fed by glutamine, supplies the electrons that produce 
the energy in form of ATP, required for the cellular processes, in the respiratory chain. These 
pathways collectively are referred to as the primary or central metabolic pathways. Along 
with glucose and glutamine, amino acids also play an important role in mammalian 
metabolism, both in anabolic as well as catabolic pathways, and interact with the central 
metabolic pathways (Eagle, 1955; Werner and Noe, 1993; Berg et al., 2002). The 
biochemistry of mammalian cells has been much researched and the principle pathways 
responsible for the catabolism and anabolism in cellular metabolism are well established 
(Berg et al., 2002). The mammalian cell biochemistry model considered in this thesis is given 
in Figure 5.2.1. The individual reactions corresponding to the reaction number are given in the 
appendix. The model consists of the glycolytic pathway, the pentose phosphate pathway and 
the tricarboxylic (or citric) acid (TCA) cycle. However, only the reactions that result in a 
change or contribute to the carbon skeleton of the metabolites are considered. Hence many 
linear reactions are lumped together as a single reaction. Along with the biochemistry, the 
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compartmentation of mammalian cells into cytosol and mitochondria is considered in the 
model.  
Figure 5.2.1: The metabolic model of mammalian cell. (Abbreviations: Pyr pyruvate, Lac 
lactate, mCit mitochondrial citrate, mMal mitochondrial malate, mAKG mitochondrial α-
ketoglutarate, mSuc mitochondrial succinate, mOAA mitochondrial oxaloacetate, mAcCoA 
mitochondrial acetyl-CoA. The amino acids have the standard 3 letter abbreviation) 
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Glycolysis 
Glycolysis is the pathway responsible for the anaerobic catabolism of the 6-carbon glucose to 
3-carbon pyruvate for the production of ATP and biosynthetic precursors. In mammalian cells 
glycolysis occurs in the cytosolic compartment of the cells. The reactions of the glycolysis are 
given in Table 5.2.1.  
The overall reaction of glycolysis is  
 
The pyruvate can either enter the TCA cycle for complete oxidation and production of carbon 
dioxide and ATP or it can be converted to fermentation products for the regeneration of 
NAD
+
 and excreted from the cell. In mammalian cells the main waste product formed is 
lactate catalyzed by the enzyme lactate dehydrogenase. In normal cells the production of 
lactate occurs only in anaerobic conditions. However, most mammalian cell lines exhibit high 
rates of anaerobic glycolysis also in the presence of oxygen and thus produce high amounts of 
lactate.  
 
The glycolytic pathway is controlled by the regulation of the three irreversible reactions 
catalyzed by hexokinase, phosphofructokinase and pyruvatekinase. However, cultured cells 
have an altered pattern of regulation which results in a high amount of overflow metabolism 
resulting in the formation of waste products such as lactate.  
In the biochemical model used in this work only the reactions that result in a change of carbon 
are represented. Hence the reaction of phosphofructokinase forming fructose-1,6-
bisphosphate from fructose-6-phosphate is not considered. Moreover, the series of reactions 
from glyceraldehyde-3-phosphate to pyruvate are lumped into two reactions, the formation of 
3-phosphoglycerate from glyceraldehyde-3-phosphate and the conversion of 3-
phosphoglycerate to pyruvate.  
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Table 5.2.1: The reactions of the glycolytic pathway and the enzymes involved [Adapted 
from Berg et al. (2002)]  
 
 
Step Reaction Enzyme    
 
 
1 Glucose + ATP → glucose 6-phosphate + ADP + H
+
 Hexokinase 
2 Glucose 6-phosphate fructose 6-phosphate Phosphoglucose isomerase 
3 Fructose 6-phosphate + ATP → fructose 1,6-
bisphosphate + ADP + H
+
 
Phosphofructokinase 
4 Fructose 1,6-bisphosphate dihydroxyacetone 
phosphate + glyceraldehyde 3-phosphate 
Aldolase 
5 Dihydroxyacetone phosphate glyceraldehyde 3-
phosphate 
Triose phosphate isomerase 
6 Glyceraldehyde 3-phosphate + Pi + NAD
+
 1,3-
bisphosphoglycerate + NADH + H
+
 
Glyceraldehyde 3-phosphate 
dehydrogenase 
7 1,3-Bisphosphoglycerate + ADP 3-
phosphoglycerate + ATP 
Phosphoglycerate kinase 
8 3-Phosphoglycerate 2-phosphoglycerate Phosphoglycerate mutase 
9 2-Phosphoglycerate phosphoenolpyruvate + H2O Enolase 
10 Phosphoenolpyruvate + ADP + H
+
 → pyruvate + 
ATP 
Pyruvate kinase 
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Tricaboxylic acid (TCA) cycle  
The TCA cycle is responsible for the production of reducing equivalents, required for ATP 
formation, and also for supplying biosynthetic precursors. The reducing equivalents are 
produced during the oxidation of carbon compounds. The TCA cycle occurs in the 
mitochondria of eukaryotic cells. Glucose and glutamine are the major energy sources for 
mammalian cells. The pyruvate produced by the glycolytic pathway from glucose easily 
enters the matrix of the mitochondria. The pyruvate is than converted to a two-carbon 
fragment with the loss of the carboxyl group as CO2 and this two carbon fragment attaches to 
a coenzyme known as coenzyme-A (CoA) forming acetyl-CoA. This reaction is catalyzed by 
pyruvate dehydrogenase. A complete turn of the cycle results in the oxidation of the two 
carbon fragment and formation of reducing equivalents. The reactions of the TCA cycle are 
given in Table 5.2.2. The net reaction of the TCA cycle for a single turn is given below.  
 
Coupled with the oxidative phosphorylation and with an assumption of P/O ratio of 2.5, the 
three NADH and one reduced flavin adenine dinucleotide (FADH2) can yield a maximum of 9 
molecules of ATP (GTP equivalent to ATP)  
 
In addition to the ATP from TCA cycle, glycolysis and the conversion of pyruvate to acetyl-
CoA produce an NADH each which can provide another five ATP. Hence the aerobic 
metabolism is a far more efficient mechanism for energy production than anaerobic 
metabolism. The TCA cycle is controlled by the NAD
+
/NADH ratio as well as the 
concentration of intermediates. The TCA cycle is regulated by the activities of the enzymes 
pyruvate dehydrogenase, citrate synthase, isocitrate dehydrogenase, α-ketoglutarate 
dehydrogenase and malate dehydrogenase (Berg et al., 2002). In mammalian cells it has been 
found that glutamine rather than glucose is the primary source of the TCA cycle. 
As with the glycolytic pathway only the reactions that result in a change to the carbon 
skeletons of the metabolites are considered for this work. Hence the metabolites, citrate and 
isocitrate, succinyl-CoA and succinate, and fumarate and malate are lumped together as seen 
in Figure 5.2.1.    .  
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Table 5.2.2: The reactions of the TCA cycle and the enzymes involved [Adapted from Berg et 
al. (2002)] 
 
Step Reaction Enzyme     
 
 
1 Acetyl CoA + oxaloacetate + H2O → citrate + CoA 
+ H
+
 
Citrate synthase     
2a Citrate cis-aconitate + H2O Aconitase     
2b cis-Aconitate+ H2O isocitrate Aconitase     
3 Isocitrate + NAD
+
 α-ketoglutarate + CO2 + NADH Isocitrate dehydrogenase     
4 α-Ketoglutarate + NAD
+
 + CoA succinyl CoA + 
CO2 + NADH 
α-Ketoglutarate dehydrogenase 
complex 
    
5 Succinyl CoA + Pi + GDP succinate + GTP + CoA Succinyl CoA synthetase     
6 Succinate + FAD (enzyme-bound) fumarate + 
FADH2 (enzyme-bound) 
Succinate dehydrogenase     
7 Fumarate + H2O L-malate Fumarase     
8 L-Malate + NAD
+
 oxaloacetate + NADH + H
+
 Malate dehydrogenase     
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Pentose phosphate pathway (PPP) 
The PPP is responsible for the production of NADPH, and pentose and erythrose carbon units 
for the biosynthetic requirement of the cell. The pathway consists of an oxidative branch 
producing NADPH and a non-oxidative branch responsible for the inter-conversion of sugars 
and connecting the PPP with glycolysis. The reactions are given in Table 5.2.3. The overall 
reaction of the oxidative branch is given below.  
 
 
The PPP can operate in different modes depending on the cellular requirement (Berg et al., 
2002). In the non-oxidative branch it can interconvert sugars from 3-carbon molecules to 5-, 
4- and 7-carbon molecules or it can completely oxidize glucose-6-phosphate to CO2 for 
production of NADPH and also contribute to ATP production by converting glucose-6-
phosphate to pyruvate. The first step of the oxidative branch by the enzyme glucose 6- 
phosphate dehydrogenase which is irreversible acts as the main regulatory control for the 
pathway. The activity of this enzyme is determined by the ratio of NADP
+
/NADPH. The 
activity of the PPP has been found to be low in mammalian cells, probably due to the slow 
growth rates of the cells. In the biochemical model considered for this work, both the 
oxidative and the non-oxidative branch of the pathway are considered.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 PHYSIOLOGICAL INVESTIGATIONS ON CHO CELLS 
 
 61 
 
Table 5.2.3: The reactions of the pentose phosphate pathway and the enzymes involved 
[Adapted from Berg et al. (2002)] 
 
 
 
Reaction Enzyme 
 
 
Oxidative phase  
Glucose 6-phosphate + NADP
+
→ 6-phosphoglucono-δ-lactone 
+ NADPH + H
+
 
Glucose 6- phosphate 
dehydrogenase 
6-Phosphoglucono-δ-lactone + H2O → 6-phosphogluconate + 
H
+
 
Lactonase 
6-Phosphogluconate + NADP
+
→ ribulose 5- phosphate + CO2 + 
NADPH 
6-Phosphogluconate 
dehydrogenase 
Nonoxidative Phase  
Ribulose 5- phosphate ribose 5- phosphate Phosphopentose isomerase 
Ribulose 5- phosphate xylulose 5- phosphate Phosphopentose epimerase 
Xylulose 5- phosphate + ribose 5- phosphate sedoheptulose 7- 
phosphate + glyceraldehyde 3- phosphate 
Transketolase 
Sedoheptulose 7- phosphate + glyceraldehyde 3- phosphate 
fructose 6- phosphate + erythrose 4- phosphate 
Transaldolase 
Xylulose 5- phosphate + erythrose 4- phosphate fructose 6- 
phosphate + glyceraldehyde 3- phosphate 
Transketolase 
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Oxidative phosphorylation 
The NADH and FADH2 produced from the glycolysis and TCA cycle are primarily used to 
generate energy in form of ATP for the cellular requirement. Oxidative phosphorylation 
produces ATP from the energy released when the electrons in NADH and FADH2 are 
transferred to oxygen. Hence oxygen is essential for this process to occur. In eukaryotes 
oxidative phosphorylation occurs in the mitochondrial compartment via the electron transport 
assembly. The electron transport assembly is comprised of a series of protein complexes that 
catalyze sequential oxidation reduction reactions and are located in the mitochondria. This 
process is facilitated by a proton carrier in the inner mitochondrial membrane known as ATP 
synthase. From thermodynamics it is possible to produce 3 ATP from every 2 electrons 
transferred from NADH to oxygen and 2 ATP from FADH2 (Berg et al., 2002). However, it 
has been has shown that for every 2 electrons transferred from NADH to oxygen only 2.5 
equivalents of ATP are synthesized and 1.5 for FADH2. The oxidative phosphorylation is 
controlled by the availability of ADP. Higher amount of ADP drives the process faster, as the 
cells require more ATP. The total amount of theoretically possible ATP molecules produced 
from the complete oxidation of a single molecule of glucose is given in Table 5.2.4. This 
pathway does not have any effect on the carbon skeleton of the metabolites and hence is not 
considered in the model. 
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Table 5.2.4: The amount of ATP produced from the complete oxidation of a single molecule 
of glucose [Adapted from Berg et al. (2002)] 
 
 
Reaction sequence ATP yield per 
glucose molecule 
 
 
Glycolysis: Conversion of glucose into pyruvate (in the cytosol)  
Phosphorylation of glucose - 1 
Phosphorylation of fructose 6-phosphate - 1 
Dephosphorylation of 2 molecules of 1,3-BPG + 2 
Dephosphorylation of 2 molecules of phosphoenolpyruvate + 2 
2 molecules of NADH are formed in the oxidation of 2 molecules of 
glyceraldehyde 3-phosphate 
 
Conversion of pyruvate into acetyl CoA (inside mitochondria)  
2 molecules of NADH are formed  
Citric acid cycle (inside mitochondria)  
2 molecules of guanosine triphosphate are formed from 2 molecules 
of succinyl CoA 
+ 2 
6 molecules of NADH are formed in the oxidation of 2 molecules 
each of isocitrate, α-ketoglutarate, and malate 
 
2 molecules of FADH2 are formed in the oxidation of 2 molecules of 
succinate 
 
Oxidative Phosphorylation (inside mitochondria)  
2 molecules of NADH formed in glycolysis; each yields 1.5 
molecules of ATP (assuming transport of NADH by the glycerol 3-
phosphate shuttle) 
+ 3 
2 molecules of NADH formed in the oxidative decarboxylation of 
pyruvate; each yields 2.5 molecules of ATP 
+ 5 
2 molecules of FADH2 formed in the citric acid cycle; each yields 
1.5 molecules of ATP 
+ 3 
6 molecules of NADH formed in the citric acid cycle; each yields 
2.5 molecules of ATP 
+ 15 
  
NET YIELD PER MOLECULE OF GLUCOSE + 30 
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Metabolism of amino acids 
Mammalian cells in tissue culture require a complex mixture of nutrients to grow (Eagle, 
1955). Cell culture media typically consists of a mixture of amino acids, vitamins, buffers, 
salts, essential fatty acids, growth factors etc. Many of these components, especially amino 
acids and growth factors, interact with the primary pathways and their metabolism needs to be 
taken into account for a quantitative analysis of the cellular physiology. In the present set of 
experiments the cells were grown in a media which was chemically defined and contained no 
peptides or proteins. This simplifies the analysis as only the metabolism of amino acids needs 
to be taken into consideration. All the amino acids are supplied in the medium and the major 
utilization of amino acids is for the biosynthesis of proteins. However, a majority of them can 
also undergo catabolism. The metabolic routes of amino acids and their interaction with the 
central metabolism are well researched (Berg et al., 2002). A very brief description of their 
metabolism and interaction with the primary pathways is given below.  
Glutamine is an important metabolic fuel required for the energy production in mammalian 
cultured cells (Eagle, 1955; Reitzer et al., 1979; Newsholme et al., 1985; Neermann and 
Wagner, 1996). It is the major nitrogen provider for the cells required for the biosynthesis of 
nucleotides and other compounds. It is the primary fuel for the TCA cycle. It is linked 
biochemically with the metabolism of ammonia, glutamate and many other amino acids. The 
use of glutamine as a substrate for the production of energy takes place via glutaminolysis. 
The 5-carbon skeleton of glutamine enters the TCA cycle in form of α-ketoglutarate. Though 
there are several possible routes for the conversion of glutamine to α-ketoglutarate it has been 
found that the primary route is the conversion of glutamine to glutamate via the activity of the 
mitochondrial enzyme glutaminase (Newsholme et al., 1985).  
 
The glutamate formed can then be converted to α-ketoglutarate via the activity of the enzymes 
alanine transaminase, 
 
 aspartate transaminase  
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or glutamate dehydrogenase.  
 
The catabolic pathways of other amino acids such as proline, histidine and arginine all 
produce glutamate which can then produce α-ketoglutarate. Serine can be produced from the 
glycolytic intermediate 3-phosphoglycerate and undergoes catabolism to give glycine and 
N
5
,N
10
-methylene-tetrahydrofolate (THF). The N
5
,N
10
-methylene-THF acts as a methylene 
group donor and is involved in many biosynthetic pathways. Serine is also used for the 
biosynthesis of lipids whereas glycine is utilized for nucleotide biosynthesis. Asparagine is 
converted to aspartate by the enzyme asparagenase. The TCA cycle intermediates are also 
supplied by the metabolism of other amino acids. Valine, methionine, tyrosine, phenylalanine, 
isoleucine and threonine all supply intermediates of the TCA cycle. Leucine, lysine and 
isoleucine undergo catabolism to produce acetyl-CoA. Aspartate can form oxaloacetate via 
the action of transaminase and hence can interact with the TCA cycle. Aspartate and 
glutamate also play a part in the transport of reducing equivalents from the cytoplasm to the 
mitochondria. All these reactions are considered in the metabolic model to be used for the 
quantification of metabolic fluxes in the primary network.  
 
Anaplerotic reactions 
Anaplerotic reactions are reactions which replenish the pools of metabolic intermediates
 
in the 
TCA cycle. The TCA
 
cycle along with the formation of the reducing equivalents also 
functions in biosynthetic processes in which intermediates
 
are removed from the cycle; this 
necessitates anaplerotic reactions
 
to replenish TCA cycle intermediates to ensure its continued 
function (Owen et al., 2002). The main anaplerotic reaction is the entry of pyruvate in the 
TCA cycle after being carboxylated to oxaloacetate via pyruvate carboxylase. The formation 
of oxaloacetate from aspartate and α-ketoglutarate from glutamate also serve as anaplerotic 
reactions. These reactions are shown in Figure 5.2.1 and will be used for further quantitative 
analysis.  
 
Malic enzyme 
Malic enzyme catalyses the formation of pyruvate from the TCA cycle intermediate malate 
and its activity allows for the complete oxidation of glutamine by removing excess carbon 
atoms from the TCA cycle (Newsholme et al., 1985). This in turn allows the efficient use of 
glutamine for the production of ATP.  
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Mitochondrial transport of metabolites 
The mitochondrial membrane is impervious to reducing equivalents and hence special 
transport shuttles are used for their transport. The most important shuttle for the transport of 
the equivalents is the aspartate-malate shuttle. The transport occurs with the electrons being 
carried into the mitochondria via malate which forms oxaloacetate and transferring the 
electrons for the formation of NADH. This is followed by the transamination of oxaloacetate 
to give aspartate with the amino group provided by glutamate which forms α-ketoglutarate. 
Aspartate is then transported to the cytoplasm where it is converted back to oxaloacetate. The 
oxaloacetate in the cytoplasm then takes up the electrons from the reducing equivalents and is 
converted back to malate. This energy rich malate then undergoes the same process forming 
reducing equivalents in the mitochondria with the formation of oxaloacetate. This results in a 
continuous carbon exchange between the TCA intermediates with glutamate and aspartate. 
These reactions are considered in the biochemical model to be used for the determination of 
carbon fluxes. 
The other transport reaction considered in the biochemical model is the transport of citrate out 
of the mitochondria for the synthesis of fatty acids. Acetyl-CoA is the main precursor for the 
biosynthesis of fatty acids and the process occurs in the cytosol. However, acetyl-CoA cannot 
be transported out of the mitochondria. Citrate is transported out of the mitochondria into the 
cytoplasm where the enzyme citrate lyase converts it to acetyl-CoA and oxaloacetate. The 
acetyl-CoA formed is used for fatty acid synthesis. Oxaloacetate is converted to malate by the 
enzyme malate dehydrogenase which is than decarboxylated to pyruvate by the cytosolic 
malic enzyme.  
 
Biomass formation 
The central metabolic pathways provide the precursors required for the synthesis of biomass 
(cells). The amount of precursors required for the biosynthesis of the major biomass 
components can be estimated from the composition of the biomass and known biosynthetic 
metabolic pathways. The major components of biomass are proteins, lipids, nucleotides and 
carbohydrates. The equations deriving each of the major biomass components along with their 
average molecular weight are given in the appendix.  
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5.3 Metabolic flux analysis 
 
The growth and maintenance of cells is governed by the operation of complex systems of 
biochemical reactions. These systems of biochemical reactions are called metabolic networks 
and involve the action of numerous enzymes along with several regulatory mechanisms. The 
biochemistry of the mammalian cell along with the various networks/pathways has been 
explained briefly in the previous section. Metabolic flux analysis (MFA) is a powerful 
methodology for the determination of intracellular pathway fluxes (reaction rates) through 
these networks to study cellular physiology. The advantage of MFA is that it provides a 
quantitative snapshot of the physiological state of the cell. It has been used for information 
about pathway control (e.g. at branch points), identification of new or alternative pathways, 
quantifiable changes to normal cellular physiology under conditions of stress or under 
influence of environmental changes and for strain optimization. It has also emerged as a 
powerful technique in the field of metabolic engineering (Nielsen, 1998).  
5.3.1 Methodology 
Metabolite balancing 
Conventional flux analysis of primary metabolic pathways is based on a stoichiometric model 
and on the measurement of a certain number of extracellular fluxes. The intracellular fluxes 
are calculated by using a stoichiometric model (metabolic pathway network) for the major 
intracellular reactions depicting the active metabolism and applying mass balance equations 
around the metabolites. Reaction kinetics specifies that the intracellular reactions depicting 
the rate of change of the metabolites be described by sets of differential equations. However, 
with an assumption of steady state the variation with respect to time tends to zero and thus the 
whole system is reduced to a set of algebraic equations. The idea of determining the 
intracellular steady state reaction rates by material balances was first used for a metabolic 
model of citrate production from glucose (Verhoff and Spradlin, 1976). This method solely 
relies on the known stoichiometry of a given biochemical reaction network (Varma and 
Palsson, 1994; Vallino and Stephanopoulos, 2000).  
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With the knowledge of the metabolic network along with a set of measurable fluxes (the 
uptake and secretion rates of metabolites along with biomass composition) it is possible to 
calculate the fluxes through each of the reaction described in the network using matrix algebra  
 
)()( tXAtr ×=     (5.3.1) 
 
where A is n × m matrix of stoichiometric coefficients of the reactions; X (t) is m-dimensional 
flux vector; r (t) is n-dimensional metabolite rate vector. Application of least square method 
results in solving the system of equation and determination of the intracellular fluxes.  
The application of metabolite balance techniques for flux calculation is highly limited 
(Bonarius et al., 1998; Wiechert, 2001). Linearly dependent reactions such as in metabolic 
cycle can cause singularity in the network thus making the system underdetermined (Bonarius 
et al., 1997).  
 
Metabolic flux analysis using isotopic tracers 
Metabolic flux analysis by metabolite balancing can be complimented with the inclusion of 
additional measurement techniques providing more detailed flux information than that 
embedded in typical extracellular metabolite data. Such information is particularly important 
for the study of underdetermined systems, which occur when the number of unknown fluxes 
exceeds the number of available flux measurements and metabolite balances. This is usually 
the case with highly interconnected networks, networks comprising metabolic cycles and 
reversible reactions. The basis of such measurement methods is the use of isotope labels as 
cellular substrates which distribute the label in the metabolites formed based on its 
metabolism (Wiechert, 2001). Both radioactive and stable isotopes have been applied for the 
determination of metabolic fluxes (Kelleher, 2001).  
With their ease of handling and advances in the analytical techniques such as mass 
spectrometry (MS) and nuclear magnetic resonance (NMR), stable isotope labeled compounds 
are becoming the substrates of choice for metabolic studies (Wiechert and de Graaf, 1996; 
Szyperski, 1998). With experiments performed with isotope enriched substrates and 
measurement of the fractional enrichment of the isotopes in intracellular and extracellular 
metabolites, it is possible to apply an additional set of constraints in the stoichiometric model, 
and a better estimation of the intracellular fluxes may be obtained (Wiechert and de Graaf, 
1996). For the measurement of the enrichment, techniques such as MS and NMR have been 
used. Each system brings with advantages and disadvantages (Szyperski, 1998; Wiechert et 
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al., 2001). In recent times, gas chromatography mass spectrometry (GC-MS) has emerged as a 
powerful technique for the measurement of the isotopic enrichment of metabolites due to its 
high precision, sensitivity and fast measurement (Wittmann and Heinzle, 1999; Wittmann, 
2007). A key concept in evaluating the data from GC-MS concept of is that of an isotopomer 
of a given metabolite. The term isotopomer refers to the different labeling states of a 
particular metabolite (Malloy et al., 1988; Wiechert, 2001). For example, a metabolite with 
’n’ carbon atoms can be labeled or unlabeled at each carbon atom position. Thus there can be 
2
n
 different labeling states of this molecule which means that there are 2
n
 different carbon 
isotopomers (Wiechert, 2001). GC-MS can resolve single mass isotopomers of a compound 
differing by the number of labeled atoms and thus allows the measurement of mass 
isotopomer distributions. The mass isotopomers distribution of a compound can be obtained 
from the analysis of the ions from the metabolite, which contains the whole isotopic skeleton 
of the analyte. The mass isotopomers distribution can be used to calculate the average isotopic 
enrichment of a molecule called the fractional isotope labeling (Wittmann, 2007). The most 
commonly used stable isotopes for flux calculation involve substrates with 
13
C labeling. In 
these cases, the cells are fed with 
13
C labeled substrates, most commonly 
13
C labeled glucose. 
The distribution of the isotope in the monomers of cellular macromolecules, the intracellular 
and extracellular metabolites of the cells at steady state is then determined using GC-MS. 
These data combined with metabolite balancing can be used for the calculation of metabolic 
fluxes by a computer flux model. For determination of the intracellular fluxes, the model 
should contain all relevant reactions and pathways of the metabolic network being 
investigated. The model is based not only on the balancing of the metabolites but also on the 
transfer of the carbon atoms during each of the reactions in the metabolic network (Wiechert 
and de Graaf, 1996; Wittmann, 2007).  For the computation of the fluxes, random initial 
values for the free fluxes are supplied from which the model calculates the dependent fluxes 
and the labeling pattern of the metabolites for the supplied fluxes based on the network. 
Numerical optimization protocols are applied to minimize the difference between the 
simulated and experimental data. Thus from the ‘fit’ of these data sets the absolute carbon 
fluxes throughout the network are obtained (Wiechert and de Graaf, 1996; Wittmann and 
Heinzle, 1999; Wittmann, 2007).  The determination of 
13
C labeling patterns in large 
metabolic networks is a computationally demanding task and various methods are available 
for their calculation. Few of the methodologies are briefly explained below.  
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Atom mapping matrices (AMM) 
The concept of atom mapping matrices (AMM) was introduced for solving the complexities 
associated with positional isotope labeling or isotopomer distribution (Zupke and 
Stephanopoulos, 1994). The AMM describe the transfer of the carbon atoms from the 
reactants to products of every reaction in a metabolic network. Thus the AMM are used to 
relate the reactant and product isotopomers. The AMM are generated for each reaction in the 
metabolic network based upon the known biochemistry and do not depend on the network 
structure. Thus a series of equations are created using the mass balance along with the 
appropriate AMM and solved iteratively to give the absolute carbon fluxes in the network.  
 
Isotopomer mapping matrices (IMM) 
Shortly after the concept of metabolite vectors in AMM, the concept of isotopomer 
distribution vector (IDV) and isotopomer mapping matrices (IMM) were introduced (Schmidt 
et al., 1997). The IDV’s contain mole fractions rather than the fractional enrichment of single 
atoms of metabolite molecules that are labeled in a specific pattern. Thus, the IDV of a 
molecule with ‘n’ carbon has 2
n
 elements. There are generally one or two reactant molecules 
and one or two product molecules involved in biological carbon exchange reactions. The 
isotopomer distribution of the product molecules is determined by the isotopomer distribution 
of the reactants and the reaction mechanism, which is specified by the AMM’s of the 
particular conversion. Hence, IDV’s of the product molecules can be calculated when the 
AMM’s and the reactant IDV’s are available. Isotopomers mapping matrices (IMM’s) can be 
constructed to sum up all pairs of reactant isotopomers that produce the respective product 
isotopomer in all positions of the product IDV. There is one IMM defined for each pair of 
reactant and product molecules in a biochemical carbon exchange reaction. Using the 
equations created for a metabolic network, along with the mass balances, the flux analysis can 
be carried out (Schmidt et al., 1997).  
 
Isotopomer path tracing  
Isotopomer path tracing identifies paths between observable (measurable) isotopomers, many 
of which are separated by nonadjacent (non-measurable) isotope paths. It generates a direct 
mapping from isotopomer measurements to metabolic fluxes (Forbes et al., 2001).  
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Elementary metabolite units 
The elementary metabolite unit (EMU) framework is based on a decomposition method that 
identifies the minimum amount of information needed to simulate isotopic labeling within a 
reaction network using the knowledge of atomic transitions occurring in the network 
reactions. The functional units generated by the decomposition algorithm, called EMU, form 
the basis for generating system equations that describe the relationship between fluxes and 
stable isotope measurements (Antoniewicz et al., 2007). EMU are distinct subsets of 
metabolite atoms as defined by Antoniewicz et al. (2007). A metabolite with ‘n’ atoms would 
have 2
n
-1 EMU. For example a metabolite with 3 atoms would have 3 EMU of size 1 (A1, A2, 
A3), 3 EMU of size 2 (A12, A13, A23) and 1 EMU of size 3 (A123). The EMU’s in a metabolic 
network follow two types of reactions, condensation and uni-molecular. The metabolic 
network is decomposed into EMU reactions and can be solved for intracellular fluxes.  
 
Cumomer network 
The method of IMM made it possible to simulate all isotopomers distribution for the given set 
of metabolic fluxes, while the best fit to the experimental distribution pointed to the set 
compatible with the measured distribution. However, the presence of large exchange fluxes 
causes severe instability of numerical solution or convergence problems, which restricts the 
application of this method. This instability can be circumvented by the application of an 
automatic correction involving the isotopomers pools of certain metabolites (Wittmann and 
Heinzle, 2001). Another elegant way to overcome the problem of instability is by 
reformulating isotopomer balance equations into cumomer balance equations (Wiechert et al., 
1999). The term cumomer (derived from cumulative isotopomers) designates a sum of 
isotopomers with fixed positions of label (a 1-cumomer fraction is a sum of the positional 
enrichments). Thus cumomers are a set of one or more isotopomers that contain a particular 
labeled fragment. Cumomers are specified using a notation in which 1 indicates a labeled 
carbon atom, and X indicates an atom that is either labeled or unlabeled. The transformation 
of the equations in terms of cumomers simplifies the computation and makes it possible to 
obtain the solution in a single step based on matrix calculus. The equations formulated in 
terms of cumomer fractions can be solved analytically as a cascade of linear systems, 
evaluating the cumomer fractions one by one starting from the 0-cumomer fraction. Then the 
cumomer fractions can be transformed back into isotopomer fractions.  
For the present analysis, it will be attempted to create a cumomer network for the metabolic 
reactions of a mammalian cell. However, the creation of such a network requires a thorough 
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knowledge of the biochemistry and considerable modeling efforts. In this thesis the required 
experimentation leading to data required for such an analysis is carried out. Along with this, 
an investigation into the mammalian biochemistry for an improvement in the network 
described earlier is also attempted. The modeling efforts for the whole cell metabolic flux 
analysis of a mammalian cellular system are presently underway (in co-operation with Dr. 
Tae Hoon Yang, James Brown Cancer Centre, Louisville, USA) but will not be discussed in 
this thesis.  
 
5.3.2 Metabolic flux analysis in mammalian cells 
Traditionally metabolic fluxes have been determined by the use of isotopic-tracers. However, 
these techniques were earlier generally applied to elucidate the biochemical pathway, rather 
than its quantification. Examples of the use of tracer substrates for the quantification of 
carbon fluxes at certain branch points by tracing the fate of the carbon atoms have been 
provided in a later chapter. To determine the fluxes through primary metabolic pathways the 
technique of metabolite balancing has been widely used. This methodology requires the 
measurement of extracellular metabolites only (Varma and Palsson, 1994). By measuring the 
consumption of given substrate(s) and/or the production of specific end product(s) it is 
possible, knowing the reactions of the metabolic pathways and assuming a steady-state for the 
metabolic intermediates, to calculate the fluxes through different pathways as described 
earlier. This method has been applied frequently in mammalian cell cultures and few of the 
studies performed are briefly described.  
Rat heart metabolism was investigated using material balancing to study the cytosolic-
mitochondrial interactions with regard to citric acid cycle intermediates (Safer and 
Williamson, 1973). Wanders et al. (1983) applied this technique to study the effect of 
bicarbonate and for the determination of glutamate oxidation in rat liver mitochondria. The 
effect of dissolved oxygen concentration on the metabolism of a hybridoma cell line was 
determined by using stoichiometric balancing (Zupke et al., 1995). The metabolism of 
peptides as substitute for serum in a Chinese hamster ovary cell line was studied using mass 
balances (Nyberg et al., 1999). The phenomenon of multiple steady states in continuous 
cultures of mammalian cell cultures was investigated in various studies using metabolic flux 
analysis by metabolite balancing (Follstad et al., 1999; Europa et al., 2000). Investigations 
into hepatic metabolism have also been carried out using material balancing techniques (Lee 
et al., 2000; Arai et al., 2001; Chan et al., 2003b; Chan et al., 2003a). The effects of a 
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glutamate based media in the absence of glutamine on intracellular fluxes have been studied 
in the industrially important CHO cell line (Altamirano et al., 2001). A high-throughput 
methodology based on metabolic flux analysis to screen cellular cultures, to study the effects 
of toxins, for media optimization etc has been introduced recently (Balcarcel and Clark, 
2003). Metabolic differences as described by intracellular fluxes during different 
physiological states in a hybridoma cell line has also been studied (Gambhir et al., 2003). 
MFA was instrumental in the identification of a key limitation in the metabolic pathways of 
HEK-293 cell line which led to an improvement in the glucose and glutamine metabolism by 
expression of cytosolic pyruvate carboxylase enzyme (Elias et al., 2003). Increase in 
adenovirus vector production by HEK-293 cells was achieved using strategies developed by 
investigation of metabolic fluxes (Henry et al., 2005). The metabolism of CHO cell line on 
galactose for the reduction of overflow metabolism was investigated with MFA (Altamirano 
et al., 2006).  
The above are only few of the many examples for the applications of material balance 
technique for determination of intracellular fluxes in primary pathways of mammalian cells.  
Nevertheless this methodology is limited in its usage and fails in situations for the estimation 
of fluxes in parallel pathways, bidirectional reaction steps, split pathways and in metabolic 
cycles (Wiechert, 2001). Moreover, frequently the system of equations to be solved is under-
determined. Bonarius et al. (1997) described a theoretical constraint based approach for 
overcoming the above limitations. The most commonly used methodology for the solution of 
the problems encountered with under-determined system is linear optimization by applying 
objective functions such as “minimizing the sum of squares of fluxes” , “maximize ATP 
production” etc (Bonarius et al., 1996; Bonarius et al., 1997). However, it has been seen that 
the above methodologies do not give exact fluxes and need to be complimented with data 
from isotopic tracers for the accurate determination of fluxes in cyclic reactions such as those 
found in the pentose phosphate pathway (Bonarius et al., 1998; Schmidt et al., 1998). Hence 
most of the studies described above do not consider these pathways in their flux analysis 
(Paredes et al., 1998; Follstad et al., 1999; Nyberg et al., 1999; Chan et al., 2003b; Chan et al., 
2003a). Therefore, even if the analysis of fluxes by material balancing is a useful technique, it 
is not sufficient to give information about the entire primary central cellular metabolism. For 
the accurate quantification of cellular fluxes, it is necessary to compliment the stoichiometric 
balancing of metabolites with isotopic labeling analysis. A few examples for the use of 
isotopic tracers in mammalian flux analysis are provided in later chapters of the thesis.  
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5.4 Materials and methods 
 
5.4.1 Cell line and culture conditions 
The cell line and culture conditions are similar to the one described in the previous part under 
materials and methods. Briefly, the Chinese Hamster Ovary (CHO) cell line T-CHO ATIII, 
obtained from Gesellschaft for Biotechnologische Forschung mbH (Braunschweig, Germany), 
was used for this research. The cells produce recombinant antithrombin III, which has clinical 
applications for its coagulation inhibitory activity. The cells are adapted to grow in a protein 
and peptide free, chemically defined medium (SMIF 6, Life Technologies, Karlsruhe, 
Germany). The cells were grown in 250 ml spinner flasks placed in a 12 % CO2 humidified 
gas controlled incubator at 37°C. The cultures were maintained in growth phase by changing 
the medium using the serial dilution method. 
5.4.2 Cell viability assays 
Cells were counted using a Neubauer heamocytometer. Cell concentration and viability were 
determined using the Trypan Blue exclusion method already described in the previous part.  
5.4.3 Chemicals 
All chemicals used for media formulation were obtained from Sigma Aldrich and were cell 
culture grade. Other chemicals were obtained from the following sources: Acros Organics 
(Geel, Belgium); Merck (Darmstadt, Germany); Aldrich (Steinheim, Germany); Fluka 
(Buchs, Switzerland). The tracer substrates used were supplied by Cambridge Isotopes, Inc. 
(Andova, MA). 
5.4.4 Dry weight determination 
A known volume of culture containing approximately 1 × 10
10
 cells was taken in replicates. 
These were centrifuged and concentrated to a volume of about 1 mL and transferred to a pre-
weighed 1.5 mL centrifuge tubes. The tubes were then centrifuged, the supernatant removed 
and the pellet was washed twice with saline (0.9 % NaCl). The weight of the wet pellet in the 
centrifuge tubes was noted. The tubes were then placed in an 80 ˚C incubator for 72 h and 
weighed.  The difference in the weight of the tubes with pellet and without pellet along with 
the number of cells gives the dry weight of the cells.  
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5.4.5 Sampling for analysis 
The cells were cultured in media containing labeled substrates. Briefly the cells grown in 
normal medium were washed twice with the respective substrate deficient media and 
centrifuged. The cells were then transferred to the media containing the labeled substrates and 
resuspended. The initial samples were taken after the addition of the media. Hence the initial 
time represented by time “0” is after the addition of the media. In the experiment with parallel 
cultures this time varied from 5 minutes to a maximum of 30 minutes.  
5.4.6 Quantification of extracellular metabolites 
The quantification of glucose and lactic acid was done by high pressure liquid 
chromatography (HPLC) (Kontron Instruments, Neufahrn, Germany) using an Aminex HPX-
87H column (300 by 7.8; Biorad, Hercules, CA, USA) at 45°C, with 7 mM H2SO4 as the 
mobile phase in an isocratic mode and a flow rate of 1 ml min 
-1
, and subsequent detection via 
determination of refraction indexes for Glucose (ERC-7515A, ERC Inc, Alteglofsheim bei 
Regensburg, Germany) or UV absorption at 210 nm for lactate and pyruvate (HPLC 535, 
Biotek, Neufahrn, Germany).  
The quantification of the amino acids in the cell medium was done with HPLC (Agilent 1100, 
Agilent, Waldbronn, Germany) as described in Kromer et al. (2005). The cell medium was 
diluted 1:2 with a solution containing 225 µM of α-aminobutyric acid (ABU). ABU acts as an 
internal standard for the quantification. The separation was via a guard cartridge and a Gemini 
column (Phenomenex, Aschaffenburg, Germany) and was carried out at a flow rate of 1 mL 
min
-1
 at a column temperature of 40ºC using 40 mM NaH2PO4 (eluent A, pH 7.8, adjusted 
with NaOH) as polar phase and an acetonitrile/methanol/water mixture (45/45/10) as non-
polar phase (eluent B). The following gradient was applied: Start 0 % B, 40.5min 40.5 % B, 
41min 61 % B, 44min 82 % B, 44.5min 100 %B, 47min 0 % B, 2min 0 % B for equilibration. 
The amino acids are pre-derivatized with o-phtaldialdehyde (OPA) and mercaptoethanol 
(Roth, 1971) subsequently followed by 9-fluorenylmethyl chloroformate (FMOC-Cl) with 3-
Mercaptopropionate (0.5 % in 0.5M Bicin) for proline (Schuster, 1988; Haynes et al., 1991). 
OPA reacts with primary amines in the presence of the thiol compound, to form highly 
fluorescent isoindole products. However, this does not detect amino acids that exist as 
secondary amines (e.g. proline). 9-Fluorenylmethyl chloroformate (FMOC-Cl) reacts with 
both primary and secondary amino acids to form highly fluorescent products. The detection of 
the amino acids is via a florescence detector (Agilent, Waldbronn, Germany) with 340 nm 
excitation and 450 nm emission for the primary amines and changed at 43.5 minutes to 266 
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nm excitation and 305 nm emission for the detection of proline. The peaks are manually 
integrated, and the quantification is done knowing the dilution and the concentration of the 
internal standard. 
 
Specific rate calculation:  
The specific rates of metabolites during the exponential phase were calculated using the 
equation (Zupke et al., 1995): 
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where qs is the specific rate, [S] is the measured metabolite conc. , [S0] is the initial conc. , N0 
is the initial biomass, µ is the specific growth rate and t is the time. Glutamine is hydrolyzed 
to pyrrolidone-carboxylic acid under cultivation conditions. The rate of glutamine 
decomposition is first order and calculated to be 0.0037 h
-1
.  The actual uptake rate was 
calculated by using the equation  
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where k is the rate constant; qGLN  is actual uptake rate; X is cell number with d/dt(X) = µX 
with µ being the sp. growth rate. 
The equation was fitted with obtained cell growth and glutamine uptake data using the 
software Berkeley Madonna.  
5.4.7 Gas chromatography-mass spectrometry analysis 
The mass-isotopomers and the fractional carbon labeling (FCL) of the monomers in the 
cellular macromolecules and the extracellular metabolites were obtained by analyzing the 
samples using Gas Chromatography-Mass Spectrometry (GC MS) with HP 6890 GC (Hewlett 
Packard, Palo Alto, CA, USA), equipped with a HP-5MS Column 5 % Phenyl-Methyl-
Siloxan- diphenylpolysiloxan; 30 m x 0.251 mm x 0.25 µm, Agilent, Waldbronn, Germany) 
and Quadrupole- Mass Spectrometer (MS 5973, Agilent, Waldbronn, Germany). Electron 
Ionization was carried out at 70eV. Carbon mass isotopomer fractions and the fractional 
labeling of the analyzed samples were calculated from the measured mass distribution of the 
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derivatized analyte using the method developed by Yang (2006), which is based on earlier 
work of  Wiechert et al. (2001).  
 
Extraction and analysis of lactate 
Lactate was extracted from the cellular supernatant using a protocol modified from Suh et al. 
(1997) . Briefly, 100µl of supernatant was acidified with 25µl of conc. HCl. To this 100µl of 
ethyl acetate was added and thoroughly vortexed for 10-15 min. The organic phase containing 
lactic acid was then carefully removed and derivatized to its t-butyldimethylsilyl (t-BDMS) 
derivative by N-Methyl-N-(t-butyldimethylsilyl)trifluoroacetamide (MTBSTFA, Macherey-
Nagel, Dueren, Germany) (Schwenk et al., 1984) by adding an equal amount to the amount of 
organic phase removed. The mixture was then incubated at 80 ºC for 1 h. 1 µl was then 
injected into the GC MS. The separation was carried out in GC (carrier gas 1 mL min
-1 
helium) with the temperature program: Initial column temperature of 100 ºC for 1 min, 
increase of 5 ºC min
-1
 till 170 ºC and then at 30 ºC min
-1
 till 280 ºC with a final holding time 
of 1 min. The inlet had a temperature of 250 ºC and the quadrupole of 280 ºC. The total run 
time was 19.67 min. The ions at 261, 262, 263 and 264 were monitored in the Selected Ion 
Monitoring (SIM) mode of the MS. The ions contain the carbon backbone of the whole 
molecule.  
 
Extracellular amino acids 
Extracellular amino acids were analyzed by lyophilizing 100µl of either cellular supernatant 
or the aqueous phase of the lactic acid extraction procedure, and converting them to t-BDMS 
derivative by MTBSTFA (Mawhinney et al., 1986). 50 µL of Dimethylformamid (0.1 % 
pyridne) was added to the sample along with 50 µL of MTBSTFA and incubated for 1 h at 80 
ºC. 1 µl was then injected into the GC MS. The separation was carried out in GC (carrier gas 
1.1 mL min
-1 
helium) with the temperature program: Initial column temperature of 135 ºC, 
increase of 10 ºC min
-1
 till 325 ºC with a final holding time of 1 min. The inlet had a 
temperature of 320 ºC and the quadrupole of 320 ºC. The total run time was 20.00 min. In the 
present experiments where ever possible the aqueous phase of the lactic acid extraction 
procedure was used. The ions corresponding to the whole carbon backbones of the amino 
acids were monitored in the SIM mode of the MS.  
 
Proteinogenic amino acids 
For the analysis of amino acids from the cell protein, around 2 × 10
6 
- 3 × 10
6
 of cells were 
washed twice with PBS. The washed cell pellet was hydrolyzed for 48h with 250µL 6M HCl 
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at 105°C. The obtained hydrolysate was neutralized (6M NaOH), and freeze-dried. GC/MS 
analysis of the amino acids was performed after derivatization into the t-BDMS derivate with 
MTBSTFA. 50 µL of dimethylformamid (0.1 % pyridne) was added to the sample along with 
50 µL of MTBSTFA and incubated for 1 h at 80 ºC. The same conditions as those used for the 
extracellular amino acids were used in the GC MS analysis.  
 
Extraction and analysis fatty acids 
The methyl esters of palmitic acid and stearic acid from cellular samples were monitored in 
GC-MS. Briefly the fatty acids were extracted in their ester form as follows; to 2 × 10
6 
- 3 × 
10
6
 of the cellular sample was added 500µl of 1:1 Toluene and Methanol along with 10µl of 
conc. sulphuric acid. This was incubated overnight at 55°C and the organic phase obtained by 
the addition of 400µl of 0.5M ammonium bicarbonate separated. 1 µl was then injected into 
the GC MS. The separation was carried out in GC (carrier gas 1 mL min
-1 
helium) with the 
temperature program: Initial column temperature of 150 ºC for 5 min, increase of 5 ºC min
-1
 
till 260 ºC and then at 30 ºC min
-1
 till 300 ºC with a final holding time of 5 min. The inlet had 
a temperature of 250 ºC and the quadrupole of 280 ºC. The total run time was 33.33 min. The 
ions at 298 till 317 were monitored for stearic acid and from 270 till 288 were monitored for 
palmitic acid in the Selected Ion Monitoring (SIM) mode of the MS. The ions contain the 
whole carbon backbone of the molecule.  
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5.4.8 Online monitoring of oxygen in spinner flasks 
Introduction 
The increasing importance of industrial operations based on biochemical engineering has long 
been recognized. Dissolved oxygen concentration is one of the most important control 
variables in any aerobic reactor. Oxygen plays an important role in the metabolism of cells 
and is essential for the oxidative phosphorylation pathway for the production of ATP. It also 
plays a role in the determination of the redox potential of the cellular medium. The 
importance of oxygen uptake rates has been stressed in the previous chapter. The metabolism 
of mammalian cells is highly influenced by the dissolved oxygen concentrations (Zupke et al., 
1995). The most commonly used small scale culture devices for mammalian cells are 
microtiter plates. The transfer characteristics of oxygen in 96-well plates have been discussed 
in earlier chapters. Mammalian cells in suspension are generally grown in spinner flasks. This 
is the method of choice for suspension lines including hybridomas, CHO cells and attached 
lines that have been adapted to growth in suspension. Also attached cell lines can be scaled up 
with microcarrier beads and grown in spinner flasks. Spinner flasks are either plastic or glass 
bottles with a central magnetic stirrer shaft and side arms for the addition and removal of cells 
and medium, and gassing with CO2 enriched air. Inoculated spinner flasks are placed on a 
stirrer and incubated under the culture conditions appropriate for the cell line. Commercial 
spinner flasks are available in the range of 125 ml to 5000 ml. However, the oxygen transfer 
characteristic in spinner flasks has not been much studied. It has been reported that insect 
cells undergo oxygen limitation under standard spinner flask cultivation conditions (Annathur 
et al., 2003). However, the oxygen consumption of mammalian cells is much lower than 
insect cells and it has been assumed that suspension cells do not undergo oxygen limitation in 
spinner flasks under normal operating conditions. For metabolic studies, it is essential that the 
cells undergo normal metabolism without any stress. Hence it is of prime importance that the 
cells do not undergo oxygen limitation. To test if the cells undergo oxygen limitation in 
spinner flasks, the spinner flasks were equipped with optical oxygen sensors for on-line 
monitoring. Moreover the characteristics of oxygen transfer in spinner flasks were studied. 
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Spinner flasks with oxygen sensing 
The optical sensing system employed is similar to a system described earlier for shake flask 
cultures (Wittmann et al., 2003). Briefly the system consists of three parts: (i) an optical 
sensor spot immobilized on the spinner flask bottom, (ii) a coaster placed below the flask 
containing an optical fiber, and (iii) a module for data processing and connecting to a PC. The 
spinner flask with sensor attached to the bottom was supplied by Pre-Sens GmbH 
(Regensburg, Germany). The sensor was placed in the centre of 250 mL spinner flask to allow 
uninterrupted rotation of the shaft. The system uses phase modulation technique to determine 
the luminescent decay time of the O2 sensor. The decay time is related to the actual dissolved 
O2 (DO) by the Stern–Volmer equation (Wittmann et al., 2003).  The system uses a two-point 
calibration with water; zero dissolved oxygen achieved by purging water with nitrogen and 
100 % dissolved oxygen achieved by purging water with air. The experiments were carried 
out in normal culture conditions of CHO cells.  
  
Characterization of oxygen transfer in spinner flasks 
The volumetric gas-liquid mass transfer coefficient (kLa) was calculated two different spinner 
speeds at various volumes using the method described earlier (Wittmann et al., 2003). The 
speeds used were 40 rpm and 80 rpm. 80 rpm is the maximum speed allowed on the stirrer 
(Model 104-S, Techne, Staffordshire, United Kingdom). Figure 5.4.1 gives the plot depicting 
the relationship between various volumes at two different speeds with the gas-liquid mass 
transfer coefficient. At higher volumes the transfer at both the speeds almost reaches the same 
values of 0.02 min
-1
 thus giving a maximum oxygen transfer rate of 0.28 mM h
-1
. Considering 
an average specific oxygen uptake rate of 2 ×10
-13
 mol (O2) cell
-1
 h
-1
 and average cell density 
of 1 × 10
6
 cells mL
-1
, this maximum transfer rate would be just enough to avoid oxygen 
limitation. However, in exponential phase of cell growth, the specific oxygen uptake rates of 
cells are much higher and hence the use of large volumes is not recommended for cell culture 
in spinner flasks.  
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Figure 5.4.1: The relationship between the volumetric gas-liquid mass transfer coefficient 
(kLa) and volume at two different speeds. The kLa was calculated by dynamic method using 
gas-liquid mass transfer equation after removal of oxygen from water by nitrogen, followed 
by flushing the air space with air.  
 
Another interesting facet about cellular growth in spinner flasks is the use of the side arm. The 
main purpose of these arms is for the removal of cells or addition of media. These side arms 
are usually provided with screw caps, and it is recommended to grow the cells without closing 
them tightly to avoid oxygen limitation. It was decided to investigate the influence of the 
number of turns the screw cap of the side arms is open on the oxygen transfer. The number of 
turns the caps takes to fully close was counted. Oxygen transfer characteristic was determined 
for the flask with no caps, flask with half opened caps and flask whose caps were turned only 
once after closing the cap completely. The flask was filled with 60 mL water and oxygen 
removed by purging with nitrogen, placed into the incubator on the stirrer with 80 rpm with 
the desired rotation of cap and the rise of oxygen monitored. Figure 5.4.2 gives the rise of 
oxygen under the three conditions. It is seen that the rise is the fastest in the case where there 
are no caps, and slowest in flask with a single turn. The kla values of the above conditions are 
not determined since the air space was not flushed with air.  
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Figure 5.4.2: The influence of the turns of the screw caps on the side arm of the spinner 
flasks on the transfer of oxygen. Flask with no caps (fully open), flask with half opened caps 
(half open) and flask whose caps were turned only once after closing the cap completely 
(single turn) were investigated.  
 
Online monitoring of cell growth  
Cells were grown in the spinner flasks with a volume of 60 mL and at a stirrer speed of 80 
rpm. Cells were inoculated at a density of 2 × 10
5
 cells mL
-1
 and monitored for 190 h. Figure 
5.4.3 gives the online profile for the cultivation for 190 h. It is seen that there is a rise in the 
dissolved oxygen concentration from 150 h probably indicating that the cells start to die 
during this phase.  
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Figure 5.4.3: Online monitoring of dissolved oxygen with spinner flasks equipped with 
optical oxygen sensor. The cells were grown in a 60 mL volume at 80 rpm.  
 
A second experiment was carried out where parallel cultures were grown, one in the normal 
media and the other in a modified medium where the concentrations of glucose and glutamine 
had been halved. Additionally samples were taken during the cell growth to determine the cell 
density. Figure 5.4.4 gives the oxygen consumption of both the cell cultures along with the 
growth curve. It is seen that the oxygen consumptions are very similar as are the growth 
curves. Moreover, none of the culture goes into oxygen limitation. However, the process of 
sampling disturbs the measurements indicated by a rise in the dissolved oxygen concentration 
after the sampling. Nonetheless the oxygen concentrations reach equilibrium after some time. 
Hence it was seen that under normal cell culture conditions, the cells do not undergo oxygen 
limitation when grown in spinner flasks. This system of oxygen monitoring can be later 
applied for the determination of oxygen uptake rates and also for online process monitoring.  
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Figure 5.4.4: (A) Online monitoring of dissolved oxygen with spinner flasks equipped with 
optical oxygen sensor for parallel cell cultures. (B) The growth curve of the two cultures. The 
cell density was determined with trypan blue method. The cells were grown in a 60 mL 
volume at 80 rpm. The modified medium indicates medium with half the concentration of 
glucose and glutamine as in the normal medium. The sampling is indicated by arrows. 
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5.5 Investigative physiological studies on CHO cell 
 
5.5.1 Theory 
Consideration of the metabolism of cell is an important parameter in the optimization of 
industrial processes. However, many industrial processes using mammalian cells often run on 
suboptimal conditions, mainly due to the lack of understanding of the complex mammalian 
metabolism and the inability to quantify the metabolism. A brief overview of the mammalian 
cell biochemistry and the usage of metabolic flux analysis to quantify central metabolic 
pathway fluxes are provided in the previous chapters. Industrially important mammalian cells 
have been the focus of many investigations and the effects of various parameters on their 
physiology have been determined (Hu et al., 1987; Miller et al., 1987; Newland et al., 1990; 
Ozturk and Palsson, 1990a; Ozturk and Palsson, 1990b; Franek and Dolnikova, 1991; Ozturk 
and Palsson, 1991; Ronning et al., 1991; Fitzpatrick et al., 1993; Hansen and Emborg, 1994a; 
Hansen and Emborg, 1994b; Jeong and Wang, 1994; Haggstrom et al., 1996; Neermann and 
Wagner, 1996; Miller et al., 2000).  
Metabolism consists of anabolism, which is the building up of monomers for macromolecular 
synthesis and catabolism, which is the breakdown of substrates for energy generation. 
Glucose and glutamine are the primary energy sources for the cells. Both these substrates are 
broken down to provide cellular energy. Neermann and Wagner (1996) studied the 
metabolism of glucose and glutamine in various cell lines and their distribution in different 
pathways. Glutamine entering the TCA cycle was found to be the major energy source for 
cells whereas the majority of glucose was utilized by glycolysis to form lactate. Along with 
these two substrates, amino acids play an important role, both in anabolic as well as catabolic 
pathways. Eagle (1959) studied the metabolism of amino acids in cellular tissue culture and 
was able to identify essential and non-essential amino acids requirements for cells. Many 
essential amino acids enter the primary metabolism and break down to provide cellular 
energy. These pathways have been discussed in the previous chapter on cellular biochemistry. 
However, every cell line has individual characteristics and has to be studied independently 
due to variations in its individual physiology and inherent instability (Kromenaker and Srienc, 
1994; Wurm, 2004). In this chapter an attempt is made to investigate the cellular physiology 
and to quantify metabolic fluxes of the CHO cells, with a special emphasis on the metabolism 
of amino acids. 
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5.5.2 [U-13C]Glucose studies of metabolism  
5.5.2.1 Motivation  
Malignant cells display uncontrolled rates of cellular proliferation and require an increased 
supply of precursor amino acids to support key biosynthetic pathways. Amino acids interact 
with glucose metabolism both as carbon substrates and by recycling glucose carbon, e.g. 
alanine and glutamine. The amino acids essential for mammalian cell growth have been 
determined earlier (Eagle, 1955; Eagle, 1959). However, the requirements and metabolism of 
individual cell lines vary and depend on numerous extraneous factors; most importantly the 
cultivation conditions and media used. Generally media are supplemented with serum, 
proteins or peptides to support growth. However, the present industrial trend is to develop and 
use chemically defined media because of safety and the control they offer over process 
conditions. Since the media used in these particular experiments is chemically defined with no 
protein or peptides, it was necessary and essential to determine the cellular amino acid 
metabolism.  
Carbon labeling experiments offer an elegant way of determining the anabolic or catabolic 
pathways followed by metabolites. There is a constant interchange of atoms between 
metabolites in a cell. Thus a labeled metabolite can contribute its label to other metabolites 
depending on the atom interaction. In such a case, a substrate with labeled atoms should 
distribute its label to the metabolites it is involved in formation. Hence the anabolic 
metabolites from a culture grown in fully carbon labeled glucose should show carbon 
labeling. Using mass spectrometric analysis of the metabolites to determine their labeling 
along with their uptake rates can thus provide initial information whether a particular 
metabolite is anabolic or catabolic in nature. This information can be then incorporated to 
appropriately design strategies to reduce the complexity of the model for the cell biochemistry 
and to further assist in flux calculations. 
5.5.2.2 [U-13C]Glucose culture and anabolic amino acids 
Cell culture with [U-
13
C]glucose 
Exponentially growing cells in normal media were washed with medium without glucose 
twice and transferred to medium where normal glucose was replaced with [U-
13
C]glucose.  
The cells were grown till exponential phase and transferred to fresh [U-
13
C]glucose medium 
after washing twice with glucose free medium. This transfer of cells was done thrice to check 
if there is a possibility of reaching isotopic steady state in proteinogenic amino acids. 
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Supernatant samples for analysis were taken at regular interval and cellular samples were 
taken at the end of every cultivation cycle for macromolecular analysis. 
Cell growth characteristics 
The cell growth of all the four cultures is given in Figure 5.5.1 (A).  As seen from the Figure 
all the growth cycles showed similar growth patterns. The specific growth rates are given in 
Table 5.5.1. The four cultures showed comparable growth.  
The uptake of extracellular glucose along with the production of lactate is shown in Figure 
5.5.1 (B). As seen, the production and excretion followed similar patterns. Table 5.5.1 gives 
the rates of the metabolites. With the exception of the last culture, all show comparable rate 
patterns. The profile of glutamine, the other major energy source besides glucose is given in 
Figure 5.5.1 (C). Due to the hydrolysis of glutamine, its initial concentration is found to 
reduce in subsequent cultures, with it approaching limiting proportions in the final culture. 
The difference in the rates in the final culture is probably due to the limitation of glutamine, 
which in turn makes to cell reduce the overflow metabolism as seen from a reduced lactate to 
glucose ratio.  
 
Table 5.5.1:  Growth rate and uptake rates for glucose and lactate during the 4 cycles of 
cultivation 
 
 
Growth 
rate (h
-1
) 
Glucose Uptake 
 (10
-3 
mM/ 
10
6
cells h) 
Lactate 
Production 
(10
-3 
mM/ 
10
6
cells h) 
    
1st Medium 0.025 0.4275 0.655 
2nd Medium 0.03 0.393 0.618 
3rd Medium 0.033 0.4455 0.6237 
4th Medium 0.03 0.318 0.417 
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Figure 5.5.1: (A) Cell growth of CHO cells during 4 cycles of cultivation. The medium was 
replaced at time 54 h, 157 h and 226 h. (B) Glucose and lactate profiles during the 4 
cultivation cycles for the same cultures shown in Figure 5.5.1 (A). (C) Glutamine profile 
during the four cultivation cycles for the same cultures shown in Figure 5.5.1 (A). 
 
In the case of amino acids, few did not show linear relationship to glucose consumption rate 
e.g. aspartate and glutamate. Due to this, only the metabolic quotients on glucose (difference 
of final and initial concentration) were considered. Figure 5.5.2 depicts the comparative 
metabolic quotients of the amino acids. Among the amino acids, only aspartate, glutamate, 
alanine and glycine showed production whereas all the others were consumed.  
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Figure 5.5.2: Metabolic quotients of amino acids at the end of each of the four cultivations 
shown in Figure 5.5.1 
 
Data from the four cultures were combined and the interdependency of the variables was 
determined by several plots (Figure 5.5.3 A, B & C). The metabolite concentrations were 
plotted against the corresponding glucose concentrations and a few were also plotted against 
each other. Yields were determined from the plots using linear regression at two distinct 
growth phases, at high glucose and at lower glucose concentrations and are shown in Table 
5.5.2. The goodness of fit represented by the regression coefficient (R
2
) is given in the 
bracket. Except aspartate, glutamate and glutamine all the others show a linear relationship 
with glucose. Aspartate shows a linear relationship with glutamate probably due to their 
involvement in the malate - aspartate shuttle. However, aspartate with asparagine, glutamate 
with glutamine and aspargine with glutamine show no linear relationship. Serine shows a 
linear relationship with glycine as both the amino acids are related at the biochemical level by 
the enzyme serine hydroxymethyltransferase. The yields obtained at both the growth phases 
are comparable for all amino acids showing linear relationships. The non-linear pattern of few 
amino acids can lead to complications in further analysis and add complexity to further 
calculations.  
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Figure 5.5.3 (A): Metabolite concentrations of all the four cultivations plotted against glucose 
for the four cultures described in Figure 5.5.1. Two separate linear regressions were 
performed, one for glucose concentrations higher than 15 mM and the other for lower than 15 
mM. The closed symbols represent high and the open symbols represent low glucose 
concentrations. 
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Figure 5.5.3 (B): Metabolite concentrations of all the four cultivations plotted against glucose 
for the four cultures described in Figure 5.5.1. Two separate linear regressions were 
performed, one for glucose concentrations higher than 15 mM and the other for lower than 15 
mM. The closed symbols represent high and the open symbols represent low glucose 
concentrations. 
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Figure 5.5.3 (C): Metabolite concentrations of all the four cultivations plotted against glucose 
and also a few against each other for the four cultures described in Figure 5.5.1. Two separate 
linear regressions were performed, one for glucose concentrations higher than 15 mM and the 
other for lower than 15 mM. The closed symbols represent high and the open symbols 
represent low glucose concentrations. 
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Table 5.5.2: Yields of the metabolites and cells on glucose at two growth phase with yield 1 
at high glucose concentration and yield 2 at lower glucose concentration as represented in the 
Figure 5.5.3 A, B & C. The goodness of fit (R
2
) of the linear regression is given in brackets.  
Metabolite Yield 1 (R
2
) Yield 2 (R
2
) Unit 
Lactate -1.3 (0.90) -1.5 (0.90) mM/mM Glucose 
Asp -18.7 (0.94) -0.9 (0.003) µM/mM Glucose 
Glu -62.7 (0.71) -4.2 (0.006) µM/mM Glucose 
Asn 29.6 (0.88) 39.9 (0.95) µM/mM Glucose 
Ser 33.4 (0.81) 23.5 (0.91) µM/mM Glucose 
Gln 189.9 (0.038) 169.2 (0.28) µM/mM Glucose 
His 4.1 (0.70) 3.9 (0.90) µM/mM Glucose 
Gly -15.3 (0.54) -21.3 (0.81) µM/mM Glucose 
Thr 9.9 (0.37) 7.9 (0.94) µM/mM Glucose 
Arg 9.9 (0.60) 9.4 (0.89) µM/mM Glucose 
Ala -87.9 (0.81) -110.9 (0.94) µM/mM Glucose 
Tyr 5.8 (0.84) 5.2 (0.93) µM/mM Glucose 
Val 10.1 (0.6) 11.3 (0.93) µM/mM Glucose 
Met 5.3 (0.81) 4.3 (0.93) µM/mM Glucose 
Trp 2.0 (0.14) 1.4 (0.86) µM/mM Glucose 
Phe 7.2 (0.82) 6.6 (0.93) µM/mM Glucose 
Ile 34.8 (0.77) 11.0 (0.62) µM/mM Glucose 
Leu 38.3 (0.79) 18.1 (0.82) µM/mM Glucose 
Lys 17.3 (0.81) 14.6 (0.91) µM/mM Glucose 
Pro 5.2 (0.13) 9.2 (0.75) µM/mM Glucose 
Cells 66.5 (0.90) 88.0 (0.86) Cells/µM Glucose 
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Carbon labeling analysis 
Gas Chromatography- Mass spectrometric (GC-MS) analysis was carried out to determine the 
mass isotopomers and fractional carbon labeling (FCL) of the samples obtained during the 
cell cultivation (Wittmann and Heinzle, 1999). The samples were analyzed for the 
extracellular amino acids, lactate and proteinogenic amino acids. The amino acids which 
showed 
13
C labeling in the extracellular as well as in the proteinogenic samples were alanine, 
glycine, serine, aspartate and glutamate. This implied that these amino acids were synthesized 
by the cells. The fractional carbon labeling of the above amino acids in the supernatant with 
respect to time along with their concentration profile is shown in Figure 5.5.4. Alanine and 
glycine are secreted in the extracellular medium whereas serine is consumed. Glutamine and 
aspartate are secreted in the initial phases but consumed during the final phase. Similarly the 
profile of lactate is also shown in the figure.  
It is seen that, with the exception of lactate, none of the others reach a steady state in labeling. 
All the lactate originating from glucose should have carbon labeling. The fractional carbon 
labeling of lactate is around 85 %, thus 15 % of lactate comes from carbon sources other then 
glucose. Since all the amino acids are initially present in the media, they dilute the carbon 
labeling. Nevertheless, taking into account the initial concentrations of alanine, it is found that 
an average of 90 % of the alanine over the end of four cultivations is derived from glucose. 
However, unlike lactate, the fractional labeling of alanine varies with time. The non-steady 
labeling pattern of other amino acids may be due to their uptake patterns. The pattern of 
labeling obtained for glutamate is probably influenced by extracellular concentrations of 
glutamine. Similarly, the labeling of glycine is influenced by serine.  
The FCL of proteinogenic amino acids at the end of each growth cycle with comparison to 
extracellular amino acids is shown in Figure 5.5.5. The lower FCL of proteinogenic amino 
acids are probably due to the fact that the proteins contain labeling information over the whole 
growth phase and depend upon their turn over rate. With the exception of alanine and serine, 
none of the amino acids display steady states in the proteinogenic labeling thus showing that it 
is difficult to reach isotopic steady states by repetitive cultivations.  This further supports the 
fact that there must be an improvement in the cultivation conditions to reduce the complexity 
of flux analysis. This was done by modifying the media.  
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Figure 5.5.4: Extracellular metabolite labeling plotted along with extracellular concentration 
profile for the four cell cultivations in [U-
13
C]glucose containing media described in Figure 
5.5.1. The right axis gives the concentration and the left axis the fractional carbon labeling of 
the metabolite indicated on the right axis. The sampling procedure is given in material and 
methods. The initial time “0” refers to the sample after the addition of media to cells. 
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Figure 5.5.5: Comparison of FCL from proteinogenic amino acid (Pro) with the extracellular 
amino acids (EC) at the end of each cycle of cultivation shown in Figure 5.5.1. 
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5.5.2.3 Media optimization for flux calculation 
Both essential and non-essential amino acids are required for protein synthesis. The essential 
amino acids are supplied in the media as they are not synthesized by the cells. Non-essential 
amino acids, depending on the metabolism can be synthesized by the cell. Generally, most of 
the cell culture media contain all the 20 amino acids in significant amounts. From the data in 
the previous section, it is seen that there is a consumption of most amino acids (Asn, Ser, Gln, 
His, Thr, Arg, Tyr, Cys, Val, Met, Tyr, Phe, Ile, Leu, Lys, Pro) regardless of being essential 
or non-essential. From the labeling in the proteinogenic amino acids as well as in the 
extracellular media of cells grown in [U-
13
C]glucose, it can be seen that although most of 
them are catabolic few of the non-essential amino acids though consumed are also anabolic. 
From the yield and labeling data, amino acids like Asp, Glu, Ser, Gly and Ala are found to be 
anabolic.  However, the fact that the amino acids aspartic acid, glutamic acid and serine are 
consumed, and also found to have labeling in the extracellular medium leads to the conclusion 
that there is continuous exchange between the intracellular and extracellular metabolites. This 
exchange can lead to problems in the calculation of fluxes. 
 
Cell growth in amino acid depleted media 
To study if the cells can potentially show similar growth with the reduction or removal of the 
above components, the media was altered and the cell growth monitored. The cells were 
grown in media containing a progressive decrease of the above labeled amino acids (LAA: 
Asp, Glu, Ser, Gly and Ala). Thus a series of media were prepared containing 50 %, 10 % and 
1 % of the normal amounts of LAA. Also a media with none of the above amino acids was 
prepared. Figure 5.5.6 (A) shows the series of growth curves in the various media. The initial 
cell density used for the normal media, 50 % and 10 % was different from the initial cell 
density used for 1 % and media without LAA since the cell growth were performed separately 
in two sets of experiments. Figure 5.5.6 (B) shows the specific growth rate of the cells in the 
various media. As seen from the figure, the growth rate is very similar in all the media. Since 
the cells also grow in the amino acid deficient medium it can be deduced that they are able to 
produce the amino acids required for their biosynthetic needs. Hence further experiments 
were conducted using the media without the LAA (i.e. Asp, Glu, Ser, Gly and Ala).  
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Figure 5.5.6:  (A) Comparison of cell growth with reduced levels of the labeled amino acids 
(LAA: Asp, Glu, Ser, Gly and Ala) in media. (B) Growth rates of CHO cells with reduced 
levels of the labeled amino acids (LAA) in media. 
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Cell growth characteristics with modified media 
The cells were grown in the modified medium containing [U-
13
C]glucose and without the 
LAA’s in parallel with cells grown in normal media, i.e. one containing all the amino acids. 
On reaching the exponential phase the cells were transferred to fresh medium after washing 
twice with no glucose containing medium. Thus the cells were grown for two batch cycles in 
the spinner flasks. Figure 5.5.7 (A) shows the comparison of growth between the modified 
medium with normal medium. The cells show similar growth pattern and the growth rates are 
comparable for the growth in modified media and that in the normal media; 0.027 h
-1
 and 
0.028 h
-1
 for the first culture and 0.031 h
-1
 and 0.031 h
-1
 for the second culture, respectively. 
Figure 5.5.7 (B) compares glucose, lactate and pyruvate profiles. The average lactate to 
glucose ratio (mol/mol) for cells grown in the modified medium (1.84) is higher then for that 
grown in normal medium (1.54) and also corresponds to higher lactate yield. The 
corresponding specific rates are given in Table 5.5.3 and found to be higher in the modified 
medium. The uptake rates of glutamine and asparagine were also found to be slightly higher 
in the modified medium. This is possibly due to the absence of aspartate and glutamate in the 
medium. However, there was a decrease in the alanine yield compared to the normal media.   
 
Table 5.5.3: Comparison of uptake and production rates for glucose, lactate, asparagine, 
glutamine and alanine in the normal media with the modified media, i.e. [U-
13
C]glucose 
supplied media without LAA.  
 
Glucose 
(10
-3
mM  
10
6
 Cells
-1
 h
-1
) 
Lactate 
(10
-3
mM  
10
6
 Cells
-1
 h
-1
) 
Gln 
(10
-3
µM  
10
6
 Cells
-1
 h
-1
) 
Asn 
(10
-3
µM  
10
6
 Cells
-1
 h
-1
) 
Ala 
(10
-3
µM  
10
6
 Cells
-1
 h
-1
) 
1
st
 
Culture 
-0.23 0.33 -76.02 -13.67 34.79 
Normal 
Media 2
nd 
Culture 
-0.18 0.26 -64.46 -10.91 30.62 
1
st
 
Culture 
-0.29 0.48 -86.43 -15.00 32.21 
U
13
C6 
Media 2
nd
 
Culture 
-0.25 0.38 -70.33 -13.42 29.09 
 
The most interesting aspect was the extracellular concentration of aspartate and glutamate as 
seen in Figure 5.5.8 (A). In the medium, the said amino acids were first produced and then 
consumed towards the end of the cultivation phase. Viewing the extracellular concentration 
profiles of asparagine and glutamine [Figure 5.5.8 (B)] along with that of aspartate and 
glutamate, it is seen that the uptake of aspartate and glutamate correspond to the low levels of 
asparagine and glutamine present in the medium during the end of the cultivation phase. Thus 
the consumption might be related to the depletion of the above amino acids.  
 PHYSIOLOGICAL INVESTIGATIONS ON CHO CELLS 
 
100 
 
 
Figure 5.5.7:  (A) Comparison of cell growth of CHO cells in modified media with [U-
13
C]glucose and original media during two cultivation cycles. (B) Glucose, lactate and 
pyruvate profiles during the 2 cultivation cycles of CHO cells in modified media with [U-
13
C]glucose. (C) Glucose, lactate and pyruvate profiles during the 2 cultivation cycles of CHO 
cells in original media 
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Figure 5.5.8: (A) Aspartate and glutamate profiles during the 2 cultivation cycles of CHO 
cells in modified media with [U-
13
C]glucose showing their consumption during the latter 
stages of growth. (B) Aspargine and glutamine profiles during the 2 cultivation cycles of 
CHO cells in modified media with [U-
13
C]glucose.  
 
Similar to the previous section, the metabolite concentrations were plotted against the 
corresponding glucose concentrations and also against each other (Figure 5.5.9). The plots of 
serine, glycine, aspartate and glutamate show two distinct phases. At high glucose 
concentration the linear regression on the plot of aspartate with asparagine and glutamate with 
glutamine gives a positive slope whereas at low glucose it gives a negative slope [Figure 
5.5.9(C)]. This is due to the consumption as aspartate and glutamate towards the end of the 
cultivation whereas glutamine and asparagine are continuously consumed.  In the normal 
medium, serine was consumed and glycine was produced whereas in the modified medium 
both serine and glycine were found to be secreted in the medium initially and then consumed 
at the end of the cultivation. The secretion and consumption pattern of the two amino acids 
are found to be related as seen from the plot of serine against glycine [Figure 5.5.9(C)]. Yields 
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were determined from the plots using linear regression at two distinct growth phases, at high 
glucose concentration and at lower glucose concentrations and are shown in Table 5.5.4. 
Similar to their plots, the yields of aspartate, glutamate, serine and glycine show two distinct 
phases due to their uptake at the end of the cultivation. This pattern might be due to the 
limitation of asparagine and glutamine towards the end of the batch cultivation. This is also 
seen in the yield of lactate, where the overflow metabolism is reduced significantly. Looking 
at the cellular yield, it is clearly seen that there is efficient utilization of glucose resulting in a 
significantly higher yield of cells.  
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Figure 5.5.9 (A): Metabolite concentrations of the two cultivations in modified medium 
described in Figure 5.5.8 plotted against glucose. Two separate linear regressions were 
performed, one for glucose concentrations higher than 15 mM and the other for lower than 15 
mM. The closed markers indicate the concentrations at high glucose concentration whereas 
the open symbols indicate low glucose concentration. 
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Figure 5.5.9 (B): Metabolite concentrations of the two cultivations in modified medium 
described in Figure 5.5.8 plotted against glucose. Two separate linear regressions were 
performed, one for glucose concentrations higher than 15 mM and the other for lower than 15 
mM. The closed markers indicate the concentrations at high glucose concentration whereas 
the open symbols indicate low glucose concentration. 
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Figure 5.5.9 (C) Metabolite concentrations of the two cultivations in modified medium 
described in Figure 5.5.8 plotted against each other. Two separate linear regressions were 
performed, one for glucose concentrations higher than 15 mM and the other for lower than 15 
mM. The closed markers indicate the concentrations at high glucose concentration whereas 
the open symbols indicate low glucose concentration. 
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Table 5.5.4: Yields of the metabolites and cells on glucose at two growth phase with yield 1 
at high glucose concentration and yield 2 at lower glucose concentration as represented in the 
Figure 5.5.9 A, B & C. The goodness of fit (R
2
) of the linear regression is given in brackets.  
 
Metabolite Yield 1 (R
2
) Yield 2 (R
2
) Unit 
Lactate -2.1 (0.98) -1.0 (0.99) mM/mM Glucose 
Asp -11.7 (0.80) 12.9 (0.85) µM/mM Glucose 
Glu -34.1 (0.77) 32.8 (0.87) µM/mM Glucose 
Asn 45.7 (0.89) 58.6 (0.99) µM/mM Glucose 
Ser -3.7 (0.69) 2.7 (0.96) µM/mM Glucose 
Gln 338.4 (0.92) 221.1 (0.99) µM/mM Glucose 
His 6.3 (0.90) 7.7 (0.99) µM/mM Glucose 
Gly -1.9 (0.79) 1.1 (0.63) µM/mM Glucose 
Thr 8.8 (0.78) 16.1 (0.99) µM/mM Glucose 
Arg 16.0 (0.9) 18.4 (0.99) µM/mM Glucose 
Ala -118.6 (0.89) -111.0 (0.99) µM/mM Glucose 
Tyr 8.3 (0.90) 9.9 (0.99) µM/mM Glucose 
Val 18.9 (0.85) 20.0 (0.99) µM/mM Glucose 
Met 7.9 (0.90) 7.5 (0.99) µM/mM Glucose 
Trp 3.9 (0.66) 1.3 (0.54) µM/mM Glucose 
Phe 10.7 (0.91) 11.9 (0.99) µM/mM Glucose 
Ile 26.0 (0.80) 16.6 (0.99) µM/mM Glucose 
Leu 33.9 (0.86) 27.3 (0.99) µM/mM Glucose 
Lys 37.1 (0.95) 31.9 (0.99) µM/mM Glucose 
Pro 7.1 (0.47) 13.3 (0.96) µM/mM Glucose 
Cells 97.1 (0.93) 13.6 (0.92) Cells/µM Glucose 
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Carbon labeling analysis 
Similar to previous section, GC-MS analysis was carried out to determine the mass 
isotopomers and fractional carbon labeling (FCL) of the samples obtained during the cell 
cultivation. The profiles of the metabolites substrates are shown in Figure 5.5.10. In contrast 
to the previous medium, with the exception of aspartate and glutamate all the metabolites 
approach steady state in the modified medium. This is clearly a marked improvement above 
the previous medium since it reduces the complexity of the biochemical model.  
The fractional carbon labeling of lactate is around 80 % and 17 % of lactate comes from 
carbon sources other then glucose. Fully labeled lactate forms 75 % of the total lactate and 
thus the rest of the labeling (7 %) must be derived from the formation of pyruvate from the 
TCA cycle. Serine has a fully labeled fraction of 88 %, since the production of serine is 
mostly in the top part of the glycolysis. Around 5 % of serine is found to be formed from non-
labeled carbon sources. In comparison, glycine, which is derived from serine, has a fractional 
labeling of 81 % and with 17 % unlabeled fraction. This might be due to the intracellular 
partitioning of glycine and serine metabolism or due to other metabolic pathways related to 
the anabolism of these amino acids. There is evidence that the major fraction of glycine 
originates from the mitochondrial pool of serine in CHO cells (Narkewicz et al., 1996).  The 
labeling of alanine is only 70 % compared to the 80 % of lactate. Thus there is an increased 
non-glucose production of alanine. This is in contrast to the earlier medium where the glucose 
produced alanine was higher then lactate. Of the above, 60 % is fully labeled and therefore 10 
% of alanine is originating from the TCA cycle. This might support the theory of the presence 
of two pyruvate pools in mammalian cells (Peuhkurinen et al., 1983). The pattern of labeling 
obtained for glutamate and aspartate is influenced by extracellular concentrations of 
glutamine and asparagine, respectively. Studying the mass isotopomers of aspartic acid; 15 % 
is 
13
C3 and, 20 % of each are the 
13
C2 and 
13
C1 isotopomers. It implies that pyruvate enters the 
TCA cycle via both, the pyruvate carboxylase and the pyruvate dehydrogenase routes. 
13
C3 
aspartate is derived from 
13
C3 oxaloacetate which in turn is formed via the pyruvate 
carboxylase route without the loss of carbon atoms. 
13
C2 and 
13
C1 aspartate are formed when 
there is a loss of carbon atoms from pyruvate via the pyruvate dehydrogenase route.  
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Figure 5.5.10: Extracellular substrate labeling plotted along with extracellular concentration 
profile during the cell growth. The right axis gives the concentration and the left axis the 
fractional carbon labeling of the metabolite indicated on the right axis. The sampling 
procedure is given in material and methods. The initial time “0” refers to the sample after the 
addition of media to cells. 
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5.5.2.4 [U-13C]Glucose study with optimized media 
The media, in which the cells were grown without the anabolic amino acids, though an 
improvement, nevertheless had the shortcoming of glutamine and asparagine limitation, 
which was probably responsible for the consumption of aspartate, glutamine and serine 
towards the end of the batch cultivation. This meant that for the prevention of the 
consumption, the cells would have to be harvested at a much earlier time point. This would 
lead to fewer cells to be available for analysis. However, in this case, it was decided to try to 
supplement the media with an increased amount of asparagine and glutamine. This was done 
to see if the actual consumption of the few anabolic amino acids were indeed due to the 
limitation and if the said consumption could be prevented by the use of this strategy. To 
achieve this, the concentrations of asparagine and glutamine were increased by half their 
original concentrations in the media.  
Cell growth characteristics for optimized media 
The cells were grown in the medium supplemented with increased amount of asparagine and 
glutamine containing [U-
13
C]glucose. The cell growth is shown in Figure 5.5.11 (A) and has a 
specific growth rate of 0.026 h
-1
 which is very similar to the growth rates obtained earlier. The 
glucose and lactate show similar profiles as in earlier media [Figure 5.5.11 (B)] and the lactate 
to glucose ratio is 1.72, which is normal under the conditions. Thus the cells show normal 
physiology with regard to growth in the new media.  
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Figure 5.5.11: (A) Cell growth of CHO cells in optimized media with [U-
13
C]glucose.  
(B) Glucose and lactate profiles of CHO cell growth in optimized media. 
 
Table 5.5.5 shows the specific rates of the major metabolites. There is an increase in the rates 
of both lactate and glucose compared to the rates shown in Table 5.5.3 for the previous 
medium. The metabolism of glutamine and asparagine are inter-related (Mancuso et al., 
1998). In comparison to the previous media, glutamine consumption is decreased and 
asparagine is increased. However, the precise reasons for this have to be further investigated. 
Also the production of alanine is higher. This might be due to increased metabolism of the 
amino acids via the TCA cycle leading to the production of alanine from pyruvate.  
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Table 5.5.5:  Uptake and production rates for glucose, lactate, asparagine, glutamine and 
alanine in the optimized media: 
Glucose 
(10
-3
mM  
10
6
 Cells
-1
 h
-1
) 
Lactate 
(10
-3
mM   
10
6
 Cells
-1
 h
-1
) 
Gln 
(10
-3
µM  
10
6
 Cells
-1
 h
-1
) 
Asn 
(10
-3
µM  
10
6
 Cells
-1
 h
-1
) 
Ala 
(10
-3
µM  
10
6
 Cells
-1
 h
-1
) 
-0.37 0.63 -44.7 -23.4 87.5 
 
 
The concentrations of asparagine and glutamine along with asparatate and glutamate are 
shown in Figure 5.5.12. There is no limitation of glutamine and asparagine and also no 
consumption of glutamate and asparatate. This implies that the strategy of using increased 
concentration of asparagine and glutamine is successful to avoid the re-consumption. This is 
also seen in the case of serine which shows no consumption at the end, unlike in the previous 
media.  
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Figure 5.5.12: (A) Aspartate and glutamate consumption profiles of CHO cells in optimized 
media with [U-
13
C]glucose. (B) Aspargine and glutamine consumption profiles of CHO cells 
in optimized media with [U-
13
C]glucose. 
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Plots of the metabolites were made as in the previous sections and are shown in Figure 5.5.13. 
Unlike in the other media, the amino acids showed consistent behavior with regard to their 
uptake or secretion. Aspartate, glutamate, serine, glycine and alanine were secreted while the 
rest were consumed. The formation of glycine was found to be higher during the later stages 
of growth. For a comparison with the previous media, the growth was assumed to be in two 
phases; one at high glucose concentration and the other at lower glucose concentration. Since, 
there was only a single sample point above the concentration of 15 mM of glucose; 10 mM 
was taken as the cut off point.  Linear regression was performed on the two phases and is 
shown in the figure. Table 5.5.6 shows the yields of the various metabolites on glucose at the 
two phases. The value in the bracket indicates the regression coefficient. The regression at the 
second phase could not be calculated because only two points are available for each 
metabolite. It is seen that at later phases, there is an excess of lactate production going up to a 
lactate to glucose ratio of 2.24. This is in complete contrast to the results obtained with the 
earlier media, where there was a reduction in the overflow metabolism due to decreased 
amounts of glucose. The possible explanation might be the presence of excess glutamine in 
the media since the metabolism of glutamine and glucose have been found to be 
complimentary except at low concentrations (Ljunggren and Haggstrom, 1992; Jeong and 
Wang, 1994; Neermann and Wagner, 1996). This is also seen in the previous medium where 
there is a reduction in the glutamine yield corresponding with reduction in the overflow 
metabolism. Also, the biomass yield is reduced due to the excess consumption of glucose.   
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Figure 5.5.13 (A): Metabolite concentrations of the cell cultivation plotted against glucose. 
Two separate linear regressions were performed, one for glucose concentrations higher than 
10 mM and the other for lower than 10 mM. The closed markers indicate the concentrations at 
high glucose concentration whereas the open symbols indicate low glucose concentration. 
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Figure 5.5.13 (B): Metabolite plotted against glucose. Two separate linear regressions were 
performed, one for glucose concentrations higher than 10 mM and the other for lower than 10 
mM. The closed markers indicate the concentrations at high glucose concentration whereas 
the open symbols indicate low glucose concentration. 
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Figure 5.5.13 (C): Metabolite concentrations plotted against each other. Two separate linear 
regressions were performed, one for glucose concentrations higher than 10 mM and the other 
for lower than 10 mM. The closed markers indicate the concentrations at high glucose 
concentration whereas the open symbols indicate low glucose concentration. 
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Table 5.5.6: Yields of the metabolites and cells on glucose at two growth phase with yield 1 
at high glucose concentration and yield 2 at lower glucose concentration as represented in the 
Figure 5.5.13 A, B & C. The regression coefficient (R
2
) of the linear regression is given in 
brackets. The regression coefficient of yield 2 could not be calculated because only two 
measurements were available for this phase. 
 
Metabolite Yield 1 (R
2
) Yield 2 (R
2
) Unit 
Lactate -1.6 (0.99) -2.2  mM/mM Glucose 
Asp -33.0 (0.99) -21.6  µM/mM Glucose 
Glu -79.3 (0.99) -40.8  µM/mM Glucose 
Asn 52.3 (0.99) 73.8  µM/mM Glucose 
Ser -4.9 (0.97) -4.8 µM/mM Glucose 
Gln 109.2 (0.99) 180.8  µM/mM Glucose 
His 6.1 (0.99) 7.3  µM/mM Glucose 
Gly -1.9 (0.98) -8.9  µM/mM Glucose 
Thr 10.9 (0.99) 11.3  µM/mM Glucose 
Arg 15.0 (0.99) 9.7  µM/mM Glucose 
Ala -181.0 (0.98) -383.3  µM/mM Glucose 
Tyr 8.0 (0.99) 6.3  µM/mM Glucose 
Val 18.2  (0.98) 11.0   µM/mM Glucose 
Met 6.8  (0.99) 3.9   µM/mM Glucose 
Trp  1.4 (0.99) 2.8  µM/mM Glucose 
Phe 10.1 (0.99) 7.8  µM/mM Glucose 
Ile 31.7 (0.98) 18.4  µM/mM Glucose 
Leu 31.1 (0.99) 15.7  µM/mM Glucose 
Lys 20.2  (0.99) 12.2  µM/mM Glucose 
Pro 5.7 (0.99) 12.3  µM/mM Glucose 
Cells 55.6 (0.99) 79.6  Cells/µM Glucose 
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Carbon labeling analysis 
Figure 5.5.14 gives the fractional carbon labeling profile along with the concentrations of the 
metabolites found to be labeled. All the metabolites show or approach steady state in their 
fractional labeling. Lactate has a fractional carbon labeling of 80 % which is similar to the 
labeling obtained in the previous media. 75 % of the lactate is fully labeled and is thus formed 
directly from the glycolytic pathway. 9 % are either 
13
C1 (2 %) or 
13
C2 (7 %) isotopomers, 
implying that they originate from the pyruvate produced from TCA cycle. Compared to the 
previous media, a lower percentage of serine is found to be fully labeled at 84 % with 5 % 
being unlabeled. The same percentage of glycine is found to be fully labeled with 12 % being 
unlabeled. This shows that there might be other sources for glycine production. Fully labeled 
alanine makes up 66 % of the total with 21 % being unlabeled compared to 14 % in lactate. 
Thus a higher percentage of alanine is formed from carbon sources other than glucose. 10 % 
of aspartate is formed via the pyruvate entering TCA cycle via pyruvate carboxylase and 16 % 
from pyruvate dehydrogenase. The above results indicate a higher amount of amino acid 
carbon entering the TCA cycle.  
This media without the anabolic amino acids and excess concentrations of asparagine and 
glutamine offers the best possible solution to reduce the complexity of further calculations 
due to the linear relationship of the metabolites and the approach of steady state in the 
labeling.  
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Figure 5.5.14: Extracellular substrate labeling plotted along with extracellular concentration. 
The right axis gives the concentration and the left axis the fractional carbon labeling of the 
metabolite indicated on the right axis. The sampling procedure is given in material and 
methods. The initial time “0” refers to the sample after the addition of media to cells. 
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5.5.2.5 Elemental carbon balance for the estimation of carbon dioxide 
production rate (CPR)  
Material balances are routinely used in microbial fermentation. These are determined 
generally by applying elemental balances on carbon, nitrogen, oxygen, etc.  On the other hand 
because of the complex nutritional requirements, detailed stoichiometric material balances in 
animal cell culture have been difficult to achieve (Xie and Wang, 1996). Due to the 
complexities of animal cell metabolism, the elemental balances for animal cell cultivation are 
a difficult problem to solve. Closing carbon balances in animal cell culture pose a peculiar 
problem due to the slow growth rates, low specific metabolic rates of such cultures, the low 
cell densities normally obtained in suspension cultures, and particularly the use of bicarbonate 
buffers in media (Lovrecz and Gray, 1994; Xiu et al., 1999). This buffer improves the pH 
control of media incubated in a CO2 atmosphere and provides cells with carbonate ions that 
are necessary for the metabolic functions of most cells particularly for the carboxylation 
reactions. Though theoretically it is possible to replace bicarbonate buffering with other 
organic buffering systems like HEPES, it is important to maintain sufficient bicarbonate in the 
medium for nutritional purposes and intracellular pH regulation (Ganz et al., 1989). There are 
few published reports on closing carbon balances in mammalian cell cultures (Lovrecz and 
Gray, 1994; Bonarius et al., 1999; Oezemre and Heinzle, 2001) which all require the 
measurement of the carbon dioxide evolution rate.  
Xiu et al. (1999) estimated the carbon dioxide evolution rate by employing an elemental 
balance around carbon and obtained results similar to those reported in literature. A similar 
analysis was performed here, by which it was attempted to use the carbon balance to estimate 
the carbon dioxide evolution rate. Briefly, the methodology involves the calculation of the 
specific rates of measured components and estimating the carbon input and output. The 
difference between the input and output gives the carbon dioxide production rate (CPR).  
The carbon balance for the culture is given by the equation 
 
2CO654321
q  q  3q  3q  q  5q   6q +++=++   (5.5.1) 
 
where q1, q2, q3, q4, q5, q6, qCO2 are the specific consumption rates of glucose, glutamine, 
amino acids and production rates of lactate, alanine, biomass, and CO2, respectively.  q6 is the 
carbon mole specific biomass production rate. The biomass rate is calculated from the 
biomass equations derived in the earlier section.  
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 The consumption rate for amino acids excluding glutamine and alanine are given by 
 
AAii3 qC∑=q    (5.5.2) 
 
Ci is the carbon atom number of i
th
 amino acid (excluding glutamine and alanine) and qAAi  
represents the specific utilization rate of amino acid i. 
Table 5.5.7 gives the specific rates of the major metabolites involved in carbon metabolism. 
By employing the above method, the CPR of the culture was found to be 1.85 × 10
-13 
mol cell
-
1
 h
-1
. This value is in the lower range of the values reported by (Zupke et al., 1995) of 2 × 10
-
13
 mol cell
-1
 h
-1
 and (Bonarius et al., 1999) of  2 ~ 5 × 10
-13
 mol cell
-1
 h
-1
. The carbon input 
and output are given in percentage in the Figure 5.5.15. Without considering CPR it was 
possible to close the carbon balance at 93 %. However, using the above analysis around 7 % 
of the carbon forms CO2 and this value is represented in the figure as difference referring to 
the difference between input and output elemental carbon.  
 
Table 5.5.7: The specific rates of metabolites involved in carbon metabolism for CHO cells 
grown in the optimized media shown in Figure 5.5.11. The positive sign indicates production 
and the negative sign indicates consumption of the metabolite.   
 
Metabolite 
Specific Rate 
(mol cell
-1
 h
-1
) 
Metabolite 
Specific Rate 
(mol cell
-1
 h
-1
) 
Glucose -3.3×10
-13
 Cystine -1.4×10
-15
 
Lactate 5.7×10
-13
 Valine -5.6×10
-15
 
Pyruvate -1.6×10
-14
 Methionine -2.1×10
-15
 
Aspartate 9.7×10
-15
 Tryptophan -2.9×10
-16
 
Glutamate 2.1×10
-14
 Phenylanaline -3.4×10
-15
 
Asparagine -2.1×10
-14
 Isoleucine -5.3×10
-15
 
Serine 1.4×10
-15
 Leucine -8.3×10
-15
 
Glutamine -4.0×10
-14
 Lysine -7.0×10
-15
 
Histidine -1.9×10
-15
 Proline -2.5×10
-15
 
Glycine 1.4×10
-15
 Protein 5.2×10
-14
 
Threonine -3.4×10
-15
 DNA 4.9×10
-16
 
Arginine -4.9×10
-15
 RNA 1.4×10
-15
 
Alanine 7.9×10
-14
 Lipids 8.5×10
-16
 
Tyrosine -2.7×10
-15
 Carbohydrates 3.4×10
-15
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Figure 5.5.15: Carbon balance on the cell culture in optimized media described in Figure 
5.5.11. 
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5.5.2.6 Conclusions 
In this part of the work an attempt was made to understand the physiology of the cells and use 
this information for the simplification of the model to be used later for the metabolic flux 
analysis. In this regard considerable progress was achieved towards the goal. From cell 
culture experiments with [U-
13
C]glucose, the anabolic amino acids were determined. Alanine, 
serine, glycine, aspartate and glutamate were found to be labeled with 
13
C and thus the 
biosynthetic pathways of these amino acids are active. This was in-spite the fact that the 
media, as most of the commercially available media, contained these amino acids in 
significant amounts. To simplify the biochemical model to be used for flux calculation, cells 
were grown in media with reduced amounts of the above amino acids and also media lacking 
the amino acids. The cell growth in all the media was similar to the growth in the original 
media. Thus the cells were able to produce these amino acids in sufficient amounts for their 
metabolic maintenance. The physiology of cells in the media lacking these amino acids was 
investigated. It was observed that there was an initial production and a subsequent 
consumption of the amino acids aspartate, glutamate and serine. This was linked to possible 
limitation of the amino acids asparagine and glutamine. The above media was modified with 
an increased concentration of asparagine and glutamine, and cell growth and physiology was 
investigated. The cell growth was observed to be normal; however, as expected some 
differences were noted with respect to cell physiology in comparison to the other media. 
There was no consumption of the anabolic amino acids, and the fractional carbon labeling of 
the extracellular metabolites was found to approach steady state. A necessary precondition for 
the exact calculation of carbon metabolic fluxes is the determination of carbon balance. 
Hence, the carbon balance in the cell culture was determined using which the carbon dioxide 
evolution rate could be estimated. These results enable us to simplify the model by removing 
the uptake fluxes of anabolic amino acids, to avoid the exchange of amino acids and to 
approach a steady state with regard to the fractional carbon labeling. The next part of the work 
deals with the actual experimentation and data which can be used for the absolute flux 
quantification.  
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5.5.3 Parallel labeling studies for metabolic studies  
5.5.3.1 Motivation and choice of labeling substrates 
Isotopic tracers have played an important role in biomedical research since the invention of 
artificial radioactivity by J.F Joliot-Curie and Irene Joliot-Curie in Paris in 1934, the 
production of radioisotopes by cyclotron invented by Ernest O. Lawrence in Berkeley in 1930 
and by nuclear reactor demonstrated by Enrico Fermi and co-workers in Rome in 1942. They 
have been playing a vital role in the growth and development of life science and medicine 
right from the understanding of the chemistry of the photosynthesis (by Melvin Calvin's 
Berkeley team using 
14
C) to the development of molecular biology. The most commonly used 
radioactive isotopes are 
14
C and 
3
H (tritium). In parallel to the research using radioisotopes, in 
the 1930’s Schoenheimer and Rittenberg provided the scientific foundation for the 
development and application of stable isotope techniques in biological research (Young and 
Ajami, 1999). The use of stable isotopes has increased dramatically with advances in 
analytical capabilities like NMR and GC-MS. Aspects of metabolism have been investigated 
employing molecules labeled with 
2
H, 
13
C, 
15
N, and 
18
O. At present more than 6000 stable 
isotope labeled compounds (tracers) are commercially available for use in metabolic studies. 
Kelleher (2001) has reviewed the usage of tracers in metabolic studies and as a consequence 
for flux estimation.  
Isotopes of carbon offer an elegant method to investigate the central metabolism. Reeds et al. 
(1997) have reviewed the use of uniform stable isotope labeled substrates for metabolic 
studies. Isotopomers of glucose have long been and are still the most favored for the 
investigation of mammalian cellular physiology, since glucose is the primary substrate for 
cellular metabolism. The use of fully labeled [U-
13
C]glucose as a substrate to study 
physiology has been demonstrated in the previous section. Katz and Wood (1960) presented a 
theoretical consideration of the methods to evaluate metabolic pathways using 
14
C glucose. 
The rates of carbon dioxide evolution from the simultaneous incubation with [1-
13
C1] and [6-
13
C1]glucose are used to measure the activity of the pentose phosphate shunt (Katz and Wood, 
1963; Mancuso et al., 1994; Bonarius et al., 1998). [1-
13
C1]Glucose has been used to 
determine the metabolic flux rates in a simplified network depicting the central metabolic 
pathway of C6 glioma cells (Portais et al., 1993). Longenecker and Williams (1980) 
quantified the type-L pentose phosphate cycle in hepatocytes using [2-
14
C1] and [5-
14
C1] 
glucose. [1,2-
13
C2]Glucose has been applied to quantify the oxidative pentose-phosphate 
activity along with anaplerosis and rate of macromolecule synthesis (Lee et al., 1998; Boren 
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et al., 2003). Ross et al. (1994) found [1,6-
13
C2 6,6-
2
H2]glucose a better substrate to quantify 
pentose phosphate activity in a single incubation when compared to [1,5,6-
13
C3]glucose and 
[6-
13
C 1,6,6- 
2
H3]glucose. Schrader et al. (1993) applied [2-
13
C1]glucose to study the pentose 
phosphate shunt activity and also fluxes through phosphofructokinase, the 2,3-
diphosphoglycerate bypass, and phosphoglycerate kinase in erythrocytes. Sibson et al. (2001) 
demonstrated the use of [2-
13
C1] and [5-
13
C1]glucose to study the glutamate cycling, 
anaplerosis and TCA cycle flux in cerebral cortex.  
Amino acids labeled at their carbon positions have been also used to study the metabolism of 
mammalian cells. Fully radio-labeled [U-
14
C]glutamine was used by Reitzer et al. (1979) to 
show that glutamine oxidation and not glycolysis is the major energy source in cultured cells. 
Piva and McEvoy-Bowe (1998) studied the oxidation of glutamine in truncated TCA cycle of 
cultured cervical cancer (HeLa) cells using [U-
14
C]glutamine. Sharfstein et al. (1994) used [3-
13
C1] glutamine to study the primary metabolism in a hybridoma cell line. Harper et al. (1984) 
have reviewed the metabolism of branched chained amino acids (isoleucine, leucine and 
valine) and the role played by isotopes for their elucidation. Glutamate and aspartate play an 
important role as neurotransmitters and hence many studies on their metabolism in neurons 
and glial cells have been performed using labeled isotopes (Snyder et al., 1973; Man et al., 
1987; Erecinska and Silver, 1990). Olsen et al. (1943) were the first to investigate the 
metabolism of glycine using stable isotopes. Narkewicz et al. (1996) used stable isotope 
labeled serine and glycine to study the intracellular partitioning of their metabolism. House et 
al. (2001) investigated threonine catabolism in rat hepatocytes using [1-
14
C1]threonine. Along 
with sugars and amino acids, other carbon substrates have also been used to study certain 
aspects of metabolism. Kelleher et al. (1987) used 
14
C labeled citrate, succinate and pyruvate 
for the metabolic investigation of the TCA cycle. [U-
13
C]Pyruvate and [U-
13
C]acetate have 
been used for the studies of the TCA cycle (Fernandez and Des Rosiers, 1995). Cruz et al. 
(2001) used labels of pyruvate and glucose to determine the intracellular compartmentation of 
pyruvate.  
The above are only few of the numerous examples involving labeled substrates. A detailed 
review of the applications of isotope labels and methods in biological research can be found in 
Berliner and Robitaille (1998) and Wolfe and Chinkes (2004).  
A fact that stands out from the examples given above is that the complexity of the mammalian 
physiology requires multiple complimentary investigations by utilizing various different 
substrates to determine the metabolism. In the case of the central metabolism, this complexity 
is also induced by the fact that the carbon requirement of the cells is not fulfilled by a single 
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(e.g. glucose in case of many bacteria) but by many carbon substrates (e.g. glucose, amino 
acids, pyruvate etc) entering the metabolic pathway. Quantitative analysis of the whole cell 
metabolism in mammalian cells is thus an arduous task. In earlier chapter, the methodology of 
metabolic flux analysis for the quantitative analysis of cellular physiology has been explained. 
Also, the application of this methodology for mammalian cell culture and the shortcomings of 
the methods employed have been discussed. In this chapter, the application of parallel cell 
cultures with different labeled substrates for flux calculations is shown.  
The culture media of the mammalian cells is composed of many carbon containing substrates, 
which are taken up by the cells and participate in the central metabolism. The previous 
chapter described the optimization of the media with a view to reduce the complexity in the 
calculation of metabolic fluxes. This involved the elimination of substrates which are 
simultaneous both catabolic and anabolic in nature. To accurately quantify the fluxes of the 
metabolic pathways, the knowledge of the contribution of individual carbon substrates to the 
central metabolism is essential. In this regard, we employ a strategy of parallel cell 
cultivations with differently labeled substrates. The labeling data along with the uptake and 
production rates of the main metabolites will then be utilized for the calculation of fluxes. 
Along with the quantification, it is also important to gain an insight into the metabolism. In 
order to carry out the analysis, the choice of substrates to be labeled and the position of 
labeling are of prime importance. An ideal situation would be to carry out labeling 
experiments with all carbon substrates labeled at various different positions. This, however, 
would not be feasible as among other pitfalls it would be expensive, time consuming and 
would lead to redundant data sets. Studying the biochemistry and the network to be quantified 
makes the choice of labeled substrates simpler. Also, the simultaneous use of two labeled 
substrate in the same culture leads to the possibility of gaining a more informative insight into 
the metabolism. 
The isotopic substrates used in this study and the information they could provide are listed 
below.  
 
[1-
13
C1]Glucose and [U-
13
C]glutamine 
[1-
13
C1]Glucose is a widely used substrate to quantify fluxes in microbial cultures particularly 
providing information about glycolysis-PPP splitting (Wittmann and Heinzle, 1999; 
Wittmann, 2007). Glutamine is the major energy source in cultured cells (Reitzer et al., 1979), 
and its metabolism has been investigated using labeled substrates as explained earlier. The use 
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of the simultaneous application of these substrates would help to quantify among others, the 
pentose phosphate activity, the TCA cycle, and anaplerotic fluxes.  
 
[1-
13
C1]Glucose and [U-
13
C]threonine 
The carbon chain of threonine is converted to succinyl-CoA, which feeds directly into the 
citric acid cycle. This was long thought to be the only active catabolic mechanism of 
threonine present in mammalian cells. However, in recent literature this has been 
contradicted. The oxidation of threonine can be broadly classified glycine dependent and 
glycine independent (House et al., 2001). One of the pathways produces glycine and acetyl-
CoA, and the other pathway produces succinyl-CoA. To study the contribution of each 
mechanism to the central metabolism, [U-
13
C]threonine is used as one of the substrates along 
with [1-
13
C1]glucose.  
 
[1,2-
13
C2]Glucose 
The advantage of using [1,2-
13
C2]glucose has been explained earlier. The oxidative pentose-
phosphate activity along with anaplerosis and rate of macromolecule synthesis can be 
estimated.  
 
[3-
13
C1]Pyruvate 
Peuhkurinen et al. (1983), Cruz et al. (2001) and Zwingmann et al. (2001) have reported the 
presence of intracellular cytosolic compartmentation of pyruvate. [3-
13
C1]Pyruvate is used in 
this study to investigate the compartmentation and also the contribution from extracellular 
pyruvate to the central metabolism. [3-
13
C1]Pyruvate would enter the TCA cycle as singly 
labeled acetyl-CoA losing a carbon atom as CO2. Alanine and lactate formed from 
extracellular [3-
13
C1]pyruvate would be singly labeled whereas that from the glycolysis would 
be unlabeled. The recycled pyruvate would be a mixture of unlabeled, single, double and fully 
labeled molecules. The labeling patterns of lactate and alanine along with the data from the 
other cultures help to investigate the pyruvate compartmentation.   
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5.5.3.2 Parallel cell growth and carbon labeling  
The results obtained from the parallel culture with multiple labeled substrates are discussed 
below. In the first part the general comparison of growth and physiology is described. The 
growth characteristics of individual experiments are discussed in the second part. The third 
part gives an overall comparative view of the whole cell metabolism and physiology from all 
the four cultures with emphasis on the metabolic pathways.  
 
Comparison of growth in the four cultures 
The cells were grown in parallel in the media with the labeled substrates, i.e. [1-
13
C1]glucose 
and [U-
13
C]glutamine, [1-
13
C1]glucose and [U-
13
C]threonine, [1,2-
13
C2]glucose, and [3-
13
C1] 
pyruvate. The cell growth of all the four cultures is given in Figure 5.6.1. The cells show 
similar growth patterns and growth rates. The lactate and glucose concentration profiles of the 
cultures are shown in Figure 5.6.2. Table 5.6.1 also gives the specific rates of glucose uptake 
and lactate production in the four cultures. The starting concentration of glucose in the four 
cultures is different and is possibly responsible for the slight differences in the rates, with the 
cultures having a higher starting concentration showing a higher uptake. The concentration of 
glucose in cultures containing [1-
13
C1]glucose is lower than that of the other two cultures. 
This phenomenon has also been observed in other cell lines (Neermann and Wagner, 1996).  
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Figure 5.6.1: Cell growth of CHO cells in four parallel cultures with different isotopic 
labeled substrates. The isotopic labels used in the culture are depicted on top of each graph.  
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Figure 5.6.2: The glucose and lactate concentration profiles during cell growth in four 
parallel cultures of CHO cells with different isotopic labeled substrates. The isotopic labels 
used in the culture are depicted on top of each graph. The open symbols represent glucose and 
the closed symbols represent lactate. 
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Table 5.6.1:  Growth rate, glucose uptake and lactate production for the parallel cell cultures 
using different labels 
 
Labeled isotopes used 
in culture 
Growth rate (h
-1
) 
Glucose Uptake 
(× 10
-9 
Mol cell
-1 
day
-1
) 
Lactate Production 
(× 10
-8 
Mol cell
-1 
day
-1
) 
Lactate/Glucose 
(Mol/Mol) 
     
[1-
13
C1]Glc + [U-
13
C]Gln 0.033 8.06 1.31 1.63 
[1-
13
C1]Glc + [U-
13
C]Thr 0.031 8.11 1.27 1.57 
[1,2-
13
C2]Glc 0.033 9.49 1.38 1.45 
[3-
13
C1]Pyr 0.032 10.9 1.68 1.54 
Mean 0.032 9.14 1.41 1.55 
Standard Deviation 0.001 1.35 0.186 0.07 
Standard Deviation (%) 2.97 14.74 13.17 4.59 
 
 
Growth and isotope labeling characteristics of individual cultures 
 
[1-
13
C1]Glucose and [U-
13
C]glutamine 
Similar to the previous section, the interdependency of the different metabolites in the 
cultures was determined by plotting their concentrations against the corresponding glucose 
concentration. A few of the metabolites were plotted against each other. Figure 5.6.3 (A, B 
and C) gives the plots of the culture with [1-
13
C1]glucose and [U-
13
C]glutamine. Most of these 
plots show linear relationship as expected due to the use of the optimized media. There is a 
consumption of serine during the end of the cultivation subsequent to its production during 
the initial phases. This is most probably due to the lower amount of glucose present in the 
media during this phase. This leads to the non-linear relationship between serine and glucose 
as seen in Figure 5.6.3 (A), and between serine and glycine seen in Figure 5.6.3 (C). Aspartate 
and glutamate are not consumed during the end of the cultivation even in the presence of low 
amounts of glucose in the media. This probably is due to asparagine and glutamine feeding 
the TCA cycle in sufficient amounts to satisfy the biosynthetic requirement of the cells for 
aspartate and glutamate. This is in contrast to serine, which is consumed during the end phase, 
thus the biosynthetic need of serine is supplied directly from glucose. Glycine, whose 
biosynthesis is linked to serine, shows no consumption in contrast to serine. This might 
possibly be due to serine being an important gluconeogenic substrate converting readily to 
pyruvate via serine hydratase. Other reason might be the degradation of threonine to produce 
glycine.  
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Figure 5.6.3 (A): Metabolite concentrations of the cultivation using [1-
13
C1]glucose + [U-
13
C]glutamine isotopic label plotted against glucose for the culture described in Figure 5.6.1. 
Linear regression was performed on each of the metabolite.  
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Figure 5.6.3 (B): Metabolite concentrations of the cultivation using [1-
13
C1]glucose + [U-
13
C]glutamine isotopic label plotted against glucose for the culture described in Figure 5.6.1. 
Linear regression was performed on each of the metabolite.  
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Figure 5.6.3 (C): Metabolite concentrations of the cultivation using [1-
13
C1]glucose + [U-
13
C]glutamine isotopic label plotted against glucose and also a few against each other for the 
culture described in Figure 5.6.1. Linear regression was performed on each of the metabolite.  
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Gas chromatographic mass spectrometric analysis was carried out to determine the mass 
isotopomers and fractional carbon labeling (FCL) of the samples obtained during the cell 
cultivation using [1-
13
C1]glucose and [U-
13
C]glutamine. Similar to the previous section, the 
samples were analyzed for the extracellular amino acids and lactate, and the fractional carbon 
labeling of the amino acids and lactate in the culture supernatant with respect to time along 
with their concentration profile is shown in Figure 5.6.4. The final fractional carbon labeling 
of lactate is 0.19 and that of alanine is 0.21. Looking at the mass isotopomers, single labeled 
lactate makes up 39 % and fully labeled lactate 5 % as compared to alanine in which the 
single labeled species makes up 36 % and the fully labeled 7 %. In addition the doubly 
labeled species of alanine has a higher labeling (3 %) compared to lactate (2 %). Thus the 
amount of alanine formed from the carbon of the TCA cycle is higher than the amount of 
lactate formed. This is also seen in the culture using [U-
13
C]glucose in the previous section, 
where the amount of alanine formed is higher than the amount of lactate formed from carbon 
sources other than glucose. The fractional labeling of glycine reaches a maximum of 0.12 
(measured at 24 h) before reaching a final fractional labeling of 0.06. At 24 h the single 
labeled species makes up for 12 % and fully labeled species at 6 % compared with 6 % and 3 
% for the singly and fully labeled species at the end of the cultivation respectively. The final 
fractional labeling of serine is 0.18 with 37 % being the single labeled species and 6 % 
making up double (4 %) and fully labeled (2 %) serine. The decrease in the fractional labeling 
during the end of cultivation is probably due to the consumption of serine which might lead to 
exchange fluxes. This is explained in detail in the later part. Fully labeled glutamate makes up 
56 % of the total glutamate produced with a final fractional labeling of 0.76. The 
13
C3 fraction 
makes up 12 % and the 
13
C4 makes up 10 %. The 
13
C1 and 
13
C2 fractions are 7 % each 
respectively. Aspartate has a final fractional labeling of 0.37. The fully labeled fraction is 23 
% whereas the unlabeled fraction is around 50 %. The 
13
C1, 
13
C2 and 
13
C3 make up 9 % each 
respectively. The fully labeled glutamate is probably mostly formed from fully labeled 
glutamine due to the glutaminase activity. However, the presence of other labeled forms of 
glutamate and also the presence of labeled aspartate indicate high glutamate dehydrogenase 
activity for the entry of glutamate into the TCA cycle and aspartate transaminase/malate 
dehydrogenase for the aspartate-malate shuttle.  
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Figure 5.5.4: Extracellular metabolite labeling plotted along with extracellular concentration 
profile for the cultivation using [1-
13
C1]glucose + [U-
13
C]glutamine containing media 
described in Figure 5.5.1. The right axis gives the concentration and the left axis the fractional 
carbon labeling of the metabolite indicated on the right axis. The sampling procedure is given 
in material and methods. The initial time “0” refers to the sample after the addition of media 
to cells. 
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[1-
13
C1]Glucose and [U-
13
C]threonine 
 The plots showing the interdependency of the metabolites in the culture with [1-
13
C1]glucose 
and [U-
13
C]threonine show very similar patterns to the cultures with [1-
13
C1]glucose and [U-
13
C]glutamine [Figure 5.6.4 (A), (B) and (C)]. The relationship between the metabolites has 
been explained earlier. There is a linear relationship between most of the metabolites. The 
non-linear relationship of serine is due to its consumption at the end of the cultivation phase 
in the presence of low concentrations of glucose.  
The extracellular samples of the cultivation with [1-
13
C1]glucose and [U-
13
C]threonine were 
analyzed for the amino acids and lactate, and the fractional carbon labeling of the amino acids 
and lactate in the supernatant with respect to time along with their concentration profile is 
shown in Figure 5.6.5. Lactate reaches a higher final fractional carbon labeling (0.14) than 
alanine (0.13). The major labeled isotopomer in both the metabolites is the singly labeled 
species making up 38 % in lactate and 35 % in alanine. 62 % of alanine is unlabeled 
compared to 60 % of lactate offering further evidence that higher percentage of alanine is 
produced compared to lactate from TCA cycle. Glycine has a high fractional labeling of 0.16 
(at 24h) and reaches a final carbon labeling of 0.06. The single labeled species makes up for 
12 % and fully labeled species at 10 % at 24h and drops down to 6 % and 3 % for the singly 
and fully labeled species respectively at the end of the cultivation. The fractional carbon 
labeling of serine reaches 0.15 at the end of cultivation from a high of 0.28. The fully labeled 
species of serine drops down to 0.3 % from a high of 21 % at the start of the cultivation. The 
fractional labeling of aspartate and glutamate is 0.04 and 0.06 respectively. 19 % of the 
glutamate and 14 % of aspartate is single labeled. This supports the fact that there is a high 
degree of activity of glutamate dehydrogenase and aspartate transaminase/malate 
dehydrogenase.  
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Figure 5.6.4 (A): Metabolite concentrations of the cultivation using [1-
13
C1]glucose + [U-
13
C]threonine isotopic label plotted against glucose for the culture described in Figure 5.6.1. 
Linear regression was performed on each of the metabolite.  
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Figure 5.6.4 (B): Metabolite concentrations of the cultivation using [1-
13
C1]glucose + [U-
13
C]threonine isotopic label plotted against glucose for the culture described in Figure 5.6.1. 
Linear regression was performed on each of the metabolite.  
 
 
 
 
 
 
 
 
 PHYSIOLOGICAL INVESTIGATIONS ON CHO CELLS 
 
 139 
0 4 8 12 16 20
875
1000
1125
1250
L
e
u
 (
µµ µµ
M
)
Glucose (mM))
0 5 10 15 20
375
500
625
750
L
y
s
 (
µµ µµ
M
)
Glucose (mM)
0 4 8 12 16 20
100
150
200
P
ro
 (
µµ µµ
M
)
Glucose (mM)
500 750 1000 1250 1500
0
100
200
300
400
A
s
p
( µµ µµ
M
)
Asn(µM)
3750 5000 6250
0
250
500
750
G
lu
 (
µµ µµ
M
)
Gln (µM)
0 100 200 300 400
0
200
400
600
800
G
lu
 (
µµ µµ
M
)
Asp (µM)
500 750 1000 1250 1500
3750
4500
5250
6000
6750
G
ln
 (
µµ µµ
M
)
Asn (µM)
0 15 30 45
0
10
20
30
40
50
G
ly
 (
µµ µµ
M
)
Ser (µM)
0 4 8 12 16 20
3.0x10
5
6.0x10
5
9.0x10
5
1.2x10
6
1.5x10
6
C
e
ll
 D
e
n
s
it
y
 (
C
e
ll
s
 m
L
-1
)
Glucose (mM)
Figure 5.6.4 (C): Metabolite concentrations of the cultivation using [1-
13
C1]glucose + [U-
13
C]threonine isotopic label plotted against glucose and also a few against each other for the 
culture described in Figure 5.6.1. Linear regression was performed on each of the metabolite.  
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Figure 5.6.5: Extracellular metabolite labeling plotted along with extracellular concentration 
profile for the cultivation using [1-
13
C1]glucose + [U-
13
C]threonine containing media 
described in Figure 5.6.1. The right axis gives the concentration and the left axis the fractional 
carbon labeling of the metabolite indicated on the right axis. The sampling procedure is given 
in material and methods. The initial time “0” refers to the sample after the addition of media 
to cells. 
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[1,2-
13
C2]Glucose  
Figure 5.6.6 (A, B and C) gives the plots of the metabolite interdependency of the culture with 
[1,2-
13
C2]glucose. All the metabolites show linear relationship with glucose. There is no 
consumption of serine during the end of the cultivation unlike the previous culture because of 
the availability of sufficient glucose. The yield of glycine increases dramatically towards the 
end of the cultivation compared to the previous two cultures. The most probable reason might 
be the continual production of serine in the presence of glucose.  
The fractional carbon labeling of the amino acids and lactate in the supernatant with respect to 
time along with their concentration profile is shown in Figure 5.6.7. Lactate has a final 
fractional carbon labeling of 0.27 with 36 % being 
13
C2 species and 5 % being 
13
C1 labeled. 32 
% of the alanine concentration is 
13
C2 and 6 % being 
13
C1 with a final fractional carbon 
labeling of 0.24. In contrast to the previous culture, the fractional labeling of glycine increases 
with time, and it has a final fractional labeling of 0.23. 41 % of the final glycine is made up of 
13
C1 species. Serine reaches a final FCL of 0.3 with 22 % of 
13
C1 and 32 % of 
13
C2 serine. 
Aspartate and glutamate have a FCL of 0.08 and 0.1 respectively at the end of cultivation with 
13
C2 being the major contributor of the 
13
C isotope in both the amino acids (9 % for aspartate 
and 13 % for glutamate).  
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Figure 5.6.6 (A): Metabolite concentrations of the cultivation using [1,2-
13
C2]glucose isotopic 
label plotted against glucose for the culture described in Figure 5.6.1. Linear regression was 
performed on each of the metabolite.  
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Figure 5.6.6 (B): Metabolite concentrations of the cultivation using [1,2-
13
C2]glucose isotopic 
label plotted against glucose for the culture described in Figure 5.6.1. Linear regression was 
performed on each of the metabolite.  
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Figure 5.6.6 (C): Metabolite concentrations of the cultivation using [1,2-
13
C2]glucose isotopic 
label plotted against glucose and also a few against each other for the culture described in 
Figure 5.6.1. Linear regression was performed on each of the metabolite.  
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Figure 5.6.7: Extracellular metabolite labeling plotted along with extracellular concentration 
profile for the cultivation using [1,2-
13
C2]glucose containing media described in Figure 5.6.1. 
The right axis gives the concentration and the left axis the fractional carbon labeling of the 
metabolite indicated on the right axis. The sampling procedure is given in material and 
methods. The initial time “0” refers to the sample after the addition of media to cells. 
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[3-
13
C1]Pyruvate  
The interdependency of the metabolites in the culture with [3-
13
C1]pyruvate is shown in 
Figure 5.7.7 (A, B &C). The linear relationships shown are similar to the culture with 1,2 
13
C2 
glucose.  
Figure 5.6.9 shows the fractional carbon labeling of the amino acids and lactate in the 
supernatant with respect to time along with their concentration profile. The fractional carbon 
labeling of lactate at the end of 12 h is 0.13 and decreases to 0.03 at the end of the cultivation. 
Similarly, alanine has a fractional labeling of 0.11 at the end of 12 h and 0.04 at the end of the 
cultivation. 35 % 
13
C1 lactate is present at 12 h with 8 % at the end and in case of alanine it 
drops from 32 % 
13
C1 alanine at 12 h to 11 % the end of the cultivation. Glycine has 15 % 
13
C1 
and 5 % fully labeled species at 24 h decreasing to 5 % 
13
C1 and 0.3 % 
13
C2 at the end of 
cultivation. The fractional labeling also shows a decrease from 0.12 at 24 h to 0.03 at the end 
of cultivation. Serine follows a similar pattern with the 
13
C1 being 8 % at 12 h to 4 % at the 
end. The fractional labeling of serine is lower than glycine being 0.02, in contrast to the three 
previous cultures where serine had higher fractional carbon labeling. Aspartate and glutamate 
show similar final fractional labeling of 0.02. The 
13
C1 fraction makes up 7 % of the final 
aspartate and 10 % of the final glutamate.  
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Figure 5.6.8 (A): Metabolite concentrations of the cultivation using [3-
13
C1]pyruvate isotopic 
label plotted against glucose for the culture described in Figure 5.6.1. Linear regression was 
performed on each of the metabolite.  
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Figure 5.6.8 (B): Metabolite concentrations of the cultivation using [3-
13
C1]pyruvate isotopic 
label plotted against glucose for the culture described in Figure 5.6.1. Linear regression was 
performed on each of the metabolite.  
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Figure 5.6.8 (C): Metabolite concentrations of the cultivation using [3-
13
C1]pyruvate isotopic 
label plotted against glucose and also a few against each other for the culture described in 
Figure 5.6.1. Linear regression was performed on each of the metabolite.  
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Figure 5.6.9: Extracellular metabolite labeling plotted along with extracellular concentration 
profile for the cultivation using [3-
13
C1]pyruvate containing media described in Figure 5.6.1. 
The right axis gives the concentration and the left axis the fractional carbon labeling of the 
metabolite indicated on the right axis. The sampling procedure is given in material and 
methods. The initial time “0” refers to the sample after the addition of media to cells. 
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5.5.3.3 Examination of metabolic pathways 
Specific rate of metabolites 
The data from the four cultivations were compared to get a relatively complete picture of the 
metabolism. The specific rate of production and consumption of the metabolites for the four 
cultures along with the mean and standard deviation over the whole culture is given in Table 
5.6.2. The cell cultures with [1,2-
13
C2]glucose and [3-
13
C1]pyruvate show high specific rates 
for glucose consumption and lactate production compared to the other cultures. This is due to 
the presence of higher concentration of glucose in these two cultures compared to the other 
two cultures.  The lactate to glucose (L/G) (M/M) ratio of all the four cultures over the whole 
cultivation ranges from 1.45 for the culture with [1,2-
13
C2]glucose to 1.62 for the culture with 
[1-
13
C1]glucose and [U-
13
C]glutamine. However, these ratios do not show specific 
relationship to the specific rate of glucose uptake. Nevertheless the higher L/G ratio of the 
culture with [1-
13
C1]glucose and [U-
13
C]glutamine shows a higher specific uptake of 
glutamine, in comparison to the culture with [1,2 
13
C2]glucose. Hence the entry of a higher 
amount of glutamine in the TCA cycle probably redirects the glucose to the overflow 
metabolism. Also seen is that the specific rate of lactate and alanine formation show a linear 
relationship. This is due to the fact that both these metabolites are derived from pyruvate. In 
the cultivations with [1-
13
C1]glucose + [U-
13
C]glutamine and [1-
13
C1]glucose + [U-
13
C]threonine, it is seen that there is a consumption of serine towards the end of the culture 
time. This is most probably due to the reduction in the concentration of glucose available in 
the media. The cultures with [1,2-
13
C2]glucose and [3-
13
C1]pyruvate do not show this 
phenomenon of serine consumption and thus the highest deviation is shown by the 
metabolites glycine and serine for the four cultures. However, the specific rates of the two sets 
of cultures are highly comparable. The other metabolites don’t show this high deviation.  
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Table 5.6.2: Specific rates of uptake and production of metabolites in the parallel cell cultures 
using different isotopic labels. Negative values indicate uptake while positive values indicate 
production. 
Metabolite 
1
13
C-Glc 
+ U
13
C-Gln 
(mol cell
-1
 h
-1
) 
1
13
C-Glc + 
U
13
C-Thr 
(mol cell
-1
 h
-1
) 
1,2
13
C-Glc 
(mol cell
-1
 h
-1
) 
3
13
C-Pyr 
(mol cell-
1 
h
-1
) 
Mean S.D 
S.D 
(%) 
Anabolic Metabolites 
Lactate 1.3×10
-08
 1.3×10
-08
 1.4×10
-08
 1.7×10
-08
 1.4×10
-08
 1.9×10
-09
 13 
Alanine 1.7×10
-09
 1. 6×10
-09
 1.9×10
-09
 2.0×10
-09
 1.8×10
-09
 1.8×10
-10
 10 
Aspartate 2.0×10
-10
 1.7×10
-10
 2.1×10
-10
 2.0×10
-10
 2.0×10
-10
 1.6×10
-11
 8 
Glutamate 4.2×10
-10
 3.4×10
-10
 4.7×10
-10
 4.5×10
-10
 4.2×10
-10
 5.6×10
-11
 13 
Serine 10.0×10
-12
 1.0×10
-11
 2.6×10
-11
 3.2×10
-11
 2.0×10
-11
 1.1×10
-11
 57 
Glycine 2.3×10
-11
 1.8×10
-11
 6.1×10
-11
 7.3×10
-11
 4.4×10
-11
 2.7×10
-11
 62 
Catabolic Metabolites 
Glucose -8.1×10
-09
 -8.1×10
-09
 -9.5×10
-09
 -1.1×10
-08
 -9.1×10
-09
 1.3×10
-09
 14 
Pyruvate -1.8×10
-10
 -1.0×10
-10
 -1.8×10
-10
 -1.6×10
-10
 -1.6×10
-10
 3.5×10
-11
 22 
Glutamine -2.1×10
-09
 -1.7×10
-09
 -1.1×10
-09
 -1.9×10
-09
 -1.7×10
-09
 4.3×10
-10
 24 
Asparagene -5.3×10
-10
 -4.9×10
-10
 -4.7×10
-10
 -5.7×10
-10
 -5.2×10
-10
 4.7×10
-11
 9 
Histidine -4.6×10
-11
 -4.2×10
-11
 -3.2×10
-11
 -4.0×10
-11
 -4.0×10
-11
 6.0×10
-12
 15 
Threonine -9.2×10
-11
 -8.3×10
-11
 -6.7×10
-11
 -9.3×10
-11
 -8.4×10
-11
 1.2×10
-11
 14 
Arginine -1.1×10
-10
 -1.1×10
-10
 -1.0×10
-10
 -1.3×10
-10
 -1.1×10
-10
 1.0×10
-11
 9 
Tyrosine -6.0×10
-11
 -5.7×10
-11
 -5.3×10
-11
 -6.6×10
-11
 -5.9×10
-11
 5.4×10
-12
 9 
Cysteine -7.0×10
-11
 -3.4×10
-11
 -3.0×10
-11
 -3.1×10
-11
 -4.1×10
-11
 2.0×10
-11
 47 
Valine -1.4×10
-10
 -1.3×10
-10
 -1.3×10
-10
 -1.5×10
-10
 -1.3×10
-10
 1.2×10
-11
 9 
Methionine -4.6×10
-11
 -4.7×10
-11
 -4.5×10
-11
 -5.5×10
-11
 -4.8×10
-11
 4.7×10
-12
 10 
Tryptophan -1.6×10
-11
 -1.3×10
-11
 -1.3×10
-11
 -1.6×10
-11
 -1.4×10
-11
 1.6×10
-12
 11 
Phenylalanine -7.7×10
-11
 -7.4×10
-11
 -6.8×10
-11
 -8.5×10
-11
 -7.6×10
-11
 7.2×10
-12
 10 
Isoleucine -1.2×10
-10
 -1.2×10
-10
 -1.1×10
-10
 -1.5×10
-10
 -1.2×10
-10
 1.4×10
-11
 12 
Leucine -2.0×10
-10
 -2.0×10
-10
 -1.8×10
-10
 -2.3×10
-10
 -2.0×10
-10
 2.2×10
-11
 11 
Lysine -1.8×10
-10
 -2.0×10
-10
 -1.5×10
-10
 -2.0×10
-10
 -1.8×10
-10
 2.4×10
-11
 13 
Proline -5.5×10
-11
 -3.6×10
-11
 -5.1×10
-11
 -6.3×10
-11
 -5.1×10
-11
 1.1×10
-11
 22 
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Metabolic quotient of metabolites 
Due to the consumption of serine at the end of the cultivation, the metabolic quotient on 
glucose for the cultures was calculated only during their exponential growth phases. For the 
first set of two cultures i.e. with [1-
13
C1]glucose plus [U-
13
C]glutamine and with [1-
13
C1]glucose plus [U-
13
C]threonine, the quotients were calculated from the initial time (time 
0) to the cultivation time of 37h. For the other set i.e. with [1,2-
13
C2]glucose and [3-
13
C1]pyruvate, the time chosen for the quotient calculation was from 12 h to 46 h. The 
quotients were calculated using three separate methods of calculation. The first method used 
the difference of the concentrations of the metabolites and glucose. In the second method the 
concentration profile of the metabolite and glucose was smoothed by spline fitting using 
MATLAB and than calculating the difference of the concentrations from the spline curve. The 
third method used the slope of each time point on the concentration-time curves of the 
metabolite and glucose to provide the quotient. Table 5.6.3 gives the mean quotients on 
glucose calculated for the four cultures using the three methods and also the cumulative 
average and deviation. With the exception of glycine, none of the metabolites show major 
deviations. However, with regard to glycine, the cultivation set with [1-
13
C1]glucose plus [U-
13
C]glutamine and [1-
13
C1]glucose plus [U-
13
C]threonine show comparable quotients and also 
the cultivation set with [1,2-
13
C2]glucose and [3-
13
C1]pyruvate. The production of glycine is 
lower in the cultivations with low concentration of glucose. Unlike their production rates, 
alanine and lactate do not display a linear relationship with respect to their yields from 
glucose. This shows that though both these metabolites are formed from the same precursor, 
i.e. pyruvate but the source of the precursor is not solely glucose. The metabolic quotients of 
the branched chain amino acids are higher in the cultures with lower glucose, i.e. [1-
13
C1]glucose plus [U-
13
C]glutamine and [1-
13
C1]glucose plus [U-
13
C]threonine. Again this 
might be to feed the TCA cycle due to the lower amount of glucose present and this is also 
seen with the quotients of glutamine. Moreover, the catabolism of branched chain amino acids 
is a rich provider of reducing equivalents and, due to the lower uptake of glucose in these 
media, probably provides the equivalents for energy production. The metabolic quotient of 
glutamate is also higher in the cultures with lower glucose due to the higher uptake of 
glutamine. Since the growth rate of the four cultures is comparable, the cellular components 
show very low deviation. These metabolic quotients and the labeling data would form the 
basis for the quantification of the whole cell metabolism using the technique of metabolic flux 
analysis.  
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Table 5.6.3: The metabolic quotient on glucose of the metabolites in the parallel cell cultures 
with different isotopic labels. Negative values indicate uptake while positive values indicate 
production. The biomass quotients are calculated using the biomass equations. 
[1-
13
C1]Glc 
+ [U-
13
C]Gln 
(M/M) 
[1-
13
C1]Glc + 
[U-
13
C]Thr 
(M/M) 
[1,2-
13
C2]Glc 
(M/M) 
[3-
13
C1]Pyr 
(M/M) 
Cumulative 
(M/M) 
 
METABOLITE 
 
Mean Std.Dev Mean Std.Dev Mean Std.Dev Mean Std.Dev Mean Std.Dev % Deviation 
Anabolic Metabolites 
Lactate  1.763 0.058 1.861 0.056 1.686 0.157 1.664 0.034 1.744 0.089 5 
Alanine 0.177 0.003 0.192 0.010 0.198 0.007 0.184 0.011 0.188 0.009 5 
Glutamate 0.055 0.004 0.054 0.005 0.047 0.004 0.041 0.001 0.049 0.006 13 
Aspartate 0.027 0.000 0.028 0.002 0.027 0.001 0.024 0.001 0.026 0.002 6 
Glycine 0.002 0.000 0.002 0.000 0.005 0.001 0.006 0.001 0.004 0.002 54 
Serine 0.003 0.001 0.004 0.001 0.003 0.001 0.003 0.000 0.003 0.000 7 
Catabolic Metabolites 
Glutamine -0.175 0.005 -0.147 0.011 -0.126 0.011 -0.106 0.024 -0.139 0.030 21 
Asparagene -0.045 0.001 -0.042 0.005 -0.049 0.002 -0.048 0.005 -0.046 0.003 7 
Arginine -0.012 0.001 -0.011 0.001 -0.013 0.001 -0.011 0.001 -0.012 0.001 5 
Cysteine -0.006 0.001 -0.005 0.000 -0.003 0.001 -0.003 0.000 -0.004 0.001 32 
Histidine -0.004 0.000 -0.006 0.001 -0.004 0.000 -0.003 0.000 -0.004 0.001 27 
Isoleucine -0.017 0.003 -0.016 0.001 -0.008 0.001 -0.008 0.001 -0.012 0.005 38 
Leucine -0.025 0.006 -0.024 0.000 -0.018 0.003 -0.015 0.001 -0.020 0.005 25 
Lysine -0.019 0.000 -0.026 0.001 -0.020 0.002 -0.018 0.001 -0.021 0.003 17 
Methionine -0.005 0.000 -0.005 0.000 -0.005 0.000 -0.004 0.000 -0.005 0.000 7 
Phenylalanine -0.008 0.000 -0.008 0.001 -0.008 0.001 -0.007 0.000 -0.008 0.000 6 
Proline -0.004 0.001 -0.004 0.000 -0.006 0.001 -0.004 0.000 -0.004 0.001 31 
Threonine -0.009 0.000 -0.009 0.001 -0.008 0.001 -0.007 0.001 -0.008 0.001 9 
Tryptophan -0.001 0.000 -0.001 0.000 -0.001 0.000 -0.001 0.000 -0.001 0.000 33 
Tyrosine -0.006 0.000 -0.007 0.000 -0.006 0.001 -0.006 0.000 -0.006 0.000 5 
Valine -0.015 0.001 -0.015 0.000 -0.013 0.002 -0.012 0.001 -0.014 0.002 11 
Biomass 
Cells (g/mM) 0.018 0.004 0.020 0.002 0.021 0.002 0.022 0.003 0.020 0.002 9 
Protein 0.117 0.025 0.133 0.010 0.135 0.013 0.145 0.020 0.132 0.012 9 
DNA 0.001 0.000 0.001 0.000 0.001 0.000 0.001 0.000 0.001 0.000 9 
RNA 0.021 0.004 0.024 0.002 0.024 0.002 0.026 0.004 0.024 0.002 9 
Lipids 0.002 0.000 0.002 0.000 0.002 0.000 0.002 0.000 0.002 0.000 9 
Carbohydrate 0.008 0.002 0.009 0.001 0.009 0.001 0.010 0.001 0.009 0.001 9 
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Pyruvate metabolism 
In the biochemical network described in the earlier section, the cellular compartmentation into 
cytosol and mitochondria has been considered. Pyruvate has been assumed to be of a single 
pool in the cytosol entering the mitochondria as acetyl-CoA. It is known that eukaryotic cells 
have two pyruvate pools, one cytosolic and the other mitochondrial. However, since the 
transport of pyruvate into the mitochondria through the mitochondrial membrane takes place 
via the pyruvate carrier in exchange of a hydroxyl group (Lanoue and Schoolwerth, 1979), the 
assumption of a single pyruvate pool seemed to be justified. In the biochemical network, the 
formation of alanine and lactate, the two major products of overflow metabolism, was 
assumed to be from the single cytosolic pyruvate pool since there would be no difference in 
the labeling patterns. But the mass isotopomer and the fractional carbon labeling data 
obtained for lactate and alanine in the four cultivations could not be explained with the 
assumption of a single pyruvate pool. For example the fractional labeling of lactate in the cell 
cultivation with [1-
13
C1]glucose plus [U-
13
C]glutamine was found to be lower than that of 
alanine. Assuming a single pool would give both the metabolites the same fractional labeling. 
In microbial systems, alanine can be formed by the catabolism of aspartate. However, this 
would give alanine a lower fractional carbon labeling than lactate. Considering a model in 
which there are only two pyruvate pools, one mitochondrial and the other cytosolic, with 
alanine being formed from the mitochondrial pool would give lactate a higher fractional 
labeling which is contrary to the data obtained. Carbon isotopic kinetic effects have not been 
demonstrated in the activity of lactate dehydrogenase. However, if present, the kinetic effects 
of isotope would still not explain the labeling obtained in a satisfactory manner. Peuhkurinen 
et al. (1983), Bouzier et al. (1998) and Zwingmann et al. (2001) have previously postulated 
the existence of two cytosolic and one mitochondrial pools of pyruvate associated with 
mammalian cells. The metabolic model of Peuhkurinen et al. (1983) obtained using data from 
incubation of perfused rats with [1-
14
C1]pyruvate or [1-
14
C1]lactate showed one of the 
cytosolic pool as 'glycolytic', being associated more closely with glycolysis, while the other 
'peripheral' pool which communicates more closely with extracellular pyruvate than with 
cellular lactate. However, the above scheme also fails to explain the labeling patterns of 
alanine and lactate obtained in the four cultivations as seen in Table 5.6.4.  
The concept of cytosolic compartmentation of metabolites in cells is a matter of debate and 
has been mathematically contradicted (Barros and Martinez, 2007). However, the possible 
basis for the presence of two pyruvate pools might have to do with the concept of metabolic 
channeling in pathway. Channeling of metabolites in a reaction sequence is the phenomenon 
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of the transfer of the reaction product of one enzyme to the next enzyme as its substrate 
without equilibrating with bulk solution (Ovadi, 1991). Association of glycolytic enzymes 
into multi-enzyme complexes or “metabolons” has been proposed as a mechanism to control 
glycolytic flux (Fothergillgilmore and Michels, 1993). Though highly debated, the association 
of glycolytic enzymes with the cytoskeleton of the cells has been demonstrated in a number of 
mammalian cells and tissues (al-Habori, 1995). Recently there has been biochemical and 
biophysical evidence that there exists a glycolytic enzyme complex on the cytoplasmic 
surface of the human RBC membrane (Campanella et al., 2005) and that the glycolytic 
enzymes are localized on fibrous sheaths in mouse spermatozoa (Krisfalusi et al., 2006). 
Substrate or metabolite channeling refers to the restricted diffusion or direct transfer of 
intermediates which can occur between active sites of sequential enzymes. Metabolic control 
theory has shown that flux control coefficients for enzymes of channeled pathways are usually 
larger than those in the corresponding non-channeled pathway and hence channeling plays a 
substantial role in the regulatory mechanism of pathways (Kholodenko et al., 1994). Though 
the concept of channeling has been around for quite a long time, there seems to have been no 
association made between the phenomenons of multiple cytosolic compartmentation of 
pyruvate with that of channeling.  
A possible biochemical network for the metabolism of pyruvate which explains the labeling 
as seen in the experiments is shown in Figure 5.6.10. The network shown is a modified 
version of the model proposed by Peuhkurinen et al. (1983).  In the model, there are two 
cytosolic pools of pyruvate and a single mitochondrial pool of pyruvate. One of the cytosolic 
pools, depicted as pyruvate pool 1 in the figure, is derived from the glycolytic complex by 
channeling and accounts for the major production of lactate. This pool has only limited 
exchange with other metabolites except from glycolysis. The second cytosolic pool of 
pyruvate depicted as pyruvate pool 2 is associated with the first pool of pyruvate as well as 
the mitochondrial pool of pyruvate. This pyruvate pool 2 is fed by the extracellular pyruvate 
and by recycled pyruvate from either the malate shunt or synthesis of fatty acids. It is 
probable that pyruvate produced from glycolysis by free glycolytic enzymes/isoenzymes 
might also contribute to this pool. The mitochondrial pyruvate pool is depicted as pyruvate 
pool 3. The pyruvate pool 2 and pyruvate pool 3 produce alanine.  The above model is derived 
by taking into account the isotopomer and carbon labeling data of alanine and lactate obtained 
by the cell growth in different labeled substrates.  
 PHYSIOLOGICAL INVESTIGATIONS ON CHO CELLS 
 
 157 
 
 
Figure 5.6.10: The proposed model for pyruvate compartmentation and metabolism. The 
model is modified form of the model put forward by Peuhkurinen et al. (1983). The thick 
arrows depict high flux. 
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The fractional labeling of alanine was found to be higher in the cultivation of CHO cells in 
media containing [1-
13
C1]glucose plus [U-
13
C]glutamine. Looking at the mass isotopomers, 
alanine has a higher percentage of 
13
C2 and fully labeled fraction at 3 % and 7 % respectively 
compared to lactate which has 2 % of doubly labeled and 5 % of fully labeled. Nevertheless 
lactate has a higher percentage of single labeled species at 39 % compared to 37 % of alanine. 
Hence it is seen that the alanine contains a higher percentage of labeled carbon obtained from 
TCA cycle supplied by fully labeled glutamine compared to lactate. In the experiment with 
[1-
13
C1]glucose plus [U-
13
C]threonine, the fractional labeling of lactate is higher than that of 
alanine. This is due to threonine not being metabolized as highly as glutamine to feed into the 
TCA cycle. However, the mass isotopomers of unlabeled and 
13
C2 species are higher in 
alanine in comparison to lactate. The data from the cultivation with [1,2-
13
C2]glucose also 
supports the model of two cytosolic pyruvate pools with one being also fed from the TCA 
cycle, with the unlabeled and 
13
C1 fraction being higher in alanine compared to lactate, since 
these isotopomers would also be derived from TCA cycle. The feeding of the pyruvate pool 2 
with extracellular pyruvate is conclusively proved with the labeling and isotopomers data 
from the growth of cells in media containing [3-
13
C1]pyruvate. Alanine contains 12 % 
13
C1 
fraction compared to 9 % of lactate with a higher carbon fractional labeling of 0.04. The 
experiments with [U-
13
C]glucose in the previous section offer further support to the model 
described above.  
Hence, it is likely that the two cytosolic pyruvate pools are actually of dynamic nature 
differentiated by the channeling. The first cytosolic pyruvate pool is mostly derived from the 
pyruvate kinase and the major part of it is then directly channeled to the lactate 
dehydrogenase (LDH). The proposed glycolytic complex is shown in Figure 5.6.11. It has 
been shown that there exists two major isoforms of lactate dehydrogenase. One of the 
isoforms LDH-5 favors anaerobic oxidation, while the other isoform LDH-1 favors aerobic 
oxidation (Koukourakis et al., 2003). Hence it is probable that the LDH-5 isoform is 
associated with the glycolytic complex. It is also likely that the glycolytic enzymes or their 
isoenzymes would also exist in free form in the cytoplasm. The second cytosolic pyruvate 
pool is a mix of the part from the glycolysis and of the pyruvate derived from the TCA cycle, 
and undergoes further metabolism. Hence for the purpose of quantitative metabolic studies the 
assumption of a single pyruvate pool is not justified, furthermore the common approach of 
considering two pyruvate pools, one mitochondrial and the other cytosolic, seems to be 
misleading. A better quantitative picture would emerge when three pools of pyruvate are 
considered.  
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Table 5.6.4: Time course of the mass isotopomers with the fractional carbon labeling (FCL) 
of extracellular lactate and alanine in the four parallel cultures, with different isotopic labeled 
substrates. m+0, m+1, m+2 and m+3 indicate the unlabeled, single, double and fully labeled 
isotopomers respectively. The sampling procedure is given in material and methods. The 
initial time “0” refers to the sample after the addition of media to cells. 
  
LACTATE  ALANINE 
 
[1-
13
C1]Glucose plus [U-
13
C]Glutamine 
 
Time (h) m + 00 m + 01 m + 02 m + 03 FCL  Time (h) m + 00 m + 01 m + 02 m + 03 FCL 
0 0.869 0.109 0.016 0.006 0.053  0 0.923 0.071 0.000 0.005 0.029 
12 0.721 0.218 0.036 0.024 0.121  12 0.759 0.191 0.015 0.036 0.109 
24 0.616 0.318 0.028 0.038 0.162  24 0.649 0.272 0.022 0.056 0.162 
37 0.565 0.369 0.022 0.043 0.181  37 0.588 0.320 0.027 0.065 0.190 
46 0.545 0.387 0.024 0.044 0.189  46 0.558 0.346 0.031 0.065 0.201 
61 0.535 0.391 0.026 0.048 0.195  61 0.539 0.364 0.033 0.065 0.208 
 
[1-
13
C1]Glucose plus [U-
13
C]threonine 
 
0 0.902 0.087 0.011 0.000 0.036  0 0.927 0.070 0.002 0.001 0.026 
12 0.775 0.216 0.009 0.000 0.078  12 0.824 0.172 0.004 0.000 0.060 
24 0.686 0.305 0.010 0.000 0.108  24 0.747 0.247 0.006 0.000 0.086 
37 0.635 0.355 0.010 0.000 0.125  37 0.696 0.297 0.007 0.000 0.104 
46 0.614 0.377 0.010 0.000 0.132  46 0.659 0.328 0.012 0.000 0.118 
61 0.601 0.388 0.011 0.000 0.137  61 0.634 0.353 0.013 0.000 0.126 
[1,2-
13
C2]Glucose  
0 0.947 0.036 0.016 0.000 0.023  0 0.943 0.051 0.004 0.003 0.022 
12 0.800 0.039 0.157 0.004 0.122  12 0.831 0.051 0.113 0.005 0.097 
24 0.680 0.043 0.270 0.007 0.201  24 0.735 0.058 0.200 0.007 0.160 
37 0.619 0.046 0.327 0.008 0.242  37 0.673 0.059 0.258 0.009 0.202 
46 0.594 0.048 0.347 0.011 0.258  46 0.637 0.062 0.289 0.012 0.225 
61 0.578 0.051 0.358 0.013 0.268  61 0.610 0.061 0.317 0.013 0.244 
 
[3-
13
C1]Pyruvate  
 
0 0.894 0.095 0.010 0.000 0.039  0 0.897 0.098 0.003 0.002 0.037 
12 0.638 0.348 0.014 0.000 0.125  12 0.660 0.329 0.010 0.001 0.117 
24 0.781 0.212 0.008 0.000 0.076  24 0.742 0.250 0.007 0.001 0.089 
37 0.858 0.138 0.004 0.000 0.049  37 0.809 0.186 0.005 0.000 0.065 
46 0.889 0.108 0.003 0.000 0.038  46 0.845 0.151 0.004 0.000 0.053 
61 0.908 0.091 0.002 0.000 0.031  61 0.873 0.123 0.003 0.000 0.043 
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PFK
Fructose-6-
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Figure 5.6.11: The proposed glycolytic channeling for pyruvate compartmentation and 
metabolism based on the glycolytic complex detected in human erythrocytes by Campanella 
et al. 2005 . (Abbreviations: PFK Phosphofructokinase, GAPDH glyceraldehyde-3-PO4-
dehydrogenase, PK Pyruvate kinase, LDH Lactate dehydrogenase) 
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Glycine-serine metabolism 
The metabolism of serine and glycine are linked biochemically by the enzyme serine 
hydroxymethyltransferase. This enzyme catalyses the reversible reaction involving the 
transfer of the hydroxymethyl group from serine to the cofactor tetrahydrofolate (THF), 
producing glycine and N
5
,N
10
-methylene-THF. The biosynthesis of serine occurs from the 
glycolytic intermediate 3-phosphoglycerate. Serine can also form pyruvate, the reaction 
catalyzed by the enzyme serine dehydratase. Serine and glycine are both important precursors 
for the formation of cellular components in addition to proteins. Serine is involved in the 
formation of lipids while glycine in the formation of nucleotides. Serine also acts as an 
important donor of hydroxymethyl group. Both these amino acids can be synthesized by the 
cells and the cells can be grown in media without these amino acids as shown earlier. In the 
metabolic network described earlier, all the above mentioned reactions are considered. 
However, the carbon labeling and the isotopomers data obtained for these two amino acids 
from the parallel cultures with multiple labeled substrates could not be explained with the 
metabolic reactions described. The labeling patterns of serine and glycine obtained in the four 
cultivations are shown in Table 5.6.5. Considering the data obtained from the cultivation of 
cells with [1-
13
C1]glucose plus [U-
13
C]glutamine, serine shows a final carbon fractional 
labeling of 0.17 compared to 0.05 of glycine. This lower amount of labeling in glycine is due 
to the formation of unlabeled glycine from [3-
13
C1]serine derived from [1-
13
C1]glucose. 
Nevertheless 6 % of the glycine is made up of 
13
C1 species and 3 % by fully labeled. During 
the early phases of the growth, at the end of 24 h of culture these values are higher with a 
fractional labeling of 0.12 and, the 
13
C1 and fully labeled species making up 12 % and 6 % 
respectively. These values drop down to the final values given in Table 5.6.5. Considering the 
metabolic reactions in the network described earlier these labeling patterns cannot be 
explained. The presence of high amounts of labeled glycine at the beginning of the culture 
indicates a precursor other than serine and also rules out the possibility of active 
gluconeogenesis. Furthermore since [U-
13
C]glutamine is one of the substrates used in the 
culture, this probably indicates a source derived from the TCA cycle.   
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Table 5.6.5: Time course of the mass isotopomers with the fractional carbon labeling (FCL) 
of extracellular serine and glycine in the four parallel cultures, with different isotopic labeled 
substrates. m+0, m+1, m+2 and m+3 indicate mass isotopomers. The sampling procedure is 
given in material and methods. The initial time “0” refers to the sample after the addition of 
media to cells. 
 
GLYCINE  SERINE 
 
[1-
13
C1]Glucose plus [U-
13
C]glutamine 
 
Time (h) m + 00 m + 01 m + 02 FCL  Time (h) m + 00 m + 01 m + 02 m + 03 FCL 
0 0.841 0.122 0.037 0.098  0 0.758 0.183 0.023 0.036 0.112 
12 0.833 0.123 0.043 0.105  12 0.588 0.392 0.014 0.006 0.145 
24 0.819 0.115 0.066 0.123  24 0.552 0.423 0.018 0.008 0.160 
37 0.846 0.094 0.060 0.107  37 0.540 0.433 0.019 0.007 0.164 
46 0.905 0.063 0.033 0.064  46 0.512 0.431 0.040 0.017 0.188 
61 0.916 0.059 0.025 0.055  61 0.547 0.411 0.028 0.014 0.170 
 
[1-
13
C1]Glucose plus [U-
13
C]threonine 
 
0 0.803 0.099 0.098 0.147  0 0.605 0.155 0.023 0.218 0.285 
12 0.775 0.128 0.096 0.160  12 0.588 0.365 0.014 0.033 0.164 
24 0.778 0.125 0.097 0.159  24 0.572 0.404 0.012 0.011 0.154 
37 0.848 0.086 0.066 0.109  37 0.559 0.424 0.012 0.005 0.154 
46 0.890 0.066 0.044 0.077  46 0.576 0.406 0.012 0.006 0.149 
61 0.910 0.058 0.032 0.061  61 0.559 0.425 0.013 0.003 0.153 
 
[1,2-
13
C2]Glucose  
 
0 0.861 0.114 0.025 0.082  0 0.800 0.073 0.114 0.013 0.114 
12 0.691 0.284 0.025 0.167  12 0.576 0.083 0.329 0.012 0.259 
24 0.601 0.374 0.025 0.212  24 0.522 0.094 0.372 0.012 0.291 
37 0.579 0.401 0.021 0.221  37 0.489 0.132 0.367 0.012 0.301 
46 0.568 0.411 0.020 0.226  46 0.468 0.168 0.350 0.014 0.303 
61 0.569 0.409 0.022 0.227  61 0.450 0.209 0.326 0.015 0.302 
 
[3-
13
C1]Pyruvate  
 
0 0.885 0.104 0.012 0.063  0 0.902 0.082 0.007 0.009 0.041 
12 0.843 0.118 0.039 0.098  12 0.914 0.081 0.003 0.002 0.031 
24 0.800 0.153 0.047 0.124  24 0.941 0.056 0.002 0.001 0.021 
37 0.815 0.155 0.030 0.107  37 0.950 0.048 0.001 0.001 0.018 
46 0.855 0.129 0.016 0.081  46 0.952 0.046 0.002 0.000 0.017 
61 0.953 0.044 0.004 0.025  61 0.954 0.044 0.001 0.000 0.016 
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The glyoxylate cycle is catalyzed by two unique enzymes, isocitrate lyase and malate 
synthase of which isocitrate lyase, catalyses the formation of glyoxylate from isocitrate and 
the second enzyme, malate synthase, catalyses the conversion of acetyl-CoA from glyoxylate. 
However, glyoxylate can also be converted to glycine by the enzyme glyoxylate 
aminotransferase. This metabolic pathway was earlier thought to be operative in only the cells 
of higher plants and some unicellular organisms. However, it has been shown recently that 
this pathway is active in many of the mammalian tissues (Davis and Goodman, 1992; 
Vandenbosch et al., 1992). Considering the glyoxylate pathway in the metabolism of CHO 
cells could provide an explanation of the labeling data observed. In the culture with 
[1
13
C1]glucose plus [U-
13
C]glutamine, glycine would show fractions of 
13
C1 and fully labeled 
species as these would come from the TCA cycle intermediate isocitrate.  
However, it is seen that the fractions of 
13
C1 are comparably higher than the fully labeled 
fraction. Since [U-
13
C]glutamine is used as a substrate, this should not be the case. Rather we 
should observe the fully labeled fraction to be higher than the single labeled fraction if the 
glyoxylate pathway were the only other pathway active for the formation of glycine. The 
other possibility of glycine biosynthesis is the glycine cleavage system. This reaction has been 
found to be reversible in mammalian systems (Kikuchi, 1973).  The reversible glycine 
cleavage produces glycine from CO2 and N
5
,N
10
-methylene-THF. The N
5
,N
10
-methylene-THF 
would be produced from the action of serine hydroxymethyltransferase on serine and would 
thus be labeled. This would lead to the formation of 
13
C1 glycine.  
Another biosynthetic pathway for the formation of glycine is from the catabolism of 
threonine. The amino acid threonine has potentially three catabolic pathways via threonine 
dehydrogenase, threonine aldolase and threonine dehydratase. Two of these pathways via 
threonine dehydrogenase and threonine aldolase lead to the formation of glycine. In the 
majority of the previous works dealing with metabolic fluxes (Sharfstein et al., 1994; 
Altamirano et al., 2001; Gambhir et al., 2003), only the catabolism of threonine via threonine 
dehydratase to alpha-ketobutyrate leading to succinyl-CoA has been considered. This is also 
the case in the network described in the earlier section. However, there is evidence that the 
other pathways of threonine are also active in mammalian cells (House et al., 2001). From the 
data of the culture with [1-
13
C1]glucose plus [U-
13
C]threonine we see that at the end of 24 h, 
around 10 % of the glycine is made up of fully labeled fraction compared to 1 % of serine. If 
this glycine fraction was from the TCA cycle intermediate isocitrate, then the culture with [1-
13
C1]glucose plus [U-
13
C]glutamine would have shown a higher percentage, since glutamine 
is metabolized at a higher rate in the TCA cycle than threonine. Furthermore, the glycine 
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cleavage system would provide 
13
C1 glycine. Thus part of the fully labeled fraction is derived 
from the metabolism of threonine. Glycine also shows 12 % of 
13
C1 fraction at the end of 24 h. 
This fraction is derived from the TCA cycle, which is fed by [1
13
C1]glucose, and the glycine 
cleavage system. However, these fractions reduce to 3 % of fully labeled and 6 % of 
13
C1 
species at the end of the cultivation. This shows that the glyoxylate cycle and the reversible 
glycine cleavage system are probably active at a higher rate during the initial phases of 
growth for the production of glycine. This follows to reason since the cells are grown in a 
glycine and serine deficient media. In the absence of its direct precursor, i.e. serine, in 
sufficient amounts, the requirement of glycine for the cells during the early part of the cell 
growth is probably partly supplied by the two alternative pathways. Nevertheless this is the 
first reported indirect evidence for the activity of glyoxylate cycle in CHO cells and further 
biochemical studies such as enzymatic assays need to be done to confirm this. Recently the 
hepatic glyoxylate pathway was reconstructed into CHO cells as these cells were thought to 
lack the glyoxylate cycle, which was evidenced by a lack of expression of the glyoxylate 
pathway enzymes in CHO cells (Behnam et al., 2006). However, in the said study, the media 
used contained serum, glycine and serine. It might be probable that the expression of the 
glyoxylate pathway enzymes is regulated by the extracellular media composition. It has been 
shown that in rat liver the glyoxylate cycle enzymes can be induced by starvation (Popov et 
al., 1996). It is seen that in the above experiments, the highest activity of the glyoxylate cycle 
is at the start of the culture when there is no glycine and serine present in the media.  
Fractions of 
13
C2 and fully labeled species of serine are seen in the culture of both the 
cultivations with [1-
13
C1]glucose plus [U-
13
C]glutamine and [1-
13
C1]glucose plus [U-
13
C]threonine. The possible explanation of this would be the conversion of glycine to serine 
via hydroxymethyltransferase. The fully labeled fraction would occur when the labeled 
N
5
,N
10
-methylene-THF released by serine during the conversion of serine to glycine reacts 
again with fully labeled glycine to give fully labeled serine. The above labeling patterns can 
also be explained if we consider the activity of serine hydratase for the formation of serine 
from pyruvate. However, this enzyme is known to act on serine to form pyruvate and its 
reversibility in mammalian systems has not been documented. In the cultivations with [3-
13
C1]pyruvate, 15 % of glycine is 
13
C1 fraction compared to 5 % of serine. If serine was 
formed from pyruvate, this fraction would be higher in comparison to glycine. There is a 
decrease in the fractional carbon labeling of serine at the end of the cultivations in cultures 
with [1-
13
C1]glucose plus [U-
13
C]glutamine and [1-
13
C1]glucose plus [U-
13
C]threonine. Serine 
is an important gluconeogenic substrate and can be converted to pyruvate via serine 
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hydratase. The decrease in the fractional carbon labeling can be explained by the formation of 
serine from glycine and simultaneous consumption leading to extracellular exchange of 
serine. With the above observations, Figure 5.6.12 gives the possible pathways of serine and 
glycine in CHO cells.  
 
 
 
 
Figure 5.6.11: The proposed serine and glycine metabolic pathways operational in CHO 
cells.  
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Glycolysis 
As described earlier, the lactate to glucose (M/M) ratio of all the four cultures over the whole 
cultivation ranges from 1.45 for the culture with [1,2-
13
C2]glucose to 1.62 for the culture with 
[1-
13
C1]glucose and [U-
13
C]glutamine. Thus around 72 % to 82 % of lactate is produced from 
glycolysis. The alanine to glucose (M/M) ratio ranges from 0.2 for the culture with [1-
13
C1]glucose and [U-
13
C]glutamine to 0.18 for the culture with [3-
13
C1]pyruvate. Hence 82 % 
to 91 % of glucose is metabolized by overflow metabolism. However, the activity of 
glycolysis, calculated using the lactate and alanine produced, also includes the activity from 
the pentose phosphate shunt and the recycle from the TCA cycle.  
 
Pentose-phosphate pathway 
The rate of oxidative pentose phosphate relative to glycolytic flux can be estimated from the 
culture of [1,2-
13
C2]glucose. 
13
C2 Lactate originates from glucose that is converted to lactate 
directly by glycolysis, whereas 
13
C1 lactate originates from glucose metabolized by direct 
oxidation via the oxidative steps of the pentose phosphate pathways and then recycled to 
glycolysis via the non-oxidative pentose cycle. From these results, we can predict pentose 
cycle flux relative to the glycolytic flux, and it is calculated using the 
13
C1/
13
C2 ratio in lactate 
(Lee et al., 1998; Boren et al., 2003). From this it is found that the pentose phosphate activity 
is 4.5 % of the glycolytic activity. This value is similar to the values reported for hybridomas 
(4 %) (Sharfstein et al., 1994). However, this would be the maximum of the pentose-
phosphate activity. The actual value would be lower since the 
13
C1 and 
13
C2 label would be 
diluted by the pyruvate recycled from the TCA cycle and also the non-oxidative branch of 
pentose phosphate cycle.  
 
Tri-carboxylic acid cycle 
The tri-carboxylic acid (TCA) cycle is fed mainly by pyruvate derived from glucose and 
glutamine. Using simple balances with the activity of the glycolysis and the overflow 
metabolism, it is seen that 9 % (by [1-
13
C1]glucose and [U-
13
C]glutamine experiment) to 18 % 
(by [1,2-
13
C2]glucose experiment) of the glucose from the four cultures feeds into the TCA 
cycle. The rate of glutamine uptake relative to glucose uptake ranges from 12 % of the 
glucose flux for the culture with [1,2-
13
C2]glucose to 26 % for the culture with [1-
13
C1]glucose and [U-
13
C]glutamine. Hence the flux of glutamine into the TCA cycle is 
dependent on the flux of pyruvate, with a lower flux of pyruvate into the TCA cycle 
indicating a higher flux from glutamine. This is contrary to the data observed with the specific 
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rates. A higher specific rate of glucose uptake implies a higher glutamine uptake. However, 
from the data it seems that the flux of pyruvate into TCA cycle controls the rate of glutamine 
uptake. This has also been shown to work in reverse, where the overflow metabolism of a 
myeloma cell line was reduced in a glutamine limited culture (Ljunggren and Haggstrom, 
1992).  
 
Aspartate-malate shuttle 
Glutamate and aspartate are non-essential amino acids and thus play an important role in 
cellular central metabolism. The first reaction of amino acid breakdown is transamination 
which produces glutamate from alpha-ketoglutarate. Moreover, glutamine, the major provider 
of energy to the cellular metabolism, is broken down to glutamate by glutaminase in the 
mitochondria. Glutamate can be transported across the mitochondria via two carriers. One 
carrier catalyses electroneutral exchange between glutamate and hydroxyl ions, and the other 
carrier catalyses an obligatory coupled exchange between external glutamate and 
intramitochondrial aspartate. The biochemical function of the glutamate/OH-antiporter is 
thought to be the provision of glutamate for the production of ammonia via glutamate 
dehydrogenase, which is exclusively located in the mitochondria. Glutamate entering on the 
glutamate/aspartate antiporter is necessarily transaminated with intramitochondrial 
oxaloacetate to form aspartate and α-ketoglutarate, and is hence not available to the glutamate 
dehydrogenase (Bradford and Mcgivan, 1973). The mitochondrial aspartate is produced due 
to the activity of the aspartate-malate shuttle (Figure 5.6.12). For the movement of reducing 
equivalents (NADH) from the cytoplasm to the mitochondria the malate/aspartate shuttle is 
the principal mechanism. In the mitochondria the electrons of NADH can be coupled to ATP 
production during the process of oxidative phosphorylation. The electrons are "carried" into 
the mitochondria in the form of malate. Cytoplasmic malate dehydrogenase (MDH) reduces 
oxaloacetate to malate while oxidizing NADH to NAD
+
. Malate then enters the mitochondria 
where the reverse reaction is carried out by mitochondrial MDH. Movement of mitochondrial 
oxaloacetate to the cytoplasm to maintain this cycle requires it be transaminated to aspartate 
with the amino group being donated by glutamate. The aspartate then leaves the mitochondria 
and enters the cytoplasm. The deamination of glutamate generates α-ketoglutarate in the 
mitochondria which is transported readily to cytoplasm with the entry of malate. Since both 
glutamate and aspartate interact freely with the TCA cycle intermediates and can be 
transported out of the mitochondria, they exhibit labeling when isotopically labeled substrates 
are used for cell growth.  The activity of the aspartate-malate shuttle has been assumed to be 
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low and hence many previous studies concerning quantitative metabolism have neglected to 
take this shuttle into account (Zupke et al., 1995; Follstad et al., 1999; Bonarius et al., 2001).  
The mass isotopomers with the fractional carbon labeling of aspartate and glutamine are given 
in Table 5.6.6. The data from the culture with [1-
13
C1]glucose plus [U-
13
C]glutamine would 
provide clues to the activity of this shuttle. Since glutamine is the primary substrate in the 
TCA cycle, the glutamate supplying the TCA cycle would be fully labeled in the above 
culture. Aspartate can be formed from the deamination of asparagine and also from the TCA 
cycle intermediate oxaloactetate during the shuttle. Since oxaloacetate would be carrying the 
isotopic label from the TCA cycle, the isotopic labeling of aspartate would give the relative 
activity of the shuttle. From the labeling data of the culture medium, it is seen that aspartate 
has a final fractional carbon labeling of 0.37 and 49 % of it is unlabeled. Hence 51 % of 
aspartate carries isotopic labeling, and thus comes from oxaloacetate. This value gives the 
minimum activity of the shuttle. In reality this would be higher, since the aspartate pool in 
exchange with glutamate would be diluted from the aspartate produced from asparagine. This 
minimum value represents around 2 % of the total glucose flux and around 6 % of the 
glutamine flux entering the metabolism in the culture with [1-
13
C1]glucose plus [U-
13
C]glutamine.  
 
 
 
Figure 5.6.12: The malate-aspartate shuttle system in mammalian cells for the transport of 
reducing equivalents to the mitochondria. 
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Table 5.6.6: Time course of the mass isotopomers with the fractional carbon labeling (FCL) 
of extracellular aspartate and glutamate in the four parallel cultures, with different isotopic 
labeled substrates. m+0, m+1, m+2, m+3, m+4 and m+5 indicate labeled mass isotopomers. 
The sampling procedure is given in material and methods. The initial time “0” refers to the 
sample after the addition of media to cells. 
 
ASPARTATE  GLUTAMATE 
 
[1-
13
C1]Glucose plus [U-
13
C]glutamine 
 
Time (h) m + 00 m + 01 m + 02 m + 03 m + 04 FCL  Time (h) m + 00 m + 01 m + 02 m + 03 m + 04 m + 05 FCL 
0 0.91 0.05 0.01 0.01 0.02 0.05  0 0.02 0.00 0.00 0.01 0.06 0.92 0.97 
12 0.71 0.06 0.04 0.05 0.14 0.21  12 0.02 0.01 0.01 0.03 0.06 0.86 0.93 
24 0.55 0.07 0.06 0.08 0.24 0.35  24 0.03 0.02 0.02 0.05 0.07 0.82 0.91 
37 0.50 0.07 0.07 0.09 0.27 0.39  37 0.03 0.03 0.03 0.07 0.08 0.77 0.89 
46 0.51 0.08 0.07 0.09 0.25 0.37  46 0.04 0.04 0.04 0.09 0.09 0.70 0.85 
61 0.49 0.09 0.08 0.09 0.24 0.37  61 0.06 0.07 0.06 0.12 0.10 0.60 0.78 
 
[1-
13
C1]Glucose plus [U-
13
C]threonine 
 
0 0.94 0.05 0.00 0.00 0.00 0.02  0 0.94 0.06 0.00 0.00 0.00 0.00 0.01 
12 0.91 0.08 0.01 0.00 0.00 0.03  12 0.90 0.09 0.01 0.00 0.00 0.00 0.02 
24 0.89 0.10 0.01 0.00 0.00 0.03  24 0.88 0.11 0.01 0.00 0.00 0.00 0.03 
37 0.88 0.11 0.01 0.00 0.00 0.03  37 0.85 0.13 0.02 0.00 0.00 0.00 0.03 
46 0.87 0.12 0.01 0.00 0.00 0.04  46 0.83 0.15 0.02 0.00 0.00 0.00 0.04 
61 0.85 0.13 0.01 0.00 0.00 0.04  61 0.78 0.18 0.03 0.00 0.00 0.00 0.05 
 
[1,2-
13
C2]glucose  
 
0 0.94 0.05 0.00 0.00 0.00 0.02  0 0.94 0.06 0.00 0.00 0.00 0.00 0.01 
12 0.91 0.05 0.03 0.00 0.00 0.03  12 0.92 0.06 0.02 0.00 0.00 0.00 0.02 
24 0.89 0.05 0.05 0.00 0.00 0.04  24 0.90 0.06 0.04 0.00 0.00 0.00 0.03 
37 0.87 0.06 0.06 0.01 0.00 0.05  37 0.87 0.06 0.06 0.01 0.00 0.00 0.04 
46 0.85 0.06 0.08 0.01 0.00 0.06  46 0.83 0.07 0.09 0.01 0.01 0.00 0.06 
61 0.82 0.07 0.09 0.01 0.00 0.08  61 0.76 0.08 0.12 0.02 0.01 0.00 0.09 
 
[3-
13
C1]Pyruvate  
 
0 0.94 0.05 0.00 0.00 0.00 0.02  0 0.94 0.05 0.00 0.00 0.00 0.00 0.01 
12 0.89 0.10 0.01 0.00 0.00 0.03  12 0.90 0.09 0.01 0.00 0.00 0.00 0.02 
24 0.90 0.09 0.01 0.00 0.00 0.03  24 0.91 0.09 0.01 0.00 0.00 0.00 0.02 
37 0.91 0.08 0.01 0.00 0.00 0.02  37 0.91 0.08 0.01 0.00 0.00 0.00 0.02 
46 0.92 0.08 0.01 0.00 0.00 0.02  46 0.91 0.09 0.01 0.00 0.00 0.00 0.02 
61 0.92 0.08 0.01 0.00 0.00 0.02  61 0.90 0.09 0.01 0.00 0.00 0.00 0.02 
 
 
 
 
 
 PHYSIOLOGICAL INVESTIGATIONS ON CHO CELLS 
 
170 
Malate shunt 
The recycle from the TCA cycle to pyruvate occurs through malate shunt. This occurs via 
phosphoenolpyruvate carboxykinase or the malic enzyme. The data from the culture with [1-
13
C1]glucose and [U-
13
C]glutamine should give an indication for the recycle. The 
13
C2 and 
fully labeled fractions of
 
alanine and lactate must be solely derived from pyruvate derived 
from malate. This value is found to be 10 % of the alanine and 8 % of lactate formed. This 
value represents the minimum of the recycle, since the catabolism of other amino acids and 
the entry of pyruvate into the TCA cycle would contribute unlabeled and 
13
C1 fraction to the 
shunt.  
 
Modified metabolic model 
The analysis of the above data particularly dealing with the pyruvate and glycine-serine 
metabolism led to an alteration in the metabolic model presented earlier. The new metabolic 
model (Figure 5.6.13) incorporated the metabolism involving the multiple pyruvate pools and 
also the various pathways of glycine and serine metabolism. The glycolytic enzymes are 
membrane bound and the metabolites of glycolysis in this model are channeled as shown in 
the figure. However, this model does not take into account the possibility of the presence of 
cytosolic glycolytic enzymes which might contribute pyruvate to the second pyruvate pool. 
The role of pentose phosphate pathway is also unclear. The low activity of the PPP might be 
due to its linkage with the low amounts of free diffusible metabolites of the glycolytic 
pathway. The labeling of 
13
C1 serine is higher than 
13
C1 alanine in the culture with [1-
13
C1]glucose and [U-
13
C]glutamine. However, the lower labeling of alanine at 
13
C1 might be 
due to the dilution of pyruvate. In the model the serine is assumed to be derived from the 
glycolytic complex though there is no clear evidence for this. The reactions for the model are 
given in the appendix.  
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Figure 5.6.13: The metabolic model of mammalian cell. The dashed lines represent weak 
fluxes. Biomass forming fluxes are not considered.  (Abbreviations: Pyr 1 pyruvate pool 1, 
Pyr 2 pyruvate pool 2, mPyr mitochondrial  pyruvate, Lac lactate, mCit mitochondrial citrate, 
mMal mitochondrial malate, mAKG mitochondrial α-ketoglutarate, mSuc mitochondrial 
succinate, mOAA mitochondrial oxaloacetate, mAcCoA mitochondrial acetyl-CoA, GLOX 
glyoxalate. The amino acids have the standard 3 letter abbreviation) 
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5.5.3.4 Conclusions 
Parallel experiments were conducted using multiple substrates for investigating and 
quantifying the metabolism of CHO cells. The labels used were [1-
13
C1]glucose and [U-
13
C]glutamine, [1-
13
C1]glucose and [U-
13
C]threonine, [1,2-
13
C2]glucose, and [3-
13
C1]pyruvate. 
These labels were pre-selected for the optimal flux quantification. Using the methodology 
described above, many significant facets of metabolism were determined. There was evidence 
of intracellular cytosolic compartmentation of pyruvate. It is likely that the intracellular 
cytosolic pools of pyruvate might be linked to metabolite channeling. The direct transfer of 
the product from one enzyme to the subsequent without free diffusion increases the efficiency 
of the pathway. It is known that immortal cells show a high degree of glycolysis. The 
relatively low activity of the other pathways might be associated with the channeling of 
metabolites. Also, immortal cells are known to survive in hypoxia conditions due to the high 
activity of anaerobic glycolysis. It has also been proposed that the assembly of the glycolytic 
enzymes on the membrane might account for the compartmentalization of the ATP formed, 
without being released into the cytoplasm for the utilization in ion pumps (Campanella et al., 
2005). The channeling of substrates in the glycolysis might be linked to the survival of 
immortal cells under hypoxia conditions. 
 A model of the pyruvate compartmentation within the cells, with three pyruvate pools which 
can explain the labeling obtained in the extracellular lactate and alanine is proposed. One of 
the pools is linked to the metabolite channel via the glycolytic complex. The second pool 
derives from the free glycolysis as well as the recycling of pyruvate via the malate shunt. The 
extracellular pyruvate also feeds into this pool. The third pyruvate pool is located in the 
mitochondria.  
The investigations into the glycine-serine metabolism revealed indirect evidence for the 
activity of the glyoxylate cycle in CHO cells. The reversible glycine cleavage system also 
showed high activity. However, these pathways were found to be active only during the 
beginning of the culture where there was a starvation of serine and glycine. Furthermore 
relative fluxes of aspartate-malate shuttle, glycolysis, citric acid cycle and malate shunt were 
determined. It is seen that the flux of glutamine into the TCA cycle is probably controlled by 
the flux of pyruvate into the citric acid cycle. Moreover, at lower glucose concentrations, the 
uptake of branched chain amino acids was increased. There is a significant amount of malate 
shunt feeding into the pyruvate probably for the complete oxidation of glutamine feeding into 
the TCA cycle. 
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Hence, labeling with multiple substrates with parallel experiments offers the best possible 
solution for not only the complete quantification of the mammalian cell metabolism but also 
for a deeper understanding of the various metabolic pathways. The metabolic quotients and 
the labeling data obtained from the above cell cultivations can be later used for the 
quantification of whole cell metabolic pathway fluxes. However, this requires considerable 
modeling efforts which are presently underway. The quantification of these fluxes is therefore 
beyond the scope of this thesis.  
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6 CONCLUSIONS 
 
Along with their rising importance for the production of biologicals, mammalian cells are 
routinely used now a day’s for medical and biochemical research. However, the culturing of 
these cells as well as the biochemical aspects related to mammalian cells is complex when 
compared to other microorganisms. Hence new methods are needed for their cultivation as 
well as physiological studies. Part of the work carried out in this thesis was the development 
of methods for high throughput applications using innovative 96-well microplates equipped 
with optical sensors for oxygen monitoring. The innovative 96-well microplates were used for 
respiration measurements, medium optimization and in vitro cytotoxicity testing. The value of 
akL  volumetric liquid phase mass transfer coefficient was determined for the 96-well 
microtiter plates at the desired shaking rates. From the akL , the respiration rates of the cellular 
culture in each of the well could be calculated. This method of respiration rate calculation was 
then applied for process optimization by using them for cellular medium optimization. For 
medium optimization a large number of experiments could be done in a single run and on a 
single microplate thus reducing the cost, time and effort generally required for this process. 
The system can also be used as a substitute for presently available viability assays such as 
MTT and therefore be used for cytotoxicity testing. An in vitro cytotoxicity assay using these 
plates was developed. The assay developed is robust, flexible and applicable for medium to 
high-throughput systems. Its main advantages over other cytotoxicity assays are its kinetic 
nature, the automatic on-line measurement and that the cells can further be processed for any 
subsequent analysis.  
The second part of this thesis dealt with development of methods for the quantitative 
physiological studies of CHO cells with the help of metabolic flux analysis. Quantification of 
metabolites was done by HPLC and the isotopic labeling was analyzed using GC-MS. The 
cellular media used for the culture of cells was optimized to simplify the calculation of these 
fluxes by determining the anabolic and catabolic metabolites using [U-
13
C]glucose. Parallel 
experiments were performed with various different labeled substrates for the generation of 
data to be utilized for metabolic flux calculation. Using the labeling data obtained from 
alanine and lactate, a model for the metabolism of the key intermediate metabolite pyruvate is 
proposed. The model takes into account the present theory of cytosolic compartmentation of 
pyruvate and proposes the channeling of the glycolytic pathway in a glycolytic complex. 
Moreover, the data from the labeling of glycine and serine offered new insights into their 
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metabolism. It was seen that the glycine cleavage system was operating in the reverse and 
also that the glyoxylate pathway was active. This is the first reported indirect evidence for the 
activity of the glyoxylate cycle in CHO cells. A modified metabolic model was proposed 
incorporating the deductions arrived using the labeling data. Furthermore relative fluxes were 
calculated for the major pathways in CHO cells. It was seen that the flux of glutamine into the 
TCA cycle is controlled by the flux of pyruvate into the cycle. However, the absolute fluxes 
for the whole cellular metabolism were not calculated in this work. Work is presently 
underway for these calculations using the data generated by the experiments performed in this 
thesis.  
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Mammalian cells are widely applied for biochemical and medical research and for the 
manufacture of biologically relevant proteins. Both of these applications require a thorough 
knowledge about the cellular physiology. Another major application of mammalian cells is in 
drug testing. Although the human genome project is yielding clues to thousands of new 
targets for drug development, selecting suitable targets is not easy and requires a systematic 
approach. Nevertheless “intelligent drug design”, whose targets include enzymes and 
receptors, appears not to include the idea that what cells are supposed to do is metabolism and 
the major thing drugs are supposed to do is to alter the metabolism (Cornish-Bowden and 
Cardenas, 2003). In reality, the final information on the true performance of a new drug can 
only be derived from a clinical trial program. However, the capacity to test new treatment in 
patients is limited in comparison with the great number of promising new drugs. For safety 
reasons and for optimizing the chance of finding new active drugs, a lot of information needs 
to be collected during the pre-clinical stage of development of the drug. 
Early definitions of metabolic engineering were posed in terms of cell (or whole organism) 
improvement by genetic changes, often based on recombinant DNA methods. However, this 
view is changing fast. A drug is essentially an agent for metabolic engineering- by inhibiting 
or activating a particular protein or pathway. Metabolic engineers are therefore well prepared 
to consider basic strategies for attaining desired phenotype by exposing biological systems to 
particular agents and also to collect information about their action on metabolism (Bailey, 
2001). Metabolic flux analysis has become an important tool in metabolic engineering and has 
been extensively used for microorganisms. It allows the quantification of important fluxes in 
the central metabolism of an organism (Wiechert and de Graaf, 1996). Its use for mammalian 
cells has been limited owing to the complexity of the system. However, there are examples for 
the use of this technique. This has been applied by using material balance techniques, 
radioactive labeling or stable isotope labeling to measure the fluxes through major pathways 
or of a particular enzyme. Material balancing techniques have been applied to study the 
metabolism of CHO, hybridoma and other cell lines as explained earlier. The effects of drugs 
on metabolism have been studied by the use of isotopes. The metabolic effects of 
sulphonylureas, bacitracin and tocotrienols on isolated rat hepatocytes were determined by 
using radiolabeled substrates by enzymatic flux determination (Agius et al., 1983; Judd et al., 
1992; Parker et al., 1993). Stable isotope labeled glucose and butyrate has been used to study 
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the regulation of tumor cell proliferation and differentiation by metabolic pathway analysis 
(Boren et al., 2003). Astrocytes metabolism under the influence of external components have 
also been studied using isotopes (Yu et al., 1983; Hassel and Sonnewald, 2002).  Thus this 
methodology can principally be used for the determination of drug actions. 
The majority of anti-cancer drugs act as cytotoxic agents. The effect of cytotoxic drugs on 
cellular metabolism has not been a major field of research. But some knowledge is available. 
For example the drug paclitaxal has been reported to inhibit the respiratory chain in rat 
hepatocytes (Manzano et al., 1996) and doxorubicin has a stimulating effect on the respiration 
(Ganey et al., 1988). The metabolic effect of cytotoxic agents at sub-lethal doses might 
provide an answer to their mode of action and cell regulation. For example the sub-lethal dose 
of activated complement has been seen to increase rat lymphocyte glutamine utilization 
suggesting that glutamine metabolism is important for cell defense (Bacurau et al., 2002). 
However, the metabolic effects of many cytotoxic drugs, especially at the sub-lethal doses, 
are unknown. The effect of these drugs at sub-lethal doses if combined with flux analysis 
techniques might suggest their possible mode of action and might also be used as a reference 
for predictive toxicology. 
In the above work the use of material balance technique in combination with stable isotope 
labeling to quantify the intracellular fluxes has been shown to be a powerful methodology. 
However, for the method to be truly effective the use of different multiple labeled substrates 
are essential. For the future perspective, cytotoxic drugs could be applied at sub-lethal doses 
and multiple stable isotope labeled substrates could be used to quantify intracellular fluxes in 
the cells using simple metabolic models with the application of GC/MS, HPLC and enzymatic 
assay data. These could be compared with the control cells to see changes in the labeling and 
flux patterns of the metabolites to determine the metabolic effects of the drug on the primary 
metabolic pathway.  
The use of 96-well microtiter plates with oxygen sensor would complement this effort as to 
reduce the cost of labeled substrates used due to the low volume. Additionally it would 
provide a high throughput environment where experiments with multiple isotopic labels could 
be carried out in parallel with a single plate. The sensor coated plates would also provide 
additional information on the oxygen uptake rate. The additional advantage would be the use 
of these plates for the determination of sub-lethal concentrations of drugs. Recently 
microplates have been used to metabolically screen rapamycin-treated hybridomas using a 
simple metabolic model based on metabolite balancing (Balcarcel and Clark, 2003). The use 
of multiple labeled substrates would provide a more in-depth look at the metabolism under the 
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influence of different environmental stress, such as drugs, media components etc. The method 
of flux analysis in combination with sensor coated microplates could be thus used to reduce 
the time and cost associated with drug development. Moreover it could acts as a predictor for 
the metabolic effects of drugs.  
From the market approval of the first therapeutic protein to be produced from mammalian 
cells (human tissue plasminogen activator) in 1986, mammalian cells now account for the 
production of 70 % of all market approved therapeutic protein (Wurm, 2004). Initial 
development of production processes for mammalian cell culture was focused on reactor 
development and manipulation of process parameters. The reactor technology for many of the  
large-scale cell culture has now settled on the standard stirred-tank reactor as the technology 
of choice (Chu and Robinson, 2001). However, challenges such as adapting cells to 
suspension culture, development of animal-product free media, control of product quality, 
control of carbon dioxide concentration and minimizing the risk of contamination in large 
scale culture remain. Interest in the metabolism and physiology of mammalian cells in culture 
arises from the belief that high cell concentration and productivity is primarily limited by the 
accumulation of inhibitory factors. Although factors such as accumulation of lactate and 
ammonium play a significant inhibitory role, other factors such as osmolality of the media and 
also the composition contribute to the inhibition of growth and thus affect productivity (Hu 
and Aunins, 1997). Hence, investigation into the physiological effects of different factors is of 
significant importance to increase product yield. Also the effect of genetic modifications as 
well as the efficiency of various gene transfer vectors on expression levels of the required 
product in mammalian cells requires a thorough physiological study. Metabolic flux analysis 
can play an important role in this regard. The methods developed in this work for metabolic 
flux analysis along with high throughput cultivation methods can provide important clues for 
increasing the productivity of the cells in large scale cultures.  
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9 APPENDIX 
9.1 Symbols and abbreviations 
  
µ Growth rate  
2O
q  Specific oxygen uptake rate 
AcCoA Acetyl CoA 
ADP Adenosine diphosphate 
AKG α-Ketoglutarate 
ALA Alanine 
ARG Arginine 
ASN Asparagine 
ASP Aspartic acid 
ATP  Adenosine triphosphate 
Caco-2 Coloncarcinoma cell line 
CHO Chinese hamster ovary  
CIT Citrate 
CYS Cysteine 
DNA  Deoxyribonucleic acid 
E4P Erythrose 4-phosphate 
F6P Fructose 6-phosphate 
FAD Flavin adenine dinucleotide oxidised 
FADH Flavin adenine dinucleotide reduced 
FUM Fumerate 
G6P Glucose 6-phosphate 
GAP Glyceraldehyde 3-phosphate 
GLC Glucose 
GLN Glutamine 
GLOX Glyoxylate 
GLU Glutamic acid 
GLY Glycine 
HIS Histidine 
HL-60 Human acute myeloid leukemia 
ILE Isoleucine 
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LAC Lactate 
LEU Leucine 
LYS Lysine 
Kla Volumetric mass transfer coeffficient 
mAcCoA Mitochondrial acetyl CoA 
mAKG Mitochondrial α-ketoglutarate 
MAL Malate 
mCIT Mitochondrial citrate 
MET Methionine 
mMAL Mitochondrial malate  
mOAA Mitochondrial oxaloacetate 
mPYR Mitochondrial pyruvate 
mSUC Mitochondrial succinate 
MTHF 5,10-Methylenetetrahydrofolate 
MTP Microtiter plate 
MTT 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide 
NAD Nicotinamide adenine dinucleotide oxidised 
NADH Nicotinamide adenine dinucleotide reduced 
NADP Nicotinamide adenine dinucleotide phosphate oxidised 
NADPH Nicotinamide adenine dinucleotide phosphate reduced 
OAA Oxaloacetate 
OUR Oxygen uptake rate 
P5P Pentose 5-phosphate 
PG Phosphoglycerate 
PHE Phenylalanine 
PPP Pentose phosphate pathway 
PRO Proline 
PYR Pyruvate 
RNA Ribonucleic acid 
S7P Sedoheptulose 7-phosphate 
SER Serine 
SUC Succinate 
TCA  Tricarboxylic acid 
THF Tetrahydrofolic acid 
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THR Threonine 
TRP Tryptophan 
TYR Tyrosine 
VAL Valine 
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9.2 Berkeley Madonna program for kla determination 
 
{Berkeley Madonna program for calculation of kla using microtiter plate with integrated oxygen 
sensor. Oxygen removed by addition of dithionite. After consumption of dithionite which reacts 
rapidly with oxygen, oxygen concentration rises again} 
 
DT=0.01 
DTMAX=0.1 
DTOUT=0.1 
TOLERANCE=0.001 
 
KLA=0.001 ; volumetric liquid phase mass transfer coefficient  h-1 
 
CLS=100 ; Saturation concentration of Oxygen (%) 
 
init CS=0.5 ; Initial concentration of Dithionite (mM) 
 
k=200 ; Rate constant for dithionite reaction 
 
init CL =0 ; Initial concentration of oxygen  
 
{Oxygen balance for dithionite oxidation} 
 
DCLDT=KLA*(CLS-CL)-k*CL*CS 
 
d/dt(CL)=DCLDT 
 
{Rate equation for dithionite oxidation} 
d/dt(CS)=-k*CL*CS 
 
Limit CL>=0 
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9.3 Equations for the biochemical metabolic model in Figure 5.2.1 
 
Reactions for internal fluxes: 
 
Reaction no. Biochemical equation 
ν1 G6P + 2NADP = P5P + 2NADPH + CO2 
ν2 G6P = F6P 
ν2r F6P = G6P 
ν3 2P5P = S7P + GAP 
ν3r S7P + GAP = 2P5P 
ν4 GAP + S7P = F6P + E4P 
ν4r F6P + E4P = GAP + S7P 
ν5 E4P + P5P = F6P + GAP 
ν5r F6P + GAP = E4P + P5P 
ν6 F6P + ATP = ADP + 2GAP 
ν7 GAP + ADP + NAD = PG + ATP + NADH 
ν8 PG + ADP = PYR + ATP 
ν9 PYR = mPYR; PYR + CoA + NAD = mAcCoA + NADH + CO2 
ν10 mAcCoA + mOAA + H20 = mCIT + CoA 
ν11 mCIT + NAD = mAKG + NADH + CO2 
ν12 mAKG + ADP + NAD = mSUC + NADH + CO2 + ATP 
ν13 FAD + mSUC + H20 = FADH + mMAL; mMAL + NAD = mOAA + NADH 
ν14 PG + ADP + NAD = SER + ATP + NADH 
ν15 SER + TTHF = GLY + MTTHF 
ν16 SER = PYR + NH4 
ν17 PYR (+GLU)  = ALA (+AKG) 
ν18 mCIT = AcCoA + MAL 
ν19 mMAL + GLU = MAL + mAKG 
ν19r MAL + mAKG = mMAL + GLU 
ν20 MAL + NADP = PYR + CO2 + NADPH 
ν21 ASP (+AKG) = MAL (+GLU) 
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ν22 GLU = mAKG   
ν23 PYR  + CO2  + NADPH = MAL + NADP 
 
 
 
Reactions for external fluxes: 
 
Reaction 
no. 
Biochemical equation 
νext1 GLC + ATP = ADP + G6P 
νext2 extPYR = PYR 
νext3 extGLY = GLY 
νext4 extSER = SER 
νext5 CYS (+mAKG) = PYR (+GLU) 
νext6 THR = mSUC 
νext7 extASP = ASP 
νext8 ASN = ASP+NH4 
νext9 TYR + CoA (+AKG) = mSUC + 2AcCoA + CO2 (+GLU) & PHE + NADPH = TYR + NADP  
νext10 ILE + ATP + CoA + 3NAD (+AKG) = mSUC + mAcCoA + ADP + 3NADH (+GLU) 
νext11 
MET + 4ATP + 2NAD + 4H20 (+SER) (+THF) = mSUC + NH4 + 4ADP + 2NADH (+CYS) 
(+MTHF) 
νext12 VAL+2ATP+COA+4NAD(+AKG)=mSUC+2ADP+4NADH+CO2(+GLU) 
νext13 PRO + 2NAD = GLU + 2NADH 
νext14 ARG + NAD (+AKG) = GLU + NADH (+GLU) 
νext15 HIS + THF + NADPH = GLU + MTHF + NADP + 2NH4 
νext16 extGLU/GLN pool = GLU & GLN = GLU + NH4 
νext17 LEU + ATP + 2NAD + 3CoA (+mAKG) = 3AcCoA + 2NADH + ADP (+GLU) 
νext18 LYS + 2CoA + 0.5O2 + 4NAD (+mAKG) = 2AcCoA + 2CO2 + NH4 + 4NADH (+GLU) 
νext19 PYR + NADH = LAC + NAD  
νext20 PYR (+GLU) = ALA (+AKG)  
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Reactions for biomass fluxes: 
 
Reaction 
no. 
 
Biochemical equation 
Vb1 G6P+3.5ATP=CARBO+3.5ADP 
 
R5P+(4.67ATP)+1.24ASP+0.5GLY+MTHF+(1.76GLN)=RNA+(4.67ADP)+0.26FUM 
+(1.76GLU)+THF Vb2 
  
R5P+(4.7ATP)+1.295ASP+0.5GLY+1.29MTHF+(1.41GLN)=DNA+(4.7ADP)+1.29THF 
+(1.41GLU) +0.205FUM 
Vb3 
 
0.75 GAP + 17.8 AcCoA + 0.193 SER +  0.375 Choline + 0.2Ethanolamine+ 0.036 Inositol 
 = Lipids 
 
Vb4 
0.095ALA + 0.048ASP + 0.039ASN + 0.063ARG + 0.028CYS + 0.052GLN + 0.064GLU + 
0.078GLY + 0.022HIS + 0.052ILE +0.088LEU + 0.089LYS + 0.02MET + 0.021PHE + 0.028PRO 
+ 0.057SER + 0.061THR + 0.006TRP + 0.02TYR + 0.059VAL +4ATP + 4H2O = Protein + 4ADP 
+ 4Pi 
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9.4 Equations for the biochemical metabolic model in Figure 
5.6.13 
 
Reactions for internal fluxes: 
 
Reaction no. Biochemical equation 
ν1 G6P + 2NADP = P5P + 2NADPH + CO2 
ν2 G6P = F6P 
ν2r F6P = G6P 
ν3 2P5P = S7P + GAP 
ν3r S7P + GAP = 2P5P 
ν4 GAP + S7P = F6P + E4P 
ν4r F6P + E4P = GAP + S7P 
ν5 E4P + P5P = F6P + GAP 
ν5r F6P + GAP = E4P + P5P 
ν6 F6P + ATP = ADP + 2GAP 
ν7 GAP + ADP + NAD = PG + ATP + NADH 
ν8 PG + ADP = PYR 1 +ATP 
ν9 mPYR + CoA + NAD = mAcCoA + NADH + CO2 
ν10 mAcCoA + mOAA + H20 = mCIT + CoA 
ν11 mCIT + NAD = mAKG + NADH + CO2 
ν12 mAKG + ADP + NAD = mSUC + NADH + CO2 + ATP 
ν13 FAD + mSUC + H20 = FADH + mMAL; mMAL + NAD = mOAA + NADH 
ν14 PG + ADP + NAD = SER + ATP + NADH 
ν15 SER + TTHF = GLY + MTTHF 
ν15r GLY + MTTHF = SER + TTHF  
ν16 SER = PYR  2 + NH4 
ν17 PYR 2 (+GLU)  = ALA (+AKG) 
ν18 mCIT = AcCoA + MAL 
ν19 mMAL + GLU = MAL + mAKG 
ν19r MAL + mAKG = mMAL + GLU 
ν20 MAL + NADP = PYR + CO2 + NADPH 
ν21 ASP (+AKG) = MAL (+GLU) 
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ν22 GLU = mAKG   
ν23 PYR  2  + CO2  + NADPH = MAL + NADP 
ν24 PYR 1 = PYR 2   
ν25 PYR  2 = mPYR  
ν26 PYR 1 = LAC 
ν27 PYR 2 = LAC 
ν28 PYR 1 (+GLU) = ALA (+AKG) 
ν29 mPYR  (+GLU) = ALA (+AKG) 
ν30 mICIT = GLOX + mSUC 
ν31 GLOX (+ALA) = GLY (+PYR) 
ν32 THR + NAD + CoA = GLY + mAcCoA + NADH 
ν33 CO2  +NH3 = GLY 
ν34 AcCoA = Fatty acids 
  
 
Reactions for external fluxes: 
 
Reaction 
no. 
Biochemical equation 
νext1 GLC + ATP = ADP + G6P 
νext2 extPYR = PYR 2 
νext3 GLY = extGLY  
νext4 SER =  extSER 
νext5 CYS (+mAKG) = PYR (+GLU) 
νext6 THR = mSUC 
νext7 ASP = extASP 
νext8 ASN = ASP+NH4 
νext9 TYR + CoA (+AKG) = mSUC + 2AcCoA + CO2 (+GLU) & PHE + NADPH = TYR + NADP  
νext10 ILE + ATP + CoA + 3NAD (+AKG) = mSUC + mAcCoA + ADP + 3NADH (+GLU) 
νext11 
MET + 4ATP + 2NAD + 4H20 (+SER) (+THF) = mSUC + NH4 + 4ADP + 2NADH (+CYS) 
(+MTHF) 
νext12 VAL+2ATP+COA+4NAD (+AKG)=mSUC+2ADP+4NADH+CO2 (+GLU) 
νext13 PRO + 2NAD = GLU + 2NADH 
νext14 ARG + NAD (+AKG) = GLU + NADH (+GLU) 
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νext15 HIS + THF + NADPH = GLU + MTHF + NADP + 2NH4 
νext16 GLN = GLU & GLN = GLU + NH4 
νext17 LEU + ATP + 2NAD + 3CoA (+mAKG) = 3AcCoA + 2NADH + ADP (+GLU) 
νext18 LYS + 2CoA + 0.5O2 + 4NAD (+mAKG) = 2AcCoA + 2CO2 + NH4 + 4NADH (+GLU) 
νext19 LAC = exLAC  
νext20 ALA = exALA  
νext21 GLU = extGLU  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 APPENDIX 
 
204 
9.5 Biomass composition of CHO cells 
 
 
The Cellular Composition of the cell used was taken from Altamirano et al. (2001) and is 
given below: 
 
Macromolecules % Dry Weight 
DNA 1.9 
RNA 5.8 
Lipids 7.7 
Carbohydrates 7 
Proteins 70.6 
 
The cell dry weight was calculated to 0.32 mg/10
6
 cells. 
 
The Amino acid composition of cellular protein is taken from Altamirano et al. (2001) and is 
shown below: 
 
Amino Acid Molar Fraction Amino Acid Molar Fraction 
ALA 0.095 LEU 0.088 
ARG 0.063 LYS 0.089 
ASP 0.048 MET 0.020 
ASN 0.039 PHE 0.021 
CYS 0.028 PRO 0.028 
GLN 0.052 SER 0.057 
GLU 0.064 THR 0.061 
GLY 0.078 TRP 0.006 
HIS 0.022 TYR 0.020 
ILE 0.052 VAL 0.059 
The Average Molecular Weight was thus calculated to be 108. The Molar requirement for 
each amino acid per gram biomass was calculated from this. 
 
 
The Carbohydrates are taken as polyglucose with a molecular weight of 162. 
 
The GC content of the DNA is taken as 41% (Lander et al., 2001): 
 
DNA Content 
(mol/mol) 
MW(g/mol) Content % 
(w/w) 
mmol/g 
biomass 
dAMP 0.295 331.2 0.318 0.018 
dTMP 0.295 304.2 0.291 0.018 
dGMP 0.205 304.2 0.197 0.012 
dCMP 0.205 289.2 0.192 0.012 
The average molecular weight is 307.52  
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The GC content of RNA is taken as an average of 52% (Lander et al., 2001): 
 
RNA Content 
(mol/mol) 
MW(g/mol) Content % 
(w/w) 
mmol/g 
biomass 
AMP 0.24 329.2 0.246 0.043 
UMP 0.24 306.2 0.228 0.043 
GMP 0.26 345.2 0.279 0.047 
CMP 0.26 305.2 0.246 0.047 
The average molecular weight is 321.6 
 
The average molecular weight of lipids, calculated from the composition described below and 
assuming only the major classes, is found to be 717. 
 
The Lipid Composition is taken from Mackenzie et al. (1967) for mammalian cell : 
 
Lipid Fraction % total lipid 
Average Mol. 
Wt 
Sterol Esters + 
Hydrocarbons 
2.7 636 
Triglycerides 7.2 895.4 
Cholesterol+ 
Diglycerides 
8.8 386 
Polar lipids 81 742.7 
 
 
The major components of the polar lipids are given below (Tombaccini et al., 1981): 
 
Lipid Class % Polar Lipid Mol Wt. 
Phosphatidylcholine 46.3 747 
Phosphatidylethanolamine 25.2 705 
Phosphatidylinositol+ 
Phosphatidylserine (1:2) 
13.6 811 
Sphingomyelin 14.7 741 
The average molecular weight of the polar lipids is 742.7 
 
The Fatty acid Composition was determined using GC-MS. The major fatty acids detected are 
given below and the others being neglected, taken as 100%: 
 
Fatty acid % Fatty Acid Molecular Wt: 
18:1 44% 281 
18:0 27% 283 
16:0 22% 255 
16:1 5% 253 
The Average Molecular Weight was calculated as: 268.8 
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EQUATIONS FOR BIOMASS COMPONENTS FOR CHO CELLS: 
  
The biomass equations were determined from known biochemistry of biosynthesis and the 
cellular composition. 
 
Purine Biosynthesis: 
 
AMP (Adenosine monophosphate) 
 
Biosynthesis: 
 
R5P + (6ATP) + 2GLN + GLY + 2ASP + 2MTFH = AMP + 2FUM + 2GLU + 2TFH + 
(6ADP) 
 
For CHO cells DNA: 
 
0.295R5P + (1.47ATP) + 0.59GLN + 0.295GLY + 0.59ASP + 0.59MTHF = 0.295 dAMP + 
0.59FUM + 0.59GLU + 0.59THF + (1.47ATP) 
                                                  
For CHO cells RNA: 
 
0.24R5P + (1.2ATP) + 0.48GLN + 0.24GLY + 0.48ASP + 0.48MTHF = 0.24AMP + 
0.48FUM + 0.48GLU + 0.48THF + (1.2ATP) 
 
GMP (Guanosine monophosphate)  
 
Biosynthesis: 
 
R5P + (5ATP) + (3GLN) + GLY + ASP + 2MTHF + = GMP + FUM + (3GLU) + 2THF + 
(5ADP) 
 
For CHO cells DNA: 
 
0.205R5P + (1.025ATP) + 0.605GLN + 0.205GLY + 0.205ASP + 0.41MTHF   = 0.205GMP 
+ 0.205FUM + (1.025ADP) + 0.605GLU + 0.41THF 
 
For CHO cells RNA: 
 
0.26R5P + (1.3ATP) + (0.78 GLN) + 0.26GLY + 0.26ASP + 0.52MTHF = 0.26GMP + 
0.26FUM + (1.3ADP) + (0.78GLU) +0.52THF 
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Pyrimidine Biosynthesis: 
 
UMP (Uridine monophosphate) 
 
Biosynthesis: 
 
R5P + (4ATP) + ASP + GLN = UMP + GLU + (4ADP) 
 
For CHO RNA: 
 
0.24R5P + (0.96ATP) + 0.24ASP + 0.24GLN= 0.24UMP + 0.24GLU + (4ADP) 
 
 
dTMP (Thymidine monophosphate) 
 
Biosynthesis: 
 
R5P + (4ATP) + ASP + MTHF = dTMP + (4ADP) + THF 
 
For CHO DNA: 
 
0.295R5P + (1.18ATP) + 0.295ASP + 0.295MTHF = 0.295dTMP + (1.18ADP) +0.295THF 
 
CMP (Cytidine monophosphate) 
 
Biosynthesis: 
 
R5P + (5ATP) + ASP + (2GLN) = CMP + (2GLU) + (5ADP) 
 
For CHO DNA: 
 
0.205R5P + (1.025ATP) + 0.205ASP + 0.41GLN = 0.205CMP + 0.41GLU + (1.025ADP) 
 
For CHO RNA: 
 
0.26R5P + (1.3ATP) + 0.26ASP + (0.52GLN) = 0.26CMP + (0.52GLU) + (1.3ADP) 
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Combined CHO DNA 
 
0.295R5P+ (1.47ATP) + (0.59GLN) + 0.295GLY+ 0.59ASP+ 0.59MTHF= 0.295dAMP+ 
0.59FUM+ (0.59GLU) + 0.59THF+ (1.47ATP) 
 
0.205R5P + (1.025ATP) + (0.605GLN) + 0.205GLY + 0.205ASP + 0.41MTHF = 0.205GMP 
+ 0.205FUM + (1.025ADP) + (0.605GLU) + 0.41THF 
 
0.295R5P + (1.18ATP) + 0.295ASP + 0.295MTHF = 0.295dTMP + 1.18ADP + 0.295THF 
 
0.205R5P + (1.025ATP) + 0.205ASP + (0.41GLN) = 0.205CMP + (0.41GLU) + 1.025ADP 
 
DNA biosynthesis equation CHO cells: 
 
R5P + (4.7ATP) + 1.295ASP + 0.5GLY + 1.29MTHF + (1.6GLN) = DNA + (4.7ADP) + 
1.29THF + (1.6GLU) +0.205FUM 
 
Combined CHO RNA 
 
0.24R5P + (1.2ATP) + (0.48GLN) + 0.24GLY + 0.48ASP + 0.48MTHF = 0.24AMP + 
0.48FUM + (0.48GLU) + 0.48THF + (1.2ATP) 
 
0.26R5P + (1.3ATP) + (0.78GLN) + 0.26GLY + 0.26ASP + 0.52MTHF = 0.26GMP + 
0.26FUM + (1.3ADP) + (0.78GLU) + 0.52THF 
 
 
0.24R5P + (0.96ATP) + 0.24ASP + (0.24GLN) = 0.24UMP + (0.24GLU) + (0.96ADP) 
 
 
0.26R5P + 1.3ATP + 0.26ASP + (0.52GLN) = 0.26CMP+ 0.52GLU + (1.3ADP) 
 
RNA biosynthesis equation for CHO cells: 
 
R5P + (4.67ATP) + 1.24ASP + 0.5GLY + MTHF + (2GLN) = RNA + (4.67ADP) + 
0.26FUM + (2GLU) +THF 
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Lipid biosynthesis: 
 
Fatty Acid 
Considering an average carbon chain of 17.1 as determined from the lipid composition 
  
8.55AcCoA + 7.5 ATP + 15 NADPH = FA + 15 NADP + 7.5 ADP + 8.55 CoA 
 
Triglycerides (TG) 
 
Biosynthesis: 
 
GAP + 3 FA = TG 
 
For CHO cells: 
 
0.072 GAP + 0.216 FA = 0.072 Lipid 
 
Cholesterol (CHOL) 
 
Biosynthesis: 
 
18 AcCoA + 14 NADPH + 18 ATP + O2 =CHOL + 14 NADP + 18 CoA + 18 ADP + 8 CO2 
+ HCOOH  
 
For CHO cells  
 
1.58 AcCoa + 1.23 NADPH + 1.58 ATP + 0.088 O2 = 0.088 Lipid + 1.58 CoaA + 1.58 ADP 
+ 0.704 CO2 + 0.088 HCOOH 
 
Sterol Esters (SE) 
 
Biosynthesis (without ATP and reductive elements): 
 
FA + CHOL = SE 
 
For CHO cells 
 
 0.027 FA + 0.486 AcCoA = 0.027 SE 
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Polar Lipids 
 
Phosphatidylcholine (PC)  
 
Biosynthesis (Reductive factors not considered and DHAP is replaced with GAP): 
 
GAP + 2 FA + choline = PC 
 
In CHO Cells:  
 
0.375 GAP + 0.75 FA + 0.375Choline = 0.375 PC 
 
Phosphatidylethanolamine (PE) 
 
Biosynthesis: 
 
GAP + 2 FA + Ethanolamine = PE 
 
In CHO cells: 
 
0.20 GAP + 0.40 FA + 0.2Ethanolamine = 0.2PE 
 
Phosphatidylinositol (PINS) 
 
Biosynthesis: 
 
GAP + 2 FA + Inositol = PINS 
 
In CHO cells: 
 
0.036 GAP + 0.072 FA + 0.036 Inositol = 0.036PINS 
 
Phosphatidylserine (PS) 
 
Biosynthesis: 
 
GAP + 2 FA + Serine = PS 
 
In CHO Cells: 
 
0.073 GAP + 0.145 FA + 0.073 Serine = 0.073 PS 
 
Sphingomyelin (SP) 
 
Biosynthesis: 
 
FA + Serine + 8AcCoA (+ PC) = SP + (GAP+2FA) 
 
In CHO cells: 
 
0.12 FA + 0.12 Serine + 0.95 AcCoA (+0.12 PC) = 0.12 SP + 0.12(GAP+2FA) 
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Total polar lipids 
 
0.375 GAP + 0.75 FA + 0.375 Choline = 0.375 PC 
0.20 GAP + 0.40 FA + 0.2 Ethanolamine = 0.2PE 
0.036 GAP + 0.072 FA + 0.036 Inositol = 0.036PINS 
0.073 GAP + 0.145 FA + 0.073 Serine = 0.073 PS 
0.12 FA + 0.12 Serine + 0.95 AcCoA (+0.12 PC) = 0.12 SP + 0.12(GAP+2FA) 
 
Combined equation polar lipids 
0.68 GAP + 1.49 FA+ 0.193 Serine+ + 0.95 AcCoA + 0.375 choline + 0.2 Ethanolamine+ 
0.036 Inositol = 0.81 lipid 
 
   
Total Lipids:   
 
TG 
0.072 GAP + 0.216 FA = 0.072 Lipid 
 
CHOL 
1.58 AcCoA + 1.23 NADPH + 1.58 ATP + 0.088 O2 = 0.088 Lipid + 1.58 CoA + 1.58 ADP 
+ 0.704 CO2 + 0.088 HCOOH + 1.23 NADP 
 
SE 
0.027 FA + 0.486 AcCoA = 0.027 Lipid 
 
Polar Lipids 
0.68 GAP + 1.49 FA+ 0.193 Serine+ + 0.95 AcCoA + 0.375 choline + 0.2Ethanolamine+ 
0.036 Inositol = 0.81 lipid 
 
Combining the individual lipid equations for CHO cells (not including NADPH, NADP, ATP, 
ADP, CO2, O2, CoA and HCOOH): 
 
0.75 GAP+ 1.73 FA + 3.02 AcCoA + 0.193 Serine + 0.375 choline + 0.2Ethanolamine+ 0.036 
Inositol = Lipids 
 
Total lipid biosynthesis equation for CHO cells: 
 
Final Equation only based on precursors: 
  
0.75 GAP + 17.8 AcCoA + 0.193 SER +  0.375 choline + 0.2Ethanolamine+ 0.036 Inositol = 
Lipids 
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EQUATIONS FOR BIOMASS BIOSYNTHESIS IN CHO CELLS: 
 
Protein: 
 
0.095ALA+0.048ASP+0.039ASN+0.063ARG+0.028CYS+0.052GLN+0.064GLU 
+0.078GLY+0.022HIS+ 0.089LYS+0.02MET+0.021PHE+0.028PRO+0.057SER 
+0.061THR+0.006TRP+0.02TYR+0.059VAL+(4ATP)=PROTEIN+(4ADP) 
 
 
Carbohydrates 
 
G6P+3.5ATP=CARBO+3.5ADP 
 
 
Lipid 
 
0.75 GAP+17.8 AcCoA+0.193 SER+0.375 choline+0.2 Ethanolamine 
+ 0.036 Inositol = LIPIDS 
 
DNA 
 
R5P+(4.7ATP)+1.295ASP+0.5GLY+1.29MTHF+(1.41GLN)=DNA+(4.7ADP)+1.29THF+(1.
41GLU) +0.205FUM 
 
RNA 
 
R5P+(4.67ATP)+1.24ASP+0.5GLY+MTHF+(1.76GLN)=RNA+(4.67ADP)+0.26FUM 
+(1.76GLU)+THF 
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